17840 NADCP Prgm FNL
User Manual: 17840
Open the PDF directly: View PDF 
.
Page Count: 174
| Download | |
| Open PDF In Browser | View PDF |
Setting the Standard Annual Training Conference Washington, DC July 27-30, 2015 Setting the Standard Annual Training Conference Welcome Drug Court Family! Welcome to the world’s largest conference on substance abuse, mental health, and the justice system. The NADCP Annual Conference is your forum to learn and celebrate; to acknowledge and give thanks; to reenergize and educate. As a field and a movement, you work every day saving lives, reuniting families, and restoring communities. NADCP is your national membership organization and your resource. We work all year to provide you with the most current publications, training, and technical assistance, and we will not rest until there is a Drug Court, DWI Court, Tribal Healing to Wellness Court, and Veterans Treatment Court within reach of every person in need. To further that goal, this week we are proud to introduce Volume 2 of the Adult Drug Court Best Practice Standards. You, your court, and NADCP are setting the standard. Thank you for your support and encouragement in the development of this groundbreaking publication. Together we will ensure Drug Courts continue as the foundation of evidence based justice system reform. As we gather this week, prepare to make new friends, reconnect with old friends, educate your Members of Congress, gather resources, learn cutting–edge information, and reenergize. You make a difference every day. From all of us at NADCP, thank you. Enjoy the conference! Sincerely, Carolyn Hardin NADCP Washington, DC 2015 Acknowledgements Many thanks to our federal partners for their ongoing efforts and support of Drug Courts and other Problem-Solving Courts throughout the nation: Additional thanks to our other partners whose efforts contribute to this conference: The views expressed in written conference materials or publications and by speakers and moderators at HHS-sponsored conferences do not necessarily reflect the official policy of the Department of Health and Human Services or the Department of Justice; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. 1 Setting the Standard Annual Training Conference Corporate Members Many thanks to the NADCP Corporate members The NADCP Corporate Members give generously to support our efforts on behalf of Drug Courts, DWI Courts, and Veterans Treatment Courts everywhere. CHAMPION MEMBERS PIONEER MEMBERS GOLD MEMBERS SILVER MEMBERS BRONZE MEMBERS 2 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 Table of Contents NADCP Staff .................................................................................... 4 NADCP Board of Directors .............................................................. 5 Discipline Specific Breakouts .......................................................... 6 Stanley M. Goldstein Hall of Fame ................................................. 8 State Associations and other Meetings ............................................ 9 Drug Court Expo Schedule ............................................................ 10 Capitol Hill Day ............................................................................. 11 Featured Guests ............................................................................. 14 Conference At-A-Glance ................................................................. 17 Training Track Descriptions ........................................................... 28 Monday Schedule ........................................................................... 33 Tuesday Schedule ........................................................................... 55 Wednesday Schedule .................................................................... 117 Thursday Schedule ...................................................................... 135 Drug Court Expo ......................................................................... 141 Exhibitor Listing .......................................................................... 142 Session Tables .............................................................................. 164 Hotel Floor Plans ......................................................................... 170 NADCP welcomes the diversity of methods and opinions shared through the interactive format of this conference. NADCP does not necessarily endorse all of the viewpoints expressed. 3 Setting the Standard Annual Training Conference NADCP Staff Joyce Barrow Carolyn Hardin Rhonda Pence Project Director Interim CEO, NADCP Senior Director National Drug Court Institute Public Relations Manager Percy Brooks Registrar Jennifer Columbel Senior Director, Public Policy Imani Cooper Training Coordinator Elizabeth Dawson Project Coordinator, Justice For Vets Laura Dalemarre Sonya Harper Mike Soussi-Tanani Associate Director of Conferences Frank Stewart Project Director Nicarssia Herndon Training Coordinator Special Assistant to the CEO Scott Swain Project Director Clifford Jacobs Tonya Voelker Program Manager Hon. J. Michael Kavanaugh Associate Director of Legislative Affairs Senior Director National Center for DWI Courts Terrence Walton Research Coordinator Kristen Deutsch Greg Loeffler Meisha West Director of Development Chris Deutsch Director of Communications Melissa Fitzgerald Senior Director, Justice For Vets Carson Fox Chief Operating Officer Bonnie Greenslade Training Coordinator Ingrid Gutierrez Training Coordinator Chief of Standards Office Manager Training Coordinator Jennifer Lubold RESOURCE CONSULTANTS Director of Conferences Janet McCuller Douglas Marlowe, Ph.D., J.D. Chief Financial Officer Chief of Science, Law and Policy Caitlin Morrison Director of Membership Jontelle Niblock Hon. William G. Meyer (ret.) Senior Judicial Fellow Clyde J. (Butch) Tate II Accounting Technician Major General, US Army (ret.) Senior Fellow for Veteran Affairs David Pelletier Project Manager, Justice For Vets The NADCP, NCDC, NDCI, and Justice for Vets staff provide technical assistance and training, host this annual training conference, provide advocacy, sponsor research, disseminate information and provide a number of other services to the field throughout the year. We are indebted to our staff for all their hard work. 4 NADCP PROMISE STATEMENT: NADCP MISSION STATEMENT: To champion proven strategies within the judicial system that empower drug-using offenders to change their lives. We will not rest until there are Drug Courts and other Problem-Solving Courts within reach of every person in need. NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 NADCP Board of Directors Hon. Jeff Bagley Cumming, GA Mack Jenkins San Diego, CA Hon. Ruben Reyes Lubbock, TX Hon. Michael Barrasse Scranton, PA Hon. R. Eagleye Johnny Nixon, NV Lynn Richardson Dallas, TX Hon. Jonathan Blodgett Salem, MA Judi Marie Kosterman, PhD Reno, NV Charles R. Robinson Austin, TX Hon. Richard Gebelein Wilmington, DE Chief Russell B. Laine Algonquin, IL Hon. Robert Russell (Emeritus) Buffalo, NY Hon. Pamela Gray Washington, DC Hon. Leonia J. Lloyd Detroit, MI Hon. J. Wesley Saint Clair Seattle, WA Hon. Bob Helfrich Hattiesburg, MS Hon. Stephen Manley San Jose, CA Hon. John R. Schwartz (Emeritus) Rochester, NY Domingo Herraiz Washington, DC Connie Payne Frankfort, KY Hon. Chuck Simmons Greenville, SC Earl Hightower Studio City, CA Hon. Louis Presenza (Emeritus) Philadelphia, PA Hon. Keith Starrett (Chair) Hattiesburg, MS Mary Kay Hudson Indianapolis, IN Hon. Robert Rancourt (Emeritus) Center City, MN The NADCP Board of Directors works tirelessly on behalf of the Drug Court field. These individuals give generously of their time, energy, and expertise throughout the year to ensure we move towards our goal of putting a Drug Court within reach of every American in need. Please take the opportunity to thank your Board members for their dedication! 5 Setting the Standard Annual Training Conference Discipline Specific Breakouts Want to know what sessions you should attend? Have questions about the conference agenda? Need to discuss burning issues impacting your program? This year’s discipline-specific sessions are for you!! This year’s conference includes opportunities for disciplines to meet and resolve burning issues and critical questions. Starting on Monday morning at 7:30 am, enjoy continental breakfast in the Drug Court Expo located at Prince George’s Exhibition Hall E and report to the breakout designated for your discipline. An expert practitioner who shares your role on the team will facilitate the breakout. The facilitator will review the conference program, identify sessions specifically designed for your role on the team, and lead discussion to address your burning issues. Then, on Thursday, July 30, from 7:15 - 8:15 am, the discipline-specific groups will reconvene to further triage burning issues, and your facilitator will continue to suggest additional resources, so you can make the most from your conference experience! Plus, by attending the discipline breakouts, you will have the opportunity to meet other conference attendees who share your role in the Drug Court or other Problem-Solving Court! Monday, July 27 6 7:30 a.m. – 8:45 a.m. Speaker(s) Room DSB-1 Treatment Providers–Adults Terrence Walton National Harbor 10 DSB-2 Administrators/Coordinators Joseph Madonia / Michael Princevalli Maryland A DSB-3 Judges/Adult and Federal Hon. Peggy Davis Maryland D DSB-4 Treatment Providers - Juvenile Steve Hanson Maryland B DSB-5 Child Protection Services Russ Bermejo National Harbor 6-7 DSB-6 Judges/Juvenile Courts Hon. Alan Blankenship Chesapeake 4-6 DSB-7 Law Enforcement Vanessa Price Maryland 1-3 DSB-8 Judges – Family Drug Courts Hon. J. Stanley Carmical National Harbor 11 DSB-9 Prosecutors Stephen Ward National Harbor 3 DSB-10 Defense Attorneys Jim Egar Chesapeake ABC DSB-11 Community Supervision/Probation Services – Adult Courts Karen Barnes National Harbor 12 DSB-12 Mental Health Court Emily Harris / Eric Olson Maryland 4-6 DSB-13 Researchers and Evaluators Anne Dannerbeck Janku Chesapeake GHI DSB-14 Community Supervision/Probation Services – Juvenile Courts Marty Yust Maryland C DSB-15 Non-Judicial Federal Reentry Court Charles R. Robinson National Harbor 13 DSB-16 DWI Court Hon. Michael Kavanaugh National Harbor 2 DSB-17 Tribal Mark Panasiewicz National Harbor 4 DSB-18 Tribal Judges Hon. Joseph Flies-Away National Harbor 5 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 Thursday, July 30 7:15 a.m. – 8:15 a.m. Speaker(s) Room DSB-1 Treatment Providers–Adults Terrence Walton National Harbor 10 DSB-2 Administrators/Coordinators Joseph Madonia / Michael Princevalli Maryland A DSB-3 Judges/Adult and Federal Hon. Peggy Davis Maryland D DSB-4 Treatment Providers - Juvenile Steve Hanson Maryland B DSB-5 Child Protection Services Russ Bermejo National Harbor 6-7 DSB-6 Judges/Juvenile Courts Hon. Alan Blankenship Chesapeake 4-6 DSB-7 Law Enforcement Vanessa Price Maryland 1-3 DSB-8 Judges – Family Drug Courts Hon. J. Stanley Carmical National Harbor 11 DSB-9 Prosecutors Stephen Ward National Harbor 3 DSB-10 Defense Attorneys Jim Egar Chesapeake AB DSB-11 Community Supervision/Probation Services - Adult Courts Karen Barnes National Harbor 12 DSB-12 Mental Health Court Emily Harris Maryland 4-6 DSB-13 Researchers and Evaluators Anne Dannerbeck Janku Chesapeake HI DSB-14 Community Supervision/Probation Services – Juvenile Courts Marty Yust Maryland C DSB-15 Non-Judicial Federal Reentry Court Charles R. Robinson National Harbor 13 DSB-16 DWI Court Hon. Michael Kavanaugh National Harbor 2 DSB-17 Tribal Mark Panasiewicz National Harbor 4 DSB-18 Tribal Judges Hon. Joseph Flies-Away National Harbor 5 NADCP and Justice For Vets Mobile App N I Introducing the new NADCP and Justice For Vets mobile app, available to help you navigate through the NADCP 21st Annual Training Conference, Vet Court Con, and n Capitol Hill Day. Use this excellent app to keep track of schedules, locate meetings, connect with your fellow attendees, provide session feedback, and much more. The app contains numerous features to help you navigate the NADCP 21st Annual Training Conference and Vet Court Con with ease including: • Full schedule of events with customizable to do list. • Session descriptions, exhibitor information, and speaker bios. • Attendee networking and social media integration. • Real time updates on conference events. Search for NADCP or Vet Court Con on the App Store or Google Play or scan the QR Code to download the app and enhance your conference experience. 7 Setting the Standard Annual Training Conference Stanley M. Goldstein Drug Court Hall of Fame The following list of Drug Court practitioners have distinguished themselves over the years through their innovation and leadership and have been formally inducted into the Stanley M. Goldstein Drug Court Hall of Fame. This year’s winner will be inducted at Thursday’s closing ceremony. 2002 Judge Judy Lambert; Frankfort, KY Henry Pirowski; Buffalo, NY Marilyn Roberts; Washington, DC Judge Jeffrey Tauber; Berkeley, CA 2003 Judge Melanie G. May; West Palm Beach, FL Judge Stephen Manley; Santa Clara, CA Judge Robert P. Ziemian; South Boston, MA 2004 Judge Mary Noble; Lexington, KY Judge Robert T. Russell; Buffalo, NY 2005 Caroline Cooper; Washington, DC Judge Lou Presenza; Philadelphia, PA 2006 Judge Karen Freeman-Wilson (ret.); Gary, IN Tim Smith; San Diego, CA 2007 Judge William G. Schma; Kalamazoo, MI Judge John Schwartz; Rochester, NY 2008 Judge Darrell W. Stevens (posthumous); Chico, CA Ann Wilson; Jefferson City, MO 2009 Chief Justice Daniel T. Eismann; Boise, ID Judge Charles ‘Chuck’ Simmons; Greenville, SC 2010 Rose Ewing; Tulsa, OK 2011 Judge John E. Girardeau; Hall County, GA Chief Justice William Ray Price; Jefferson City, MO Earl Hightower; Studio City, CA 2012 Judge Joanne Smith; Ramsey County, MN 2013 Helen Harberts; Chico, CA Judge Robert Rancourt; Center County, MN 2014 Judge Jeffrey Ford; Champaign County, IL Previous recipients of distinguished leadership awards from 1995–2001 were grandfathered into the Drug Court Hall of Fame in 2002: Joe Brann; Washington, DC Bennett H. Brummer; Miami, FL Judge John Creuzot; Dallas, TX Lolita Curtis; Alexandria, VA Michael Smith, M.D.; Bronx, NY Katherine Fernandez-Rundle; Miami, FL Judge Robert Fogan; Fort Lauderdale, FL Luceille Fleming; Columbus, OH Edward T. Foote; Miami, FL Ron George; Sacramento, CA Judge Michael Getty; Chicago, IL Judge Stanley Goldstein; Miami, FL Judge Harl Haas; Portland, OR Chief Justice Major B. Harding; Tallahassee, FL Judge Peggy Fulton Hora (ret.); Castro Valley, CA Judge William Hunter; Franklin, LA Michael Judge; Los Angeles, CA Fran Jursco; San Francisco, CA Judge Herbert M. Klein; Miami, FL 8 NADCP 21st ANNUAL TRAINING CONFERENCE Judge Jack Lehman; Las Vegas, NV Barry Mahoney, Ph.D.; Denver, CO General Barry McCaffrey; Washington, DC Claire McCaskill; Kansas City, MO Israel Milton; Miami, FL Judge James Milliken; San Diego, CA Judge Patrick Morris; San Bernardino, CA Timothy Murray; Washington, DC Bill Ritter; Denver, CO Attorney General Janet Reno; Washington, DC Assistant Attorney General Laurie Robinson; Washington, DC Deputy Associate Attorney General Reggie Robinson; Washington, DC Frank Tapia; Oakland, CA Bill Vickery; San Francisco, CA Janna Walker; Broken Arrow, OK Andrew Wells; Vienna, Austria Judge Gerald Wetherington; Miami, FL NADCP Washington, DC 2015 12 Step Meetings – Fort Washington Boardroom Alcoholics Anonymous, Narcotics Anonymous, and Cocaine Anonymous Meetings 6:30 a.m. 11:30 a.m. 12:00 p.m. 12:15 p.m. 6:30 p.m. 7:30 p.m. 8:30 p.m. Monday, July 27 AA (Closed) MA CA NA AA (Open) Tuesday, July 28 AA (Closed) NA MA NA Wednesday, July 29 AA (Closed) NA CA NA (Open) Thursday, July 30 AA (Closed) CA MA State Associations and Committee Meetings State association meetings have been scheduled throughout this conference. They will be listed in the day’s ancillary activities. Please check to see if your state’s association has scheduled a gathering. Do you want to schedule a state association meeting? A limited number of “Pop-up” rooms and sessions may be available! Just approach any NADCP/NDCI staff member and ask them to get you in touch with Jennifer Lubold who will assign you to a room. Council of State Drug Court Associations Council of State Drug Court Associations Meeting (State Delegates Only) Monday, July 27 12:00 p.m. – 2:00 p.m. Chesapeake D Sunday, July 26 State Drug Court Coordinators 2:00 p.m. – 6:00 p.m. Annapolis 3 Monday July 27 OJJDP Family Drug Court Program Grantee Gathering 12:00 p.m. – 2:00 p.m. Baltimore 3 New England Association of Drug Court Professionals (NEADCP)Annual Meeting 5:00 p.m. – 6:00 p.m. Woodrow Wilson Ballroom D Michigan Association of Drug Court Professionals Annual Meeting 5:00 p.m. – 7:00 p.m. Woodrow Wilson Ballroom B Wednesday, July 29 OJJDP Statewide System Reform Awardee Convening 11:30 a.m. – 2:00 p.m. Chesapeake JKL 9 Setting the Standard Annual Training Conference Drug Court Expo Schedule – Prince George’s Exhibition Hall DE Sunday, July 26 2:00 p.m. – 5:00 p.m. Drug Court Expo Open Monday, July 27 7:00 a.m. – 8:00 a.m. Expo Open w/ continental breakfast for all attendees 10:00 a.m. – 2:00 p.m. Expo Open with lunch concessions for purchase at 11:45 a.m. 5:30 p.m. – 7:30 p.m. Opening Reception 6:30 p.m. – 8:00 p.m. Dessert Reception Tuesday, July 28 7:00 a.m. – 7:45 a.m. Expo Open w/ continental breakfast for all attendees Wednesday, July 29 7:00 a.m. – 7:45 a.m. Expo Open w/ continental breakfast for all attendees 7:00 a.m. – 1:00 p.m. Drug Court Expo Open 10:00 a.m. – 2:00 p.m. Drug Court Expo Open 11:30 a.m. – 12:30 p.m. Expo Open w/ lunch concessions for purchase Drug Court Expo Opening Reception Monday, July 27 from 5:30 p.m. – 7:30 0 p.m. Prince George’s Exhibition Hall DE It’s So Very Presidential: George and Abe at Drug Court Expo Your chance to meet Presidents George Washington and d Abe Lincoln is finally here. Join us at the Drug Court Expo and meet two of the famous “Racing Presidents” from Washington’s Nationals baseball team. This reception gives ives you a chance not only to mingle with the presidents but network work with your peers. And you can see the cutting edge technologyy and services available to Drug Courts around the world. There ere will be plenty of food and beverages. And while you’re there, e, we ask you to visit our great exhibitors and thank them for their support. Hope to see you there. Drug Court Expo Dessert Reception! ceptio on! Tuesday, July 28 from 6:30 p.m. – 8:00 p.m. Prince George’s Exhibition Hall DE Join us in the Drug Court Expo for a night of delicious desserts. This reception gives you a chance to network with the exhibitors and your peers. You can see cutting edge technology and services available to Drug Courts around the world. And while you’re there, we ask you thank our great exhibitors for their support. 10 NADCP 21st ANNUAL TRAINING CONFERENCE Taking Capitol Hill By Storm Special Sessions on Tuesday, July 28th Star Studded Celebration on Wednesday, July 29th Join thousands of Drug Court Professionals to take the message that Drug Courts reduce crime and save money to Capitol Hill. Your voice counts and must be heard! Tuesday, July 28th Advocacy Track Don’t miss the Advocacy Track! (Track 21) Everything you need to take Capitol Hill by storm and how to bring it back home will be covered. Highlights include: ■ Bring Drug Courts to Your State Legislators Chesapeake JKL from 12:30 p.m. – 1:45 p.m. ■ The A, B, C’s of Meeting with Your Members of Congress Chesapeake JKL from 2:00 p.m. – 3:15 p.m. ■ Raise Your Voice – How to Be an Effective Advocate for Your Drug Court Chesapeake JKL from 3:30 p.m. – 4:45 p.m. ■ Taking Your State Association to the Next Level Chesapeake JKL from 5:00 p.m. – 6:15 p.m. Don’t miss out on this great opportunity to educate Congress and ensure Drug Court is within reach of every American in need. Capitol Hill Day Kick-Off Celebration Wednesday, July 29th Potomac Ballroom Join Drug Court Professionals from your state at the Capitol Hill Day Kick-Off! With the always hilarious Alonzo Bodden kicking things off, followed by Members of Congress and other special guests, it is sure to have everyone ready to storm the Hill to let Congress know that Drug Courts $ave! Capitol Hill Day Headquarters Located near Potomac Ballroom, the Capitol Hill Day Headquarters is your resource for Congressional meeting information. • Detailed Maps • Talking Points for Congressional Meetings • NADCP’s Congressional Brief • and MORE! Bus Schedule NADCP will provide shuttle bus service from the Gaylord Woodrow Wilson Loop to Union Station in Washington, DC. Visit the Capitol Hill Day Headquarters for detailed maps. 9:15 a.m. Buses Depart to Union Station 10:00 a.m. – 7:00 p.m. Continuous Shuttle Bus service between Gaylord and Union Station every hour on the hour. Last bus departs Union Station at 7:00 p.m. Ensure Your Member of Congress Supports Drug Courts Capitol Hill Day, July 29th Drug Court participants in your state need you to meet with your Members of Congress! You are a constituent and your Members of Congress or their staff will be glad to meet with you. Even if you do not have a meeting scheduled, stop by their offices to say hello and leave a NADCP Congressional Brief behind. Not Sure What to Say in the Meeting? We have made it easy for you. Follow this easy 5-step plan and you will hit a home run. 1. Brief Introductions 2. Tell Them about your Drug Court Success 3. Provide National Statistics • Drug Courts Save Money as much as $27 for every $1 invested • Drug Courts Cut Crime 75% of Drug Court graduates remain arrest free • Today, 11,000 veterans who would otherwise be incarcerated are receiving life-saving treatment in Veterans Treatment Court 4. Urge your Member of Congress to Reach out to the Appropriation Committee and Support: • $46 million for Drug Courts, Department of Justice • $15.5 million for Veterans Treatment Court, Department of Justice • $60 million for Drug Treatment Courts, Department of Health and Human Services 5. Thank Them for Their Support Setting the Standard Annual Training Conference Featured Guests Michael Botticelli Chris Matthews Director White House Office of National Drug Control Policy Host Hardball with Chris Matthews, MSNBC Travis Howard Denise O’Donnell Award Winning Country Singer-Songwriter Director Bureau of Justice Assistance Cady Huffman Tommy Rieman Tony Award Winning Actress Executive Director The Independence Fund Pamela Hyde Dr. Mark Rosekind (Invited) Administrator Substance Abuse and Mental Health Services Administration Administrator National Highway Traffic Safety Administration Loretta Lynch (Invited) Attorney General United States Department of Justice 14 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 MARYLAND D Wednesday, July 29 7:00 p.m. – 8:30 p.m. The Anonymous People Documentary Presentation and Discussion The NADCP 21st Annual Training Conference and Vet Court Con are pleased to host an exclusive screening of the powerful film that is revolutionizing how addiction recovery is viewed by the general public, practitioners, and by recovering individuals themselves. The Anonymous People is a feature documentary film about the 23.5 million Americans living in long-term recovery from addiction to alcohol and other drugs. Deeply entrenched social stigma and discrimination have kept recovery voices silent and faces hidden for decades. The moving story of The Anonymous People is told through the faces and voices of the leaders, volunteers, corporate executives, and celebrities who are laying it all on the line to save the lives of others just like them. This passionate new public recovery movement is fueling a changing conversation that aims to transform public opinion, and finally shift problematic policy toward lasting recovery solutions. The screening will be followed by audience dialogue with a panel of recovery advocates, including some of those featured in the documentary. And the popcorn is on us! Moderator Terrence D. Walton Chief of Standards NADCP Panelists Tom Coderre Senior Advisor to the Administrator Substance Abuse and Mental Health Services Administration Darrell Harrington Counselor/Case Manager Superior Court Drug Intervention Program 4TH DIMENSION PRODUCTIONS PRESENTS “THE ANONYMOUS PEOPLE” A GREG WILLIAMS FILM CHRIS HERREN PATRICK KENNEDY TARA CONNER WILLIAM COPE MOYERS WILLIAM WHITE LAURIE DHUE EXECUTIVE PRODUCER PAUL MCCULLEY OF THE MORGAN LE FAY DREAMS FOUNDATION CO-EXECUTIVE PRODUCER JOHN SILVERMAN EDITOR JEFF REILLY DIRECTORY OF PHOTOGRAPHY CRAIG MIKHITARIAN ORIGINAL SCORE BRENDAN BERRY SOUND BUD MIKHITARIAN FEATURING KRISTEN JOHNSTON Pat Taylor Community Outreach Coordinator UNITE to Face Addiction THEANONYMOUSPEOPLE.COM 15 NADCP is the premier national membership, training, and advocacy organization for the Drug Court model, representing over 27,000 multi-disciplinary justice professionals and community leaders. NADCP hosts the largest annual training conference on drugs and crime in the world and provides 130 training and technical assistance events each year through its professional service branches, the National Drug Court Institute, the N ational Center for DWI Courts and Justice for Vets: The N ational Veterans Treatment Court Clearinghouse. NADCP publishes numerous scholastic and practitioner publications critical to the growth and fidelity of the Drug Court model and works tirelessly in the media, on Capitol Hill, and in state legislatures to improve the response of the American justice system to substance abusing and mentally ill offenders through policy, legislation, and appropriations. Visit AllRise.org. Professional Service Divisions The mission of the GCDTC is to reduce substance abuse, crime, and recidivism throughout the world by promoting and advocating the establishment of Drug Treatment Courts. The GCDTC aims to achieve these goals through; consulting with governments and N GOs worldwide about the principles of Drug Treatment Courts and other therapeutic responses to the drug problem; consulting with jurisdictions worldwide that want to establish Drug Treatment Courts, including startup information and training; informing Drug Treatment Courts across the world on developments in international drug policy; consistently surveying and reporting international Drug Treatment Court activity; maintaining an international database and disseminating the latest developments and research to assist international Drug Treatment Courts with their operations; and facilitating discussion among international Drug Treatment Courts about using the latest research and practices. Practitioners around the world use GCDTC website to maintain their country’s Drug Treatment Court history, research, statistics and progress by submitting this information to the world’s only Drug Treatment Court wiki pages. Visit globaldrugcourts.org. Justice for Vets believes that no veteran or military service member should suffer from gaps in service, or the judicial system when they return to their communities. As the stewards of the Veterans Treatment Court movement, we keep veterans out of jail and connect them to the benefits and treatment they have earned; saving their lives, families, and futures, and saving tax dollars for the American public. Justice For Vets will ensure that the criminal justice system effectively identifies, assesses, and responds to all justice-involved veterans appropriately, and will lead the national effort to establish Veterans Treatment Courts within reach of every veteran in need. As the national leader, Justice For Vets will aggressively advocate for Veterans Treatment Courts and mobilize the public to take action to join us in ensuring that no veteran is left behind. Visit JusticeForVets.org. NCDC is the only dedicated advocacy, policy, training and technical support organization for DWI Courts in the nation. Dedicated to delivering research-driven practices to reduce impaired driving recidivism nationwide, the NCDC is designed to expand DWI Courts nationwide, improve DWI Court operations through training and technical assistance, and maintain operational standards for DWI Courts. Visit dwicourts.org. N DCI has emerged as the preeminent source of research-driven training and technical assistance for Drug Court and Problem Solving Court professionals. Developed in conjunction with leading researchers and experienced Drug Court practitioners. NDCI seeks to improve Drug Court operations through a tiered training series. These trainings include the Drug Court Planning Initiative (DCPI) training designed for local jurisdictional teams planning to implement an Adult, Family, Veterans and/or DWI Drug Court; Comprehensive Drug Court Practitioner Training for judges, prosecutors, law enforcement, defense attorneys, probation & parole, treatment providers and other key Drug Court professionals; Advanced Subject-Matter Training which target topical aspects of Drug Court operation; onsite and Office-Based Technical Assistance (TA). NDCI supports investigative projects aimed at the development of more effective Drug Court and Problem Solving Court policies and procedures. NDCI also disseminates important Drug Court specific publications aimed at improving court operations. Visit NDCI.org. At-A-Glance Conference Conference At-A-Glance Setting the Standard Annual Training Conference Continuing Education Online Only Deadline to submit evaluations: August 21, 2015 Visit www.AllRise.org or the continuing education desk at the Gaylord National Resort & Convention Center onsite for further instructions. This Program is approved by the National Association of Social Workers for 19.5 continuing education contact hours. To receive continuing education credits you must register with YOUR email address. You will be able to complete your evaluations and get your certificate up until August 21, 2015. Continuing legal education (CLE) and continuing judicial education (CJE) credits will be offered for attorneys and judges attending the conference. Continuing education units (CEU) will be offered for mental health, social work, and drug addiction treatment professionals. A link will be sent to the email address you provided when you registered. This will give you access to the session evaluations, post conference evaluation, and your certificate (#, State, type of certificate) in order to get credit. To receive CLE, CJE, or CEU credits, you must register with YOUR email address. If you don’t have an email address or did not provide one when you registered – see the onsite continuing education desk or email Ann Wilson at awilson@allrise.org for assistance. Attendees cannot use another attendee’s email link to access the survey as the certificate will be in another person’s name. You must record each session you attended online in order to receive credit. Pre-approval of hours will still continue as in years past, and reports will still be made to states requiring reports from the provider. All reports will be based on the online evaluation and attendance that you complete. In order to receive credits, all evaluations must be completed in the online system by August 21, 2015. Make sure to visit the continuing education desk during the conference to obtain State required certificates. NADCP is a NAADAC-approved education provider. Onsite: • You will receive emails before, during and after the conference with a link to the session and overall conference evaluations. Emails after the conference will also include a link for the certificate of attendance. • Use your e-mail address you registered with to log-in to the automated evaluation system. • If you don’t have an e-mail address, you registered on-site, or you were a substitute for somebody else – see the continuing education desk for help. • Make sure to complete your session evaluations on-line. • Back home – enter the overall conference evaluation and print your certificate. • Continuing education hours will be reported to the respective states, after completion of the session evaluations, post conference survey, and certificate is printed. Attorneys from the following States need to come to the continuing education desk: • Arkansas • California • Kansas • Pennsylvania Judges from the State of Washington will need to pick up a certificate from the the continuing education desk in order to receive credit from the AOC. Substance Abuse Counselors from the State of Maryland will need to sign-in each day at the continuing education desk in order to get hours approved. CEU hours are only pre-approved for substance abuse counselors, some mental health counselors, and the NASW. CEU hours are NOT pre-approved for probation officers, law enforcement officers, professional licensed agencies. These hours will NOT count toward college credit. NADCP Washington, DC 2015 Conference At-A-Glance SUNDAY JULY 26 – REGISTRATION AND DRUG COURT EXPO TIME EVENT ROOM 2:00 p.m. – 6:00 p.m. State Drug Court Coordinators Meeting (State Coordinators Only) 2:00 p.m. – 5:00 p.m. Drug Court Expo Opens Prince George’s Exhibition Hall DE 2:00 p.m. – 9:00 p.m. Registration Prince George’s Exhibition Hall DE Annapolis 3 MONDAY JULY 27 – DISCIPLINE SPECIFIC BREAKOUTS, SKILLS BUILDING WORKSHOPS AND DRUG COURT EXPO OPENING RECEPTION TIME EVENT ROOM 7:00 a.m. – 7:20 a.m. Come to Your Senses (Facilitated Meditation) 7:00 a.m. – 8:00 a.m. Drug Court Expo Opens with a Continental Breakfast Prince George’s Exhibition Hall DE 7:00 a.m. – 5:30 p.m. Registration Prince George’s Exhibition Hall DE 7:30 a.m. – 8:45 a.m. Discipline Specific Breakouts 9:00 a.m. – 12:00 p.m. Skills Building Workshops SB-1 Changing Behavior With 24/7 Alcohol Monitoring: NHTSA’s Newest Study on SCRAM Use, Recidivism Rates, and Characteristics Chesapeake ABC SB-2 Data, Evaluation, and Fidelity to the Model: Best Practices Chesapeake GHI SB-3 Drug Courts in Rural Areas— Our Strengths and Special Challenges Chesapeake 4-6 SB-4 DWI Court Forum National Harbor 2 SB-5 Family Drug Court: Best Practices National Harbor 10 SB-6 Target Population: Best Practices Maryland A SB-8 Supervision Maryland 1-3 SB-9 Heroin Resurgence and Prescription Opiates: Critical Issues in Diagnosis and Treatment Maryland B SB-10 Everything You Always Wanted to Know about PTSD, Substance Abuse, and Co-Morbid Disorders: An Expert Answers Your Questions Maryland C SB-11 Legal Issues in Adult Drug Courts: Best Practices Maryland D SB-12 A Team Member’s Guide to Effective Drug Court Treatment: The Results are In! National Harbor 5 SB-13 The Critical Role of the Team: Best Practices National Harbor 3 SB-14 Judicial Role and Ethics: Best Practices National Harbor 11 SB-15 Grant Information From a Panel of Federal Experts National Harbor 6-7 SB-16 Seeking Safety National Harbor 4 12:00 p.m. – 2:00 p.m. Drug Court Expo Opens (Concessions for purchase available in Drug Court Expo) Chesapeake JKL See Page 6 Prince George’s Exhibition Hall DE 19 Setting the Standard Annual Training Conference MONDAY JULY 27 (continued) TIME EVENT ROOM 12:00 p.m. – 2:00 p.m. Council of State Drug Court Associations Meeting (State Delegates only) 1:30 p.m. – 2:00 p.m. Membership Meeting 2:00 p.m. – 5:00 p.m. Skills Building Workshops SB-17 Building the Right Team to Support Implementation of VIVITROL® (naltrexone for extended-release injectable suspension) Chesapeake ABC SB-18 Drug Testing: Best Practices Maryland A SB-19 Effective Strategies in Juvenile Drug Court Chesapeake GHI SB-20 DWI Court Forum National Harbor 2 SB-21 Incentives & Sanctions: Best Practices (Joint NADCP and Vet Court Con Session) Potomac Ballroom SB-22 Other Problem-Solving Courts: Engaging the Community and Helping Victims Chesapeake 4-6 SB-23 Case Planning and Recovery Support for Mental Health and Family Drug Courts National Harbor 11 SB-24 Tribal Nations Forum National Harbor 5 SB-25 Reentry Court on Steroids National Harbor 3 SB-26 Dos and Don’ts of Becoming a DC Coordinator: Avoiding Pitfalls (Drug Court Coordinator Forum) Maryland C SB-27 Health Care Reform: Understanding and Navigating the Affordable Care Act Maryland B SB-28 Historically Disadvantaged Groups National Harbor 6-7 SB-29 HEAT National Harbor 10 SB-30 The Dangers of Spice and the Science Behind It National Harbor 4 SB-31 Using Technology in Problem-Solving Courts: Strategies for Tuning In and Turning On Maryland 4-6 SB-32 Ancillary Services: Best Practices Maryland D SB-33 Gender Matters: Creating Trauma Services for Women and Men Maryland 1-3 5:30 p.m. – 7:30 p.m. Drug Court Expo Opening Reception Chesapeake D National Harbor 12 Prince George’s Exhibition Hall DE For Attorneys and Judges!! The NADCP 21st Annual Training Conference includes an unprecedented number of legal sessions. Sessions include topics on Ethics, Immigration, Due Process, Representing the Mentally Ill, Prosecutor’s Role in Drug Court, Defense Attorney’s Role in Drug Court, Federal Confidentiality Laws, and much more! With two tracks devoted to legal sessions, along with several Skills Building Sessions and Concurrent General Sessions, this year’s conference 20 NADCP 21st ANNUAL TRAINING CONFERENCE is an even greater tool for the lawyer or judge working in a Problem-Solving Court. Please check with the Continuing Education booth in the Gaylord National Resort & Convention Center to get more information on possible CLE credit for your attendance. Thanks for all your hard work in the Drug Court field! NADCP Washington, DC 2015 TUESDAY JULY 28 – OPENING CEREMONY AND CONCURRENT WORKSHOP SESSIONS A, B, C, D AND E TIME EVENT ROOM 7:00 a.m. – 7:20 a.m. Come to Your Senses (Facilitated Meditation) 7:00 a.m. – 8:00 a.m. Drug Court Expo Opens with a Continental Breakfast Prince George’s Exhibition Hall DE 7:00 a.m. –5:30 p.m. Registration (Closed During Opening Ceremony) Prince George’s Exhibition Hall DE 8:00 a.m. – 10:00 a.m. Opening Ceremony 10:15 a.m. – 11:30 a.m. Concurrent Workshops Session A A-1 A Team in Action Maryland D A-2 A Look Inside The Nations Family Drug Courts National Harbor 11 A-3 Seven Habits of Highly Effective Practices When Addressing Adolescent Drug Abuse in Juvenile Drug Courts National Harbor 13 A-4 Mental Health Courts A-Z National Harbor 12 A-5 From Compliance to Alliance: Using Recovery and Procedural Justice Principles to Improve Outcomes in Co-Occurring Disorder Cases Chesapeake GHI A-6 Race, Culture, Bias, Treatment, and the Courts: Cultural Competency 101 Chesapeake ABC A-7 Evaluation Challenges and Solutions in Family Drug Courts Maryland 4-6 A-8 Cocaine Maryland A A-9 Critical Role of Risk/Need in Building Incentives and Sanctions Maryland C A-10 Search and Seizure and the Role of a Probation Officer National Harbor 10 A-11 Trauma Informed Judicial Decision Making Chesapeake 7-9 A-12 HEAT Update National Harbor 3 A-13 Gender Responsive Strategies and Trauma Informed Care in Community Treatment National Harbor 4 A-14 What Does My Drug Test Result Really Tell Me? National Harbor 6-7 A-15 Technology in YOUR Court: Learn How Web Based Case Management Can Support Performance Benchmarks and Best Practices Chesapeake 4-6 A-16 The 10 Guiding Principles of DWI Courts Chesapeake 10-12 A-17 Keeping Kids Safely at Home: A Discussion on Legal Issues in an In-Home FDC Model Maryland 1-3 A-18 The New ASAM Criteria: Implications for Drug Courts and Treatment Providers National Harbor 2 A-19 Working Effectively with Native Participants National Harbor 5 A-20 Five Ways to Wreck Your Career: Ethics for Treatment Providers Maryland B A-21 Building Bridges between Drug Treatment Courts and the Addiction Recovery Community Chesapeake JKL A-22 Matrix Model for Criminal Justice Settings Chesapeake DE 11:30 a.m. – 12:30 p.m. Concessions for Purchase in Drug Court Expo Chesapeake JKL Potomac Ballroom Prince George’s Exhibition Hall DE 21 Setting the Standard Annual Training Conference TUESDAY JULY 28 (continued) TIME EVENT ROOM 12:30 p.m. – 1:45 p.m. Concurrent Workshops Session B B-1 Ten Key Components and the Research Maryland D B-2 Collaborative Approaches to Drug Endangered Children National Harbor 11 B-3 Assessing Fidelity to a Logic Model: The National Cross-Site Evaluation of JDC/RF Experience National Harbor 13 B-4 Solving the “Rubik’s Cube” of Mental Health Courts: Effective Strategies for Establishing Statewide Standards National Harbor 12 B-5 Co-Occurring Disorders in Mental Health Courts Chesapeake GHI B-6 What Your Mama Didn’t Teach You (For Men Only) Chesapeake ABC B-7 The Pathway to Minnesota’s Drug Court Expansion: Using Statewide Research as Leverage for Expansion Maryland 4-6 B-8 Alcohol Maryland A B-9 Fundamentals of Incentives and Sanctions in Adult Drug Court Maryland C B-10 The Smoking Gun: The Role of Law Enforcement and Ethical Issues in a Drug Court Setting National Harbor 10 B-11 Cultural Proficiency with Latinos in Drug Court Practice Chesapeake 7-9 B-12 From the Needle to the Pen: Telling it Like it is! Addicted to Drugs or Addicted to the Lifestyle National Harbor 3 B-13 Implementing Trauma-Informed Care Principles into Your Program National Harbor 4 B-14 Target 25: Pennsylvania’s Nationally Recognized DUI Reduction Initiative National Harbor 6-7 B-15 Alcohol Monitoring and Testing Technologies: A Primer for New Programs, a Refresher on Policies Chesapeake 4-6 B-16 The Computerized Assessment and Referral System (CARS) Identifying Mental Health Disorders Among DUI Offenders Chesapeake 10-12 B-17 Indian Country Legal Implications Maryland 1-3 B-18 Unique Aspects of Behavioral Healthcare in Drug Treatment Courts National Harbor 2 B-19 Tribal Youth Wellness: Responses to Underage Drinking Among Native Youth National Harbor 5 B-20 The Zealous Advocate Maryland B B-21 Bring Drug Court to Your State Legislators Chesapeake JKL B-22 Is “Fair Treatment” an Evidence-Based Practice? How to Measure the Presence and Effects of Procedural Justice Chesapeake DE Drug Courts perform their duties without manifestation, by word or conduct, of bias or prejudice, including, but not limited to, bias or prejudice based upon race, gender, national origin, disability, age, sexual orientation, language or socioeconomic status. 22 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 2:00 p.m. – 3:15 p.m. Concurrent Workshops Session C C-1 Target Population Maryland D C-2 Comprehensive Services: Lessons from the Prevention and Family Recovery Project National Harbor 11 C-3 Using a Gated Assessment Process to Connect the Right Kid to the Right Intervention National Harbor 13 C-4 A Dozen Years, Two Dozen Courts: Lessons from New York’s Mental Health Courts National Harbor 12 C-5 Enhancing the Continuum of Care and Expanding the Service Population via Assertive Community Treatment in Rural Drug Courts Chesapeake GHI C-6 Real Men Wear Pink (for women only) Chesapeake ABC C-7 Drug Court Peer Review: Implementation Successes and Lessons Learned Maryland 4-6 C-8 Designer Drugs 101 Maryland A C-9 Incentives and Sanctions in Juvenile Drug Court Maryland C C-10 Role of Probation in the Drug Court: Best Practices National Harbor 10 C-11 Immigration Consequences of Criminal Conduct: How Drug Courts Can Help Chesapeake 7-9 C-12 What’s in it for me? Attracting African Americans to Drug Court National Harbor 3 C-13 Vicarious Trauma & Vicarious Posttraumatic Growth Among Service Providers In Problem-Solving Courts National Harbor 4 C-14 Making Evidence-Based Decisions: Using Technology to Assess People, Cases, and Outcomes National Harbor 6-7 C-15 Improve Outcomes by Integrating On-site Drug Testing: A Collaborative Approach Chesapeake 4-6 C-16 Research Says......... Best Practices in Assessment, Management and Treatment of Impaired Drivers Chesapeake 10-12 C-17 Felony Deferred Prosecution: A Court Monitored Alternative to Traditional Prosecution for Low Risk/Low Need Offenders Maryland 1-3 C-18 The Urgency of Hepatitis C in Drug Treatment National Harbor 2 C-19 Honoring our Children by Honoring our Traditions National Harbor 5 C-20 Guess What? You’re a Family Court, Too (if your Clients have Children)—Legal Issues and Practical Considerations When Working with Families in Drug Courts Maryland B C-21 The A, B, Cs of Meeting with Your Members of Congress Chesapeake JKL C-22 Alcoholics Anonymous: How We Cooperate With Courts and the Legal Community Chesapeake DE 3:30 p.m. – 4:45 p.m. Concurrent Workshops Session D D-1 The Brain on Drugs D-2 Effective Strategies to Support Families Through Reunification D-3 Engaging Family and Community in Juvenile Drug Court and Implications for Policy D-4 How to Successfully Integrate Drug Court Evidence-Based Practices into Your Mental Health Court D-5 What Juvenile Drug Courts Need to Know About Providing Effective Treatment for Youth with Co-Occurring Disorders D-6 Are You Connected? Collaborating in Communities of Color to Meet the Diverse Needs of Clients Maryland D National Harbor 11 National Harbor 13 National Harbor 12 Chesapeake GHI Chesapeake ABC 23 Setting the Standard Annual Training Conference TUESDAY JULY 28 (continued) TIME EVENT D-7 D-8 D-9 D-10 D-11 D-12 D-13 D-14 D-15 D-16 D-17 D-18 D-19 D-20 D-21 D-22 5:00 p.m. – 6:15 p.m. 24 ROOM Applying Quality Improvement Principles to Juvenile Drug Courts Maryland 4-6 Marijuana Maryland A Incentives and Sanctions in Family Drug Court Maryland C CBT for LEO (Part 1) National Harbor 10 Homophobia and Transphobia with Hispanic LGBTQ Participants Chesapeake 7-9 From Boyz to Men: Saving Our Young African American Males from the Streets and from Themselves National Harbor 3 Creating a Trauma Informed Juvenile Drug Court National Harbor 4 ® Stone County, Missouri: 5 years of Implementing VIVITROL (naltrexone for extended-release injectable suspension) in their Specialty Courts National Harbor 6-7 The Ultimate Chain of Custody Machine Chesapeake 4-6 DWI Court Research and Best Practices: What’s the Latest Evidence? Chesapeake 10-12 Immigration Consequences of Criminal Conduct: How Drug Courts Can Help Maryland 1-3 Improving Drug Court Outcomes for Young Adult Offenders National Harbor 2 Enablement Prevention Program National Harbor 5 The Proactive Prosecutor Maryland B Raise Your Voice: How to be an Effective Advocate for your Drug Court Chesapeake JKL Innovative Use of Recovery Coaching to Improve Community Re-Integration for Drug Court Participants Chesapeake DE Concurrent Workshops Session E E-1 Data, Evaluation and Outcomes: What You Should Collect and Why E-2 Is your FDC Built to Last? The Importance of Real Sustainability Planning E-3 Mentoring in Juvenile Treatment Drug Courts: Strategies and Tips from OnSite TA and Focus Group Report E-4 Difficult Issues Faced by Mental Health Court E-5 Trauma Symptom Inventory for Treatment Planning among Drug Court Participants with Co-Occurring Mental Health Disorders E-6 Gay Lesbian Bisexual Transgender Intersex (GLBTI): Does it Really Matter in Treatment Courts? E-7 Programmatic Factors Related to Outcomes in Juvenile Outpatient Treatment: Evaluating the Effectiveness of Juvenile Drug Courts E-8 Methamphetamine E-9 Behavior Modification and The Seriously Mentally Ill or Functionally Impaired: Special Issues to Consider E-10 CBT For Probation Officers (Part 2) E-11 Serving the Needs of Latino Population in a FDC E-12 African Americans and Mental Health E-13 Addiction, Personality Disorders, and Trauma E-16 Judicial Leadership and Strong Treatment Voice and Response NADCP 21st ANNUAL TRAINING CONFERENCE Maryland D National Harbor 11 National Harbor 13 National Harbor 12 Chesapeake GHI Chesapeake ABC Maryland 4-6 Maryland A Maryland C National Harbor 10 Chesapeake 7-9 National Harbor 3 National Harbor 4 Chesapeake 10-12 NADCP Washington, DC 2015 E-21 Search and Seizure: Overview of the Law The Importance of Universal Precautions: Effects of Trauma and Health Literacy on Health Outcomes in Drug Court Juvenile and Family Healing to Wellness Courts Identifying Federal Firearm Prohibitions in Drug Courts Taking Your State Association to the Next Level E-22 Building Effective Interventions for Young Adults in Adult Drug Courts E-17 E-18 E-19 E-20 6:30 p.m. – 8:00 p.m. Drug Court Expo with a Dessert Reception Maryland 1-3 National Harbor 2 National Harbor 5 Maryland B Chesapeake JKL Chesapeake DE Prince George’s Exhibition Hall DE WEDNESDAY JULY 29 – CAPITOL HILL DAY, CONCURRENT GENERAL SESSIONS, AND DOCUMENTARY SCREENING TIME EVENT ROOM 7:00 a.m. – 7:20 a.m. Come to Your Senses (Facilitated Meditation) 7:00 a.m. – 8:00 a.m. Drug Court Expo Opens with a Continental Breakfast Prince George’s Exhibition Hall DE 7:00 a.m. – 5:30 p.m. Registration (at 2:00 p.m. registration moves to convention center pre-funtion) Prince George’s Exhibition Hall DE 8:00 a.m. – 9:00 a.m. Capitol Hill Day Kick Off 9:00 a.m. – 10:30 a.m. SAMHSA Treatment Drug Court Grantee Meeting 9:30 a.m. – 10:45 a.m. Concurrent General Sessions CG-1 Matching Service to Need: Exploring What “High Risk/High Need” Means for FDCs National Harbor 11 CG-2 Revisiting Phases: Risk Matters National Harbor 12-13 CG-3 Impacts on Health Care Reform for Offender Populations: What Works to Enhance Collaboration National Harbor 2-3 CG-4 Ethics for Judges National Harbor 4-5 CG-5 Confidentiality National Harbor 10 CG-6 Designer Drugs: What Drug Court Practitioners Need to Know Maryland C CG-7 Prescription Drug Abuse Screening and Treatment, and Dealing with Chronic Pain without use of Narcotics: A Judge’s Guide Maryland A CG-8 Are All Drug Courts Collecting Reliable and Valid Data to Examine Potential Racial or Ethnic Disparities in Their Programs? Maryland D 10:00 a.m. – 2:00 p.m. Drug Court Expo Opens Chesapeake JKL Potomac Ballroom Maryland B Prince George’s Exhibition Hall DE Badges Badges are mandatory for all NADCP events and sessions; however, while exploring the Washington, DC area, please exercise caution and remove your badge. 25 Setting the Standard Annual Training Conference WEDNESDAY JULY 29 (continued) TIME EVENT ROOM 11:00 a.m. – 12:15 p.m. Concurrent General Sessions CG-9 Collaborative Justice in All Treatment Courts: The PD and the Prosecutor: An Unlikely Couple CG-10 Crossover Youth: The Power of Treatment Courts to Impact the School to Prison Pipeline CG-11 Criminal Justice Reform and Drug Courts CG-12 Dilute Urine Samples: Courts Response to Low Creatinine Specimens CG-13 Role of Law Enforcement in Drug Court CG-14 The New ASAM Criteria: Implications for Drug Courts CG-15 Medically Assisted Treatment CG-16 Legal Eagle 12:15 a.m. – 2:00 p.m. Lunch on Your Own 2:00 p.m. – 3:15 p.m. Concurrent General Sessions CG-17 Matching Service to Need: Exploring What “High Risk/High Need” Means for FDCs CG-18 Revisiting Phases: Risk Matters CG-19 Impacts on Health Care Reform for Offender Populations: What Works to Enhance Collaboration CG-20 Ethics for Judges CG-21 Confidentiality CG-22 Designer Drugs: What Drug Court Practitioners Need to Know CG-23 Prescription Drug Abuse Screening and Treatment, and Dealing with Chronic Pain without use of Narcotics: A Judge’s Guide CG-24 Are All Drug Courts Collecting Reliable and Valid Data to Examine Potential Racial or Ethnic Disparities in Their Programs? 2:00 p.m. – 3:30 p.m Superior Court Drug Intervention Program---All Rise! Mock Drug Court Session 3:30 p.m. – 4:45 p.m. Concurrent General Sessions CG-25 Collaborative Justice in All Treatment Courts: The PD and the Prosecutor: An Unlikely Couple CG-26 Crossover Youth: The Power of Treatment Courts to Impact the School to Prison Pipeline CG-27 Criminal Justice Reform and Drug Courts CG-28 Dilute Urine Samples: Courts Response to Low Creatinine Specimens CG-29 Role of Law Enforcement in Drug Court CG-30 The New ASAM Criteria: Implications for Drug Courts CG-31 Medically Assisted Treatment CG-32 Legal Eagle 6:30 p.m.- 11:30 p.m. Washington DC Night Tour 7:00 p.m. - 8:30 p.m. The Anonymous People Documentary Presentation and Discussion 26 NADCP 21st ANNUAL TRAINING CONFERENCE Chesapeake 10-12 National Harbor 10 National Harbor 4-5 Maryland C National Harbor 2-3 Maryland D Maryland A National Harbor 11 National Harbor 11 National Harbor 12-13 National Harbor 2-3 National Harbor 4-5 National Harbor 10 Maryland C Maryland D Maryland A Maryland 1-3 Chesapeake 10-12 National Harbor 10 National Harbor 4-5 Maryland C National Harbor 2-3 Maryland A Maryland D National Harbor 11 Buses depart from Woodrow Wilson Bus Loop Maryland D NADCP Washington, DC 2015 THURSDAY JULY 30 – DISCIPLINE SPECIFIC BREAKOUTS, GENERAL SESSION, AND CLOSING CEREMONY TIME EVENT 7:00 a.m. – 7:20 a.m. Come to Your Senses (Facilitated Meditation) 7:00 a.m. – 7:45 a.m. New Member/First Time Attendee Breakfast 7:00 a.m. – 8:00 a.m. Continental Breakfast Convention Center Pre-Function 7:00 a.m. – 10:30 a.m. Registration Convention Center Pre-Function 7:15 a.m. – 8:15 a.m. Discipline Specific Breakouts 8:30 a.m. – 10:00 a.m. General Session: Adult Drug Court Best Practice Standards (the room will be cleared in between sessions) Potomac Ballroom NADCP/Vet Court Con Closing Ceremony Potomac Ballroom 10:30 a.m. 12:30 p.m. ROOM Chesapeake JKL Potomac Ballroom 1-3 See Page 6 Session Handouts and speaker biographies Go to allrise.org to access handouts, speaker biographies, and more! Tour Washington, DC at Night! Wednesday, July 29 For more information visit the OnBoard tours desk at registration or go to http://washingtondctours.onboardtours.com/nadcp/ to purchase your ticket 27 Setting the Standard Annual Training Conference Training Track Descriptions TRACK 1 TRACK 4 Ready, Set, Go! Fundamentals of Implementing Your Drug Court Mental Health Courts: From Implementation to Operation Implementing an Adult Drug Court takes the initiative and cooperation of a diverse group of players. Public health and public safety partners define goals and objectives, identify resources, and strategize on sustainability. This track will address the considerations and partnerships that must be made in the early stages of planning and implementing an Adult Drug Court . This track also provides the scientific principles and best practices to ensure that any Drug Court is built on a solid foundation to ensure success and sustainability. TRACK 2 Raising the Bar: Taking Family Dependency Treatment Courts to the Next Level Family Drug Courts are built on a foundation of shared mission and vision, supported by client services and agency collaboration, and achieved by shared outcomes. This track will address both scale and scope issues and the systems changes that are necessary to optimize the outcomes of existing FDCs and create effective new FDCs. Topics will be relevant for professionals who are working both inside and outside of FDC programs, for anyone who is seeking to better engage and serve children and families, including those in the child welfare system. TRACK 3 Juvenile Drug Courts: Building on Our Success Juvenile Drug Courts are a critical part of every juvenile justice system. They provide a unique partnership focused on the future of our communities. What is the best way to engage juveniles and their families? What is considered developmentally appropriate, gender-specific, culturally relevant, and evidence-based treatment? What roles do schools and the faith community play? Whether you are considering developing a Juvenile Drug Court, or your Juvenile Drug Court is in operation, this track is for you. Learn from national researchers as well as subject matter experts about the latest research and effective approaches to dealing with adolescent populations. 28 NADCP 21st ANNUAL TRAINING CONFERENCE Almost half of all addicted persons in the justice system have a co-occurring mental illness, and over 70 percent of incarcerated mentally ill persons wrestle with addiction. This track highlights the fundamental issues needed to understand and develop a Mental Health Court. Whether you work in a Mental Health Court, or your Drug Court serves participants with mental illness, this track has information you need. Come learn what works in treatment, supervision, and case management for the mentally ill participants in your program. NADCP Washington, DC 2015 learn how to improve your program measurement and outcomes, while also learning what recent evaluations say about program success. TRACK 8 Keeping Ahead of the Curve: Drugs of Choice TRACK 5 Participants with Co-Occurring Disorders: Advanced Issues Hundreds of Problem-Solving Courts have participants dealing with co-occurring mental illness and addiction. This track tackles some of the advanced issues for practitioners serving this population. Whether you’re looking for the research on outcomes, tips on case management, or what evidence-based treatment is available, this track is not to be missed. TRACK 6 Ensuring Cultural Proficiency: More Than Just Awareness Culture is everywhere around us. It is how we dress, what we choose to eat, and what music we enjoy. It shapes our past, present, and future. It is essential to recognize and understand the culture of our Drug Court participants in order to shape their future. It follows that we will enhance our effectiveness by becoming culturally proficient. It is so simple to see, but so challenging to implement. This track will not only focus on the ‘seeing,’ but also provide the latest in practice and research on the implementation. TRACK 7 The Facts and Nothing But the Facts: Critical Role of Research There is no doubt—Drug Court works. This track offers details into national and statewide evaluations, along with tips for operating courts on how to incorporate successful strategies. Fostering partnership with practitioners and researchers is critical toward improving Drug Court outcomes. Don’t miss the opportunity to Drug Court participants are very sophisticated consumers of their drug of choice. They select from a myriad of drugs whose effects are widely varied. Although it is critical for treatment providers to understand the effects of these drugs, all Drug Court professionals need to be trained in their impact on supervision, case management, drug testing and treatment planning. Learn the latest in pharmacology and research findings to enhance programming and improve partnerships in your community. TRACK 9 The Good, The Bad, and The Effective: Incentives and Sanctions Incentives and sanctions are essential to every Drug Court. When properly used, they are a powerful tool for improving client behavior and outcomes. Drug Courts achieve better outcomes when practitioners understand the science behind behavior management. The research is clear: managing participant behavior includes the development of graduated and individualized motivational strategies, as well as consequences to hold participants accountable for failing to meet programmatic goals. Incentives and sanctions imposed in the courtroom have an impact not only on the individual appearing before the judge, but also on the other Drug Court members present. After attending the sessions on this track, you will understand the “why” behind behavior modification, along with “how” to implement the skills and knowledge. TRACK 10 Supervision: The Challenges Faced by Probation and Law Enforcement Law enforcement, probation, and other community supervision partnerships are critical to any successful Drug Court. This track focuses on the importance of strengthening the role of law enforcement and community supervision, and assisting probation officers and law enforcement in better understanding their role in the Drug Court arena. 29 Setting the Standard Annual Training Conference TRACK 13 Trauma This track offers evidence-based approaches to assessment and treatment of trauma, which is critical to the effective operations of every Drug Court and other Problem-Solving Court. Hear from national experts and learn practical tips to enhance your court’s treatment, case management, and supervision strategies. TRACK 14 AND 15 Science and Technology TRACK 11 Working with the Latino Community Drug Courts reflect the communities in which they are located. Addressing the needs of the Latino population goes well beyond dealing with communication barriers. Culture, residency status, and employability are among the many factors that present Drug Court practitioners an extra challenge when working with these clients. This track is designed to help practitioners working with the Latino community meet that challenge. TRACK 12 African American Clients: Improving Services and Outcomes This track is a necessity for problem-solving practitioners looking to improve outcomes with African American clients. Experts from around the nation address best practices, cultural competency, treatment approaches and more. 30 NADCP 21st ANNUAL TRAINING CONFERENCE Private enterprise offers many necessary tools for Drug Court operations. From unique methods assisting with community supervision to a variety of drug testing options, from research-proven ways to use medicallyassisted treatment to successful treatment techniques, our partners in the private sector are a critical asset to Drug Courts’ success. These sessions apprise practitioners of new developments in science and technology and provide a perspective on the concerns that every Drug Court should have in selecting the right tools of the trade. These tracks provide the practitioner with a wealth of information in order to become a wise consumer of products and services intended for the Drug Court field. (NADCP does not endorse any product or service.) TRACK 16 DWI Courts DWI Courts work. According to the research, DWI Court saves lives and money and restores participants to a clean and sober life. DWI Court is based on the proven Drug Court model, however, DWI Court participants are different than Drug Court participants, and understanding those differences is critical for any DWI Court. If your Drug Court is considering starting a DWI Court, or you are updating an established DWI program, then this track is for you. Attendees in this track will gain an increased understanding of the principles specific to DWI Court, important issues in dealing with DWI Court participants, and ways to modify current operations to include this population. NADCP Washington, DC 2015 TRACK 17 TRACK 20 Legal Issues in and Beyond Problem-Solving Courts Legal and Ethical Issues in Problem-Solving Courts For attorneys practicing in Problem-Solving Courts, the legal issues are multi-faceted. The sessions in this track focus on topics of interest within Problem-Solving Courts, but also stretch far beyond the Problem-Solving Court arena. From judicial immunity to statutory revisions; from issues involving criminal defense to firearms possession, these sessions are designed to answer some of the most complex questions for the attorneys and judges in Problem-Solving Courts. TRACK 18 Advanced Issues in Drug and Alcohol Treatment One size definitely does not fit all. As in many things, this is so true in effective drug and alcohol treatment. This track identifies a variety of treatment methods, along with insight into some specific and complex issues with which many Drug Court clients struggle. TRACK 19 Learning from Native Traditions: Tribal Healing to Wellness Courts Tribal healing to wellness courts are profound expressions of sovereign, self-determining nations. Such courts have become an important part of a long, often perilous, and amazing Nation rebuilding process that began for American Indian, Alaska Native, and Native Hawaiian communities after centuries of war, oppression, and resistance. Consequently, the impact of a Tribal Drug Court is complex and multi-faceted affecting multigenerational attitudes and perceptions about alcohol and other drugs, addressing historical trauma and unresolved grief, acting as a tool to restore tribal values, expanding tribal justice systems, improving state-tribal and federaltribal relationships, and restoring individuals to their rightful place as contributing members to the tribal community. Sessions in the tribal track will convey the complexities and nuances of Tribal Healing/Wellness Courts and contain useful information for both state and tribal practitioners. Problem-Solving Courts present interesting legal issues and ethical dilemmas. This track asks and answers some of the most difficult legal and ethical questions facing the Drug Court team. Whether you are a new ProblemSolving Court professional, or you’ve been with Drug Courts for many years, this track includes sessions on the cutting edge of what every Drug Court and other Problem-Solving Court practitioner should know. TRACK 21 Advocacy From meeting with your Members of Congress to engaging your State Legislature and developing your state association, this track will cover ways Drug Court professionals can ensure Drug Courts remain a public policy priority. Learn new skills to build relationships with your states’ key policymakers and develop your state association from Drug Court professionals who have paved the way. You are guaranteed a return on investment when you choose to spend your time attending these sessions! TRACK 22 Taking Your Drug Court to the Next Level Drug Court practitioners have a variety of issues to consider in addition to providing effective treatment, case management, and supervision. From budgets to team transition, from steering committees to contract management, practitioners at the state and local levels wrestle with a host of administrative duties, which can be overwhelming. This track offers insight and guidance into many of the administrative issues facing the state and local Drug Court practitioner. 31 Monday Schedule of Events July 27, 2015 Chesapeake JKL 7:00 a.m. – 8:00 a.m. Drug Court Expo Opens with a Continental Breakfast Prince George’s Exhibition Hall DE 7:00 a.m. – 5:30 p.m. Registration Prince George’s Exhibition Hall DE 7:30 a.m. – 8:45 a.m. Discipline Specific Breakouts See Page 6 9:00 a.m. – 12:00 p.m. Skills Building Workshops 12:00 p.m. – 2:00 p.m. Drug Court Expo Opens (Concessions for purchase available in Drug Court Expo) Prince George’s Exhibition Hall E Setting the Standard Council of Drug Court Associations Meeting (State Delegates only) Chesapeake D 1:30 p.m. – 2:00 p.m. Membership Meeting National Harbor 12 Annual Training Conference 2:00 p.m. - 5:00 p.m. Skills Building Workshops 5:30 p.m- 7:30 p.m. Drug Court Expo Opening Reception Prince George’s Exhibition Hall DE Monday 7:00 a.m. – 7:20 a.m. Come to Your Senses (Facilitated Meditation) Come to Your Senses – Chesapeake JKL The practice of meditation stills the mind, relaxes the body, and refreshes the spirit. It is a simple practice that can have a profound and immediate impact on one’s life. Sessions are open to all levels of experience. Come experience meditation. Space is limited. Monday, July 27 7:00 a.m. – 7:20 a.m. Wednesday, July 29 7:00 a.m. – 7:20 a.m. Tuesday, July 28 7:00 a.m. – 7:20 a.m. Thursday, July 30 7:00 a.m. – 7:20 a.m. Notes NADCP Washington, DC 2015 SKILLS BUILDING WORKSHOPS MORNING SESSIONS Monday, July 27 MONDAY 9:00 a.m. – 12:00 p.m. SESSION SB-1 Changing Behavior With 24/7 Alcohol Monitoring: NHTSA’s Newest Study on SCRAM Use, Recidivism Rates, and Characteristics Chesapeake ABC In 2010, the National Highway Traffic Safety Administration (NHTSA) began a study to look more in-depth at the impact of SCRAM Continuous Alcohol Monitoring on DUI offender recidivism. The study focused on two jurisdictions in Wisconsin and Nebraska and looked at recidivism two years postmonitoring. The study results, published in May 2015, showed a direct correlation between SCRAM monitoring and behavior change, as well as some other characteristics of repeat DUI offenders. Objectives • Hear from the study’s authors about their key findings. • Learn how this study supports previous research. • Hear about the use of technology by two states and what elements similar jurisdictions may adopt. • Learn more about the relationship of technology and recidivism. Speaker(s) Tara Casanova Powell Director of Research Traffic Injury Research Foundation USA Hamden, Connecticut Julie Tison Senior Research Scientist Pruesser Research Group Trumbull, Connecticut SESSION SB-2 Data, Evaluation, and Fidelity to the Model: Best Practices Chesapeake GHI The research is clear: Drug Court works. But does your Drug Court work? Is your program collecting data on participants? What data? Do you have an evaluation plan? Does your court do process and outcome evaluations? This session will outline the best practices in collecting data and evaluating your Drug Court program and optimizing caseload size, ensuring that your court is keeping fidelity to the Ten Key Components. One of the critical issues discussed will be the importance of maintaining fidelity to the Drug Court model as your program grows—as research demonstrates that programs tend to stray from the model at around 125 participants. A group of national experts will review the research and give practical advice on how to build a system to collect data, evaluate your Drug Court, and ensure program success. Objectives • Understand the importance of collecting data and performing evaluations. • How to monitor and maintain fidelity to the model in a large program. • Learn strategies for implementing or enhancing data collection and evaluation in your Drug Court. Speaker(s) Juliette Mackin Executive VP & Sr. Research Associate NPC Research Portland, Oregon 35 Setting the Standard MONDAY Annual Training Conference SESSION SB-3 Drug Courts in Rural Areas—Our Strengths and Special Challenges Chesapeake 4-6 Operating a Drug Court in a rural area presents unique challenges, but it also offers opportunities and strengths not found in urban-suburban areas. This skill building session will focus on the American University document entitled “A Technical Assistance Guide for Drug Court Judges and Team Members on Drug Court Treatment Services“ and in particular the chapter on Drug Courts in Rural Areas: Responses to Special Challenges. This will be a highly interactive session with both the panelists and the audience commenting on particular challenges/strengths/solutions found in rural/frontier Drug Courts across the country. The audience will be encouraged to participate through the floor microphone. The expert panel will include panel members with rural expertise on MAT efforts. Objectives • Change the focus from rural challenges to opportunities unique to rural drug courts. • Provide proven strategies to develop and sustain rural drug courts and required ancillary supports and services. • Offer an opportunity for discussion between rural drug court professionals to learn from each other’s experiences. 36 NADCP 21st ANNUAL TRAINING CONFERENCE Speaker(s) Hon. Tim Bibaud-Dudley Judge District Court Dudley, Massachusetts Hon. Alan Blankenship Judge Stone County Circuit Court Stone County, Missouri Bobby DeBatt Treatment Provider Westcare Arizona Bullhead City, Arizona Jeffrey Kushner Statewide Drug Court Administrator Montana Supreme Court - Office of Court Administrator Victor, Montana Hon. Robert Walker Judge Fifth Judicial District, Minnesota Fairmont, Minnesota NADCP Washington, DC 2015 SESSION SB-4 DWI Court Forum National Harbor 2 Survey of Services provided by NCDC Welcome to the world of the National Center for DWI Courts. This session will provide a detailed explanation of NCDC, the services we provide including the various opportunities for training that exist, the application process, training locations, and training content. Presenters will also introduce the latest Bottom Line Publication, Research Update on DWI Courts. Michael Brown Director Impaired Driving Division National Highway Traffic Safety Administration Department of Transportation Washington, DC MONDAY 9:00 a.m. – 10:00 a.m. Panelists 11:00 a.m – 12:00 p.m. Hon. J. Michael Kavanaugh (Ret.) Senior Director NCDC Alexandria, Virginia DWI Academy Courts; Who are They and What They Can Do for You DWI Academy Courts are selected through a peerreview process administered by NCDC and funded by NHTSA. Four courts are selected from 4 regions of the country to serve for three years. NCDC’s 3.5 day implementation trainings are held at each of the Academy Courts each year, which include a trip to see the Academy DWI Court in session. Listen to each judge describe what their programs have to offer, including mentorship service to your programs. Panelists Moderator Introduction James Eberspacher Project Director NCDC Alexandria, Virginia Hon. J. Michael Kavanaugh (Ret.) Senior Director NCDC Alexandria, Virginia Cliff Jacobs Program Manager NCDC Alexandria, Virginia Panelists 10:00 a.m. – 11:00 a.m. NHTSA Fuels the DWI Court Field and NCDC The National Highway Traffic Safety Administration provides significant resources in support of DWI Courts and NADCP/NCDC. Come and listen to experts experts as they describe the agency’s relationship with us at NCDC, our field, and possibly you. Are you accessing all of the resources available to implement and enhance your programs? Don’t miss this chance to ask questions about funding opportunities and to clarify any misconceptions about the use of federal funds to support DWI Courts. Hon. Matt Anderson Judge Orange County DUI Court Newport Beach, California Hon. Charles Auslander Judge Athens/Clarke County, Georgia Hon. Robert Anchondo Criminal Court Judge DWI Drug Court Intervention and Treatment Program El Paso, Texas Hon. Kerry Meyer Judge Minneapolis, Minnesota Introduction Hon. J. Michael Kavanaugh (Ret.) Senior Director NCDC Alexandria, Virginia 37 Setting the Standard MONDAY SESSION SB-5 Annual Training Conference SESSION SB-6 Family Drug Court: Best Practices Target Population: Best Practices National Harbor 10 Maryland A In 1997, the Office of Justice Programs of the U.S. Department of Justice identified 10 key components of drug courts, providing jurisdictions with a framework for developing and refining their drug courts programs for criminal offenders with substance use disorders. NADCP published in 2013 Adult Drug Court best practice standards that quantify some of the key components. Most recently, Children and Family Futures released Family Drug Court Guidelines to help states and programs create practice and systems changes that will have a lasting impact on FDCs and the families they serve. This workshop session will examine best practice research and relate it to the 10 Key Components and the 10 FDC Guidelines. Through activities and small group discussion this interactive presentation will use the FDC Self Assessment Tool to explore how FDC Guidelines and research based best practices can be used to enhance both practice-level and systems-level change. When implementing and operating a successful Drug Court, one of the first and most critical questions is “Who will the court serve?” The research is clear. Drug Courts are best designed and most successful when serving high risk/high need populations, that is, those participants with high criminogenic risk and high prognostic need. In fact, every component of your Drug Court program, from treatment to incentives/sanctions to case management will be integrally connected with targeting the appropriate population. But how do you identify high risk/high need participants? How do you ensure your program is targeting these individuals? This presentation will outline the research on high risk/ high need, and will further discuss and explain how to ensure your program targets the correct population. Objectives • Explore the FDC Guidelines and how they converge and diverge with 10 Key Adult Drug Court Components and Adult Drug Court Best Practice Standards. • Gain understanding on how to use the FDC Guidelines and best practices to make both practicelevel and systems-level changes. • Learn how states and local jurisdictions can use FDC Guidelines and best practice standards and strategies to improve FDC practice. Speaker(s) Phil Breitenbucher FDC TTA Program Director Children and Family Futures, Inc. Irvine, California Shannon Carey Co-President & Sr. Research Associate NPC Research Portland, Oregon 38 NADCP 21st ANNUAL TRAINING CONFERENCE Objectives • Understand the research behind serving high risk/ high need populations in Drug Court. • Identify strategies for incorporating risk/need assessment into your Drug Court operations. Speaker(s) Douglas Marlowe Chief of Science, Law, and Policy National Association of Drug Court Professionals Alexandria, Virginia NADCP Washington, DC 2015 SESSION SB-9 Heroin Resurgence and Prescription Opiates: Critical Issues in Diagnosis and Treatment SESSION SB-8 Supervision Maryland 1-3 Probation and law enforcement have an indispensable role in a successful Drug Court. Community supervision is critical to ensure participants adhere to the rules of Drug Court. This session will discuss the role of law enforcement and probation in providing robust supervision for your Drug Court participants. Issues discussed will include, but not be limited to, home visits, drug tests in the field, bench warrants, bar sweeps, and the role of the supervision officer in staffing and court. Objectives • Understand the role of the supervision officer in Drug Court. • Identify strategies for successful community supervision. Speaker(s) Helen Harberts Deputy District Attorney (ret.) Chico, California Vanessa Price Law Enforcement Inspector, Ret. Chair – Oklahoma Pardon and Parole Board Oklahoma City, Oklahoma Charles R. Robinson Chief Probation Officer - Director Travis County Community Supervision and Correction Department Austin, Texas Abuse of prescription opiates is at epidemic proportions-and not coincidentally, heroin use is increasing rapidly. Emergency rooms and first responders are reporting ever increasing cases of opiate overdoses. Part one of this session will review the recent history and current state of opiate abuse and dependence in the United States, including the most current information on evidence based treatment when dealing with those addicted to opiates. Part two of this session will educate practitioners on Naloxone (e.g., Narcan®). Naloxone is a medication used to counter the effects of opioid overdose. Although traditionally administered by first-responders, take-home naloxone programs have been established in approximately 200 communities throughout the U.S. Naloxone has no potential for abuse, it can be dispensed with minimal training via injection or nose spray; making it the ideal overdose countermeasure for anyone who is in contact with an opioid user. Objectives • Understand the surge in opiate use in the United States. • Identify evidence based treatment for opioid dependence. • Learn about Naloxone a tool to prevent overdose incidents from becoming fatalities. Speaker(s) Caleb J. Banta-Green Senior Research Scientist - Alcohol & Drug Abuse Institute Affiliate Associate Professor - School of Public Health Affiliate Faculty - Harborview Injury Prevention & Research Center University of Washington Seattle, Washington Steve Hanson Director Division of Treatment and Practice Innovation, Bureau of Addiction Treatment Centers Rochester, New York 39 MONDAY Maryland B Setting the Standard MONDAY SESSION SB-10 Everything You Always Wanted to Know about PTSD, Substance Abuse, and Co-Morbid Disorders: An Expert Answers Your Questions Annual Training Conference Speaker(s) Hon. William Meyer Judge/Senior Judicial Fellow Judicial Arbiter Group Denver, Colorado Maryland C One of the problems with going to a conference is that, no matter how much you learn, only some of your questions are likely to be answered, and more are likely to arise. Because many other audience members want to ask questions, you are likely to have only one or two of your own answered during the question and answer period. This session is different: an expert in the fields of adolescent and adult trauma and substance abuse will devote the entire time to answering your questions about trauma, PTSD, alcohol and drug abuse, and their frequent co-occurring problems, including depression, traumatic brain injuries, insomnia, pain, and school/ work, child welfare, family, and legal problems. Join us for an informative and entertaining session in which you can ask and get not only your questions answered, but also learn some surprising information and tips spurred by the questions of others. Speaker(s) Brian Meyer Clinical Psychologist H.H. McGuire VA Medical Center Richmond, Virginia SESSION SB-12 A Team Member’s Guide to Effective Drug Court Treatment: The Results are In! National Harbor 5 There is a growing body of research that identifies best practice for Drug Court participants. Arguably, treatment is the ground upon which everything else in Drug Court is built. Accordingly, every team member is expected to know what treatment services participants receive and whether those services adhere to best practices. This presentation will elaborate on research summarized in the NADCP Adult Drug Court Best Practice Standards Volume 1~ Substance Abuse Treatment and the Complementary Treatment and Social Services Standard found in the newly released Volume II. It will provide every team member with a starting point for assessing and improving the integration of treatment into the overall Drug Court process. This presentation will reveal how both the Drug Court team and participants can get the maximum benefit from Drug Court treatment. Objectives SESSION SB-11 Legal Issues in Adult Drug Courts: Best Practices Maryland D Drug Courts present a myriad of legal and constitutional issues, many of which are unique and of first impression at the appellate level. Adult Drug Court Best Practices addresses many of these issues. This session will provide an overview of the Best Practices and further discuss other legal issues impacting Drug Courts and as yet unresolved in the appellate courts. Objectives • Identify the legal Best Practices in Adult Drug Courts. • Understand the major constitutional and legal issues impacting Drug Courts. • Identify trends in appellate decisions impacting Drug Courts. 40 NADCP 21st ANNUAL TRAINING CONFERENCE • Identify the evidenced based primary and complementary treatment interventions found to be effective in high risk/high need drug court populations • Identify the program practices most associated with effective Drug Court treatment • Discuss Drug Court treatment research and those areas where research is lacking Speaker(s) Terrence Walton Chief of Standards NADCP Alexandria, Virginia NADCP Washington, DC 2015 SESSION SB-14 The Critical Role of the Team: Best Practices Judicial Role and Ethics: Best Practices National Harbor 3 National Harbor 11 The Drug Court team is integral to the program’s success. In order to build and maintain a successful team, training, cross-training, and participation is critical. This session will highlight the research on team training and its importance in the Drug Court, along with providing practical strategies for giving the team ongoing updates and training opportunities locally, statewide, and on the national level. The research is clear. The Judge’s role is critical to the success of a Drug Court. This session will review the research, including the minimum optimal time for a Drug Court judge to remain on the bench, the parameters of successful status hearings with Drug Court participants, and the need for training specific to the judicial role. The presentation will also review the ethical dilemmas often faced by Drug Court judges, and strategies for building a successful Drug Court. If you are a new or experienced Drug Court judge, this session is for you. Objectives • Learn what the research says about full team participation and its relationship to program success. • Understand the importance of training to a Drug Court team. • Identify cost-effective strategies to educate and train your Drug Court team. Speaker(s) Ken Arnold Senior Director- Court services River Region Human Services Jacksonville, Florida Karen Barnes Chief Probation Officer DWI Courts Maricopa County, Arizona Objectives • Identify the best practices for Adult Drug Court judges. • Learn common ethical issues faced by Drug Court judges. • Identify strategies for improving Drug Court outcomes through research. Speaker(s) Hon. Peggy Hora Judge (Ret.) NDCI Sr. Judicial Fellow Walnut Creek, California Hon. Christine Carpenter Circuit Court Judge 13th Judicial Circuit Columbia, Missouri Jim Egar Chief Defender Monterey County Public Defender Salinas, California Mike Loeffler Senior Assistant District Attorney State of Oklahoma Bristow, Oklahoma 41 MONDAY SESSION SB-13 Setting the Standard SESSION SB-15 MONDAY Grant Information From a Panel of Federal Experts National Harbor 6-7 Are you wondering where your Drug Court can find resources in these tough economic times? Well, look no further-this is the skills building session for you. Come hear from United States Department of Justice and United States Substance Abuse and Mental Health Services Administration officials as they join an experienced national Drug Court consultant to discuss funding opportunities from their agencies. Objectives Annual Training Conference multiple life challenges. We will cover background on trauma and substance abuse (including rates, the typical client, models and stages of treatment, and clinical dilemmas) and clinical Interventions for trauma and substance abuse, as well as resources for further learning. The Seeking Safety model will be highlighted as it is the most evidence-based model for trauma and substance abuse. Objectives: • To review scientific literature on rates and presentation of trauma/substance abuse. • To increase empathy and understanding of trauma/ substance abuse. • Learn federal funding resources for Drug Courts. • To describe Seeking Safety counseling strategies. • Identify key elements of a successful grant application. • To provide assessment and treatment resources. Speaker(s) Speaker(s) Jon Berg Public Health Advisor Center for Substance Abuse Treatment Rockville, Maryland Tim Jeffries Policy Advisor Bureau of Justice Assistance Washington, DC Kellie Dressler Blue Associate Administrator Juvenile Justice System Improvement Division Office of Juvenile Justice and Delinquency Prevention Washington, DC Gwendolyn Williams State Program Manager State and Community Development Division Office of Juvenile Justice and Delinquency Prevention (OJJDP) Office of Justice Programs U.S. Department of Justice Washington, DC SESSION SB-16 Seeking Safety National Harbor 4 The goal of this presentation is to describe current state-of-the art knowledge about the treatment of patients with trauma and substance abuse, a population that is typically considered complex, with 42 NADCP 21st ANNUAL TRAINING CONFERENCE Summer Krause Licensed Professional Counselor Certified Alcohol and Drug Counselor III Western Psychological and Counseling Services Gladstone, Oregon SESSION SB-17 Building the Right Team to Support Implementation of VIVITROL® (naltrexone for extended-release injectable suspension) Chesapeake ABC The implementation of any new aspect to an established or new program can be difficult. Attendees will hear from those who have incorporated VIVITROL® into their programs. Attendees will learn about how programs have made VIVITROL® available to appropriate participants; and how it has been integrated with the court processes and other support systems. This promotional program is created and sponsored by Alkermes, Inc. Mr. Tom Fuchs is a paid speaker for Alkermes, Inc. Speaker(s) Tom Fuchs CEO Halcyon Consulting, LLC Chippewa Falls, Wisconsin NADCP Washington, DC 2015 SKILLS BUILDING WORKSHOPS AFTERNOON SESSIONS Monday, July 27 SESSION SB-18 Drug Testing: Best Practices Maryland A Effective drug testing in Drug Court is essential to the overall success of the program. This presentation is designed for new Drug Court team members who want a comprehensive review designed to provide information and strategies for building and maintaining a successful abstinence monitoring program. Collection strategies and result interpretation - two essential components of a credible testing program will be discussed. Attendees will learn the reasons for testing, how to select clients for maximum abstinence surveillance, and what specimens yield the best results. Additional focus issues will include controlling sample Objectives • Learn the best practices in drug testing to ensure the success of abstinence monitoring. • Gain knowledge about different specimen types; their advantages and disadvantages. • Understand how specimen tampering can defeat your abstinence monitoring efforts. Speaker(s) Paul Cary Director Toxicology and Drug Monitoring Lab University of Missouri Columbia, Missouri 43 MONDAY 2:00 p.m. – 5:00 p.m. tampering and the use of creatinine measurements, the application of EtG/EtS monitoring, the challenges of on-site testing, dispelling popular drug testing myths and much more. This skills building session is intended to encourage new practitioners to know more about drug testing than their clients MONDAY Setting the Standard Annual Training Conference SESSION SB-19 SESSION SB-20 Effective Strategies in Juvenile Drug Court DWI Court Forum Chesapeake GHI National Harbor 2 Juvenile Drug Courts are not equally effective. In fact, certain Juvenile Drug Courts have achieved far greater success, while others have shown very little success in outcome studies. But what differentiates successful Juvenile Drug Courts from unsuccessful ones? Research has clearly shown that Juvenile Drug Courts which incorporate specific best practices achieve far greater outcomes. This session will outline the research on Juvenile Drug Courts, including best practices, along with practical tips on how to implement those practices in your court. This session is a must for every Juvenile Drug Court practitioner. Objectives • Identify the best practices in a Juvenile Drug Court as identified in the research. • Identify concrete implementation strategies to incorporate best practices into your Juvenile Drug Court. Speaker(s) Shannon Carey Co-President & Sr. Research Associate NPC Research Portland, Oregon Jacqueline Van Wormer Associate Professor Washington State University Richland, Washington 2:00 p.m. – 3:00 p.m. At Scene On Call—Unique Approaches to DWI Supervision and Field Services This session provides critical information related to the monitoring and supervision of the offender in the DWI Court Program. Specifically, the presenters will discuss the importance of having adequate community supervision in place in order to keep track of participants, know what is going on in their lives, and hold them accountable quickly if necessary. Attendees will recognize the benefits of community-based approaches to public safety for DWI supervision, identify how early detection and intervention serve as an adjunct to participant success, and understand the critical role that field services play in overall program success. Moderator Vanessa Price Law Enforcement Inspector, Ret. Chair – Oklahoma Pardon and Parole Board Oklahoma City, Oklahoma Panelists Hon. Robert Anchondo Criminal Court Judge DWI Academy Court El Paso County, Texas Karen Barnes Chief Probation Officer DWI Courts Maricopa County, Arizona Juan Ferrell El Paso Police Department DWI Academy Court El Paso, Texas Julio Gonzales El Paso County Sheriff’s Department DWI Academy Court El Paso County, Texas Chief Russell Laine Chief of Police/NADCP Board Member Village of Algonquin Algonquin, Illinois 44 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 3:00 p.m. – 4:00 p.m. Moderator James Eberspacher Program Director NCDC Alexandria, Virginia Panelists Hon. Peggy Hora (Ret.) Judge Walnut Creek, California SESSION SB-21 Incentives & Sanctions: Best Practices Potomac Ballroom AB Joint NADCP and Vet Court Con Session Incentives and sanctions are essential tools of the Drug Court team. However, many Drug Court teams do not base their responses on scientific strategies. Over the past years, the National Drug Court Institute (NDCI) has offered topic-specific training programs for Drug Court teams after the completion of a thorough literature review of over 100 articles pertaining to shaping behavior. This session will offer an in-depth analysis of the ten science-based principles every Drug Court should consider before responding to client behavior. Objectives • Identify practical applications of the ten science based principles in developing a comprehensive strategy on incentives and sanctions. Hon. Mary Celeste (Ret.) Judge Denver, Colorado • Identify successful strategies for using incentives 4:00 p.m. – 5:00 p.m. • Learn the ten science-based principles of changing Regional DWI Courts Many states are geographically challenged when it come to being able to provide the full menu of services necessary to establish DWI Courts. Sparsely populated counties often do not have the resources within their jurisdiction and therefore, are unable to join the family of DWI Courts. Under the judicial leadership of our panelists see how Michigan has been able to consolidate the efforts and resources of several adjoining counties to create Regional DWI Courts, or Sobriety Courts as they are called in Michigan, thus allowing smaller jurisdictions to provide the life-saving benefits of DWI Courts to their communities. Moderator Cliff Jacobs Program Manager NCDC Alexandria, Virginia Panelists Hon. Patrick Bowler (Ret.) Judge Grand Rapids, Michigan Hon. Harvey Hoffman Judge Charlotte, Michigan and sanctions in an Adult Drug Court . behavior. Speaker(s) Douglas Marlowe Chief of Science, Law, and Policy National Association of Drug Court Professionals Alexandria, Virginia Hon. William Meyer Judge/Senior Judicial Fellow Judicial Arbiter Group Denver, Colorado Facilitators Hon. Christine Carpenter Circuit Court Judge 13th Judicial Circuit Columbia, Missouri Kim Kozlowski Project Director Syracuse Community Treatment Court Syracuse, New York Kim Parsons Collaborative Court Coordinator Orange County Veterans Treatment Court Santa Ana, California Meghan Wheeler Senior Consultant National Drug Court Institute, NDCI Lexington, Ohio 45 MONDAY Marijuana and Driving As more states medicalize cannabis it is crucial that DWI Courts have a clear policy on its use based on the latest research. In this session you will discover what we know, and, more importantly, what we don’t know about the effects of THC on driving. Setting the Standard Annual Training Conference SESSION SB-23 MONDAY SESSION SB-22 Other Problem-Solving Courts: Engaging the Community and Helping Victims Case Planning and Recovery Support for Mental Health and Family Drug Courts Chesapeake 4-6 National Harbor 11 2:00 p.m. – 3:30 p.m. 2:00 p.m. – 3:15 p.m. Session 1: Community Courts and Other Ideas for Community Engagement 3:30 p.m. – 5:00 p.m. Session 2: Domestic Violence, Trafficking, and Prostitution: Serving Victims in Problem-Solving Courts The two sessions of this three-hour skills building workshop will explore how Problem-Solving Courts have expanded their horizons to engage local communities and to serve the victims of crime. In particular, the session will explore major principles and practices of community courts, domestic violence courts, and trafficking and prostitution courts; offer ideas for courtcommunity engagement, an essential component of any problem-solving initiative; and summarize what the latest research tells us about the effectiveness of these types of Problem-Solving Courts. Objectives • Learn how Problem-Solving Courts other than Drug Courts engage the community and help victims. • Gain knowledge about the goals and key principles of domestic violence, trafficking and prostitution courts. • Understand what the latest research tells us about the effectiveness of these approaches. Speaker(s) Katie Crank Coordinator of Domestic Violence Programs Center for Court Innovation New York, New York Julius Lang Director, Technical Assistance Center for Court Innovation New York, New York Michael Rempel Research Director Center for Court Innovation New York, New York 46 NADCP 21st ANNUAL TRAINING CONFERENCE Effective Case Management in a Mental Health Court This skills-building session will discuss how to apply research and best-practices, including the Risk-NeedsResponsivity principle to build effective case plans. This session will address how to build case plans based on screenings and assessments; how to identify effective programming for meeting specific needs; and how to respond to participant successes and failures. Case studies will be used to help provide attendees an opportunity to practice these skills and think further about how these principles can be incorporated into their own programs. Learning Objectives: • Understand the Risk-Needs-Responsivity Principle and its application in a Problem-Solving Court. • Identify the eight criminogenic risk factors, as well as which risk factors are static or dynamic. • Develop case plans using screenings and assessments that address identified needs, with appropriate programming. • More effectively respond to participant setbacks and failures. Speakers Emily Harris Program Associate, Courts Council of State Governments Justice Center New York, New York Eric Olson District Manager Idaho Adult & Juvenile Mental Health Courts 7th Judicial District Idaho Falls, Idaho 3:15 p.m. – 3:30 p.m. Break NADCP Washington, DC 2015 3:30 p.m. – 5:00 p.m. Speakers Tara Doaty-Mundell Clinical Psychologist and Consultant Founder/Lead Mental Health Consultant Sage Wellness Group Baltimore, Maryland Learning Objectives: Rosemary Soave Family Treatment Drug Court Coordinator Rhode Island Family Treatment Drug Court Providence, Rhode Island • Understand the importance of providing parents with comprehensive recovery support services to achieve goals of safety, reunification, and permanency. MONDAY Recovery Support in Your Family Drug Court: Building and Sustaining Hope through Creative Partnerships What impact can recovery support and intensive case management have within an FDC program? According to research, recovery support provided through mentor or specialist positions has a positive impact on multiple outcome domains, including substance use, mental health, parenting practices, and family functioning. In addition, the use of recovery support staff significantly increases parents’ access to substance abuse treatment, length of stay in treatment, and the likelihood that parents will be reunified with their children. This miniskills building workshop presentation will highlight innovative models and practice strategies from three Family Drug Court programs (Rhode Island, Baltimore, MD, Santa Clara County, CA) and how they are impacting their community through client engagement and creative partnering. Special focus will emphasize lessons learned from implementation of parent mentor or peer support models and the importance of research and leveraging local resources to assist in the delivery, evaluation, and sustainability of innovations. Laurie Drabble Professor San Jose State University School of Social Work San Jose, California Hilary Kushins Drug Court and Training Programs Manager (Attorney) Dependency Advocacy Center San Jose, California Christine Munroe Peer Mentor Coordinator Rhode Island Family Treatment Drug Court Providence, Rhode Island Jane Pfeifer Senior Program Associate Children and Family Futures Lake Forest, California • Learn strategies to implement a peer mentor program and the community context for intervention and role in sustaining long-term recovery. • Identify strategies to leverage local resources to design and implement an evaluation of a mentor parent program for a Family Drug Court. 47 MONDAY Setting the Standard Annual Training Conference SESSION SB-24 SESSION SB-25 Tribal Nations Forum Reentry Court on Steroids National Harbor 5 National Harbor 3 Participants will be welcomed by a member of the NADCP Board of Directors and get a brief history of Alaska Native and Tribal experience individually melding the original 10 Key Components with tribal custom and dispute resolution before advent of the Tribal Key Components, meet each other, members of NADCP’s Tribal Drug Court Committee (“Committee”), and the agency that provides Training and Technical Assistance (T&TA) to Alaska Native and American Indian Tribes. If you wanted to implement a Reentry Court in your community, who would the court serve? What service would the participants need? What partnerships would be crucial for your Reentry Court’s success? How would you build those partnerships? What do evaluations say about the success of Reentry Courts? In this presentation a group of national experts discuss the target population of a typical Reentry Court, along with examples of challenges facing those participants and courts assist the participants successfully complete by overcoming obstacles and reintegrating into society. This presentation is a must for anyone considering a Reentry Court. Tribal Treatment and Healing to Wellness Courts In Action The best ideas and strategies come from the Tribal Drug Court Team members themselves. During the Workshop there will be two separate presentations from two operational Courts from entry to graduation. Near the conclusion of the workshop, team members from both courts will be available to answer questions. Objectives • Learn the History of Tribal Courts and the Drug Court Movement. • Learn the 2016 Goals of the Tribal Drug Court Committee. • Learn the 10 Tribal Key Components. • Receive practical advise on planning, implementing and or operating a treatment court. • Learn five strategies for sustaining their court. Speaker(s) Hon. R. Eagleye Johnny Judge (Ret.) JD, NREMT & Nevada AEMT Nixon, Nevada Hon. Lawrence Lujan Judge Ysleta del Sur Pueblo El Paso, Texas Lauren van Schilfgaarde Tribal Law Specialist Tribal Law and Policy Institute West Hollywood, California 48 NADCP 21st ANNUAL TRAINING CONFERENCE Objectives • Identify the characteristics of the Reentry Court target population. • Understand how to integrate services into your Reentry Court. • Identify strategies for building community coalitions for an effective Reentry Court. Speaker(s) Lama Hassoun Ayoub Senior Research Associate Center for Court Innovation New York, New York Leah Claire Bennett Clinical Director Pine Grove Recovery Center Hattiesburg, Mississippi Francine Byrne Supervising Research Analyst Judicial Council of California San Francisco, California Hon. Stephen Manley Judge Superior Court of California, Santa Clara San Jose, California Marla Newby Reentry Coordinator Norfolk Circuit Court Reentry Docket Norfolk, Virginia NADCP Washington, DC 2015 Carolyn Hardin Interim Chief Executive Officer Senior Executive Director NDCI - The Professional Services Branch of NADCP Alexandria, Virginia Hon. Keith Starrett NADCP Board Chair U.S. District Judge Southern District of Mississippi U.S. District Court, Mississippi Sonya Harper Project Director of NDCRC NDCI - The Professional Services Branch of NADCP Alexandria, Virginia SESSION SB-26 Dos and Don’ts of Becoming a DC Coordinator: Avoiding Pitfalls (Drug Court Coordinator Forum) Maryland C Drug Court coordinators are the glue that holds the Drug Court together. A coordinator wears many hats—a few include grant writing, budgeting, data collection and file coordination, financial planning, securing continuing education, and finding other monetary and nonmonetary resources. This special form for Drug Court coordinators will provide assistance in three critical areas: free online resources; grant writing tips; and data collection/planning for an evaluation. First, you will hear from the nation’s foremost providers of Drug Court training and technical assistance and walk through an online demonstration of distance learning projects. Next, you will receive a seminar in grant writing; and finally, you will learn the fundamentals of data collection and evaluation planning. Bring your laptop and prepare to work! MONDAY Charles R. Robinson Chief Probation Officer - Director Travis County Community Supervision and Correction Department Austin, Texas Tara Kunkel Principal Court Management Consultant National Center for State Courts Williamsburg, Virginia Dennis Reilly Deputy Director, Drug Court Programs Center for Court Innovation New York, New York Lauren van Schilfgaarde Tribal Law Specialist Tribal Law and Policy Institute West Hollywood, California Michelle White Principal Court Consultant National Center for State Courts Denver, Colorado Objectives • Identify online resources for Drug Courts. • Identify grant writing tips. • Understand the fundamentals of evaluation planning. Speaker(s) Phil Breitenbucher FDC TTA Program Director Children and Family Futures, Inc. Irvine, California Steve Collins Research Specialist/Senior Technical Assistance Coordinator American University Washington, DC 49 Setting the Standard Annual Training Conference SESSION SB-28 Historically Disadvantaged Groups MONDAY National Harbor 6-7 The Adult Drug Court Best Practice Standards state that citizens who have historically experienced sustained discrimination or reduced social opportunities because of their race, ethnicity, gender, sexual orientation, sexual identity, physical or mental disability, religion, or socioeconomic status receive the same opportunities as others. This session will explore how a Drug Court can ensure equivalent access, retention, treatment, incentives and sanctions, dispositions, and provide team training on the necessary issues. Objectives • Understand the best practice standard on Historically Disadvantaged Groups. • Identify strategies to ensure equivalent treatment of all persons in Drug Court. Speaker(s) SESSION SB-27 Health Care Reform: Understanding and Navigating the Affordable Care Act Maryland B We are in a new age of health care in the United States. In states that expand Medicaid under the ACA, many individuals who make below 138% of the federal poverty line will have health care for the first time. Many Drug Court clients will be Medicaid beneficiaries, which will change how Drug Courts operate. This session will look at how the ACA is changing Drug Courts and how Medicaid funding sources can create new revenue streams to reimburse Drug Courts for case management or connecting individuals with Medicaid. Speaker(s) Dan Mistak Research Associate COCHS Oakland, California Steven Rosenberg President Community Oriented Correctional Health Services Oakland, California 50 NADCP 21st ANNUAL TRAINING CONFERENCE Anne Dannerbeck Janku Research Manager Office of State Courts Administrator Jefferson City, Missouri Hon. Robert Russell Presiding Judge Buffalo Veterans Treatment Court Buffalo, New York Terrence Walton Chief of Standards NADCP Alexandria, Virginia NADCP Washington, DC 2015 SESSION SB-29 HEAT National Harbor 10 MONDAY HEAT—Habilitation, Empowerment & Accountability Therapy—applies to a holistic, Afro centric, strength based model that emphasizes a positive and engaging approach to treatment. It is closely modeled after Afro centric interventions that have previously been standardized and published in CSAP, CSAT, and other publications. A recent CSAT grant has provided a national pilot for this innovative, manualized curriculum. The holistic approach of HEAT focuses on treating the complete person by addressing spiritual, mental, emotional, physical, environmental, and experiential factors that influence one’s sense of self, behaviors, and choices. The curriculum seeks to validate life experiences and help the client address and resolve emotional, psychological, environmental, and experiential issues that have shaped his self-image, behavior, and lifestyle choices. Objectives • Understand the components of the manualized treatment model HEAT. • Learn the fundamentals of how to implement the HEAT holistic approach based on a cultural foundation. • Gain strategies to retain and engage difficult populations with an emphasis on African American Males in Drug Court. Speaker(s) Darryl Turpin President Darryl Turpin Consulting Louisville, Kentucky Guy Wheeler President Guy A. Wheeler Group Plantation, Florida SESSION SB-30 The Dangers of Spice and the Science Behind It National Harbor 4 This session will provide you with a comprehensive overview of Spice. Learn about the chemical composition of synthetic drugs and how it impacts your drug testing program. Understand the risks to public health and hear first-hand stories about the signs, symptoms, and impact these drugs have on our communities and court systems. Speaker(s) Leo Kadehjian Biomedical Consultant Palo Alto, California Hon. Jodi Debbrecht Switalski Senior Associate The Stutman Group Waterford, Michigan 51 Setting the Standard SESSION SB-31 MONDAY Using Technology in Problem-Solving Courts: Strategies for Tuning In and Turning On Maryland 4-6 2:00 p.m. – 2:35 p.m. New technological innovations are being developed and implemented every day. As such, embracing technology and learning how to use is increasingly important and recommended. A growing line of research has highlighted the promising role that interactive web-based and mobile technologies may play in the improving the effectiveness, cost-effectiveness, and reach of efforts to assess, prevent, treat, and support recovery from substance use disorders (SUDs) and other risk behaviors. Yet, the adoption of technologybased programs to treat SUDs has been very limited. This presentation will address emerging opportunities for using technology for the treatment of SUDs and the maintenance of recovery. Dr. Michael Chaple will address the broader issues of utilization of technology: Annual Training Conference • Explain methods for using technology to deliver treatment and other services to Drug Court clients. • Identify specific strategies for using technology to enhance court- and community-based supervision of Drug Court clients. • Access existing online training resources for Drug Court professionals. Speaker(s) Aaron Arnold Director, Drug Court Programs and Tribal Justice Exchange Center for Court Innovation New York, New York Annie Schachar Associate Director Drug Court Programs Center for Court Innovation New York, New York 3:05 p.m. – 3:15 p.m. Break Objectives: 3:15 p.m. – 3:40 p.m. • Demonstrate the widespread use of technology in Patrick Dulin, PhD, will discuss his stand-alone smartphone-based application, and the strong potential to provide needed intervention to Drug Court participants due to their in-the-moment intervention capabilities, their ability to regularly track and provide feedback on ongoing triggers, progress towards goals and their context awareness. everyday life. • Review current state of the evidence on the efficacy of technology for SUDs. • Discuss the ability of technology to improve access to care by circumventing more traditional client and programmatic barriers to treatment. • Understand the capacity of technology to serve as a “clinician-extender.” • Improve receptivity to the use of technology for the treatment of SUDs. Speaker(s) Michael Chaple Executive Director NDRI-USA New York, New York 2:35 p.m. – 3:05 p.m. The Center for Court Innovation will address the current status of the Drug Court field and the potential for use of technology in the future. Objectives • Describe several concrete challenges facing drug courts that may be addressed through innovative uses of technology. 52 NADCP 21st ANNUAL TRAINING CONFERENCE Objectives • Describe how smartphone-based intervention systems can circumvent barriers to treatment. • Discuss empirically-supported interventions that can be delivered by smartphones • Provide the audience with an overview of the content of Step Away modules and its on-going interactivity with a user. • Provide an understanding of how drug court professionals can utilize Step Away with their participants. Speaker(s) Patrick Dulin Director of Here and Now Systems, LLC Associate Professor of Psychology University of Alaska Anchorage, Alaska NADCP Washington, DC 2015 3:40 p.m. – 4:15 p.m. Objectives • Understand the current evidence base for CBT4CBT for alcohol and drug use disorders • Discuss the advantages and disadvantages of a web-based intervention targeting cognitive and behavioral skills. • Review the potential applications of web-based cognitive behavioral interventions with Drug Court and criminal justice clients. Kathleen M. Carroll Albert E Kent Professor of Psychiatry Yale University School of Medicine New Haven, Connecticut 4:15 p.m. – 4:40 p.m. 4:40 p.m. – 5:00 p.m. Question and Answer SESSION SB-32 Ancillary Services: Best Practices Maryland D As every Drug Court practitioner knows, program participants have a host of ancillary issues in addition to addiction. Therefore, Drug Courts must identify and target participants’ criminogenic and other rehabilitative needs in addition to substance abuse treatment. In doing so, Drug Courts should develop individualized case management plans identifying appropriate interventions and services that are updated as the participants’ needs change. This session will review the research and offer practical strategies for incorporating best practices into your Drug Court. Objectives • Understand the critical need for providing ancillary service to ensure participant success. Dr. Curtis will review the findings of Advocates Inc.’s “Technology and Relapse prevention Project” a three year SAMHSA funded project to provide expanded care coordination using Health Information Technology, specifically the ACHESS (Addiction - Comprehensive Health Enhancement Support System) application for smart phones by Drug Court participants. The project provided smart phones equipped with ACHESS, a promising and emerging practice, and distributed those phones to Drug Court participants. • Learn the research supporting the best practices Objectives Richard Schwermer Assistant State Court Administrator Utah AOC Salt Lake City, Utah • Review project goals of Advocates Inc.’s “Technology and Relapse prevention Project.” • Learn implementation success and challenges. MONDAY Dr. Carroll will describe development of the web-based version of CBT (CBT4CBT), now validated in 3 independent trials with treatment seeking substance users. CBT4CBT is effective in reducing substance use, its effects (like those of standard CBT) are durable, and the computer program teaches the targeted coping and cognitive control skills. She will describe the program and its potential uses with criminal justice populations, including an ongoing pilot with the Montana Drug Courts. Hilary Curtis Program Director Behavioral Treatment Court Collaborative Advocates Inc. Ayer, Massachusetts in providing ancillary services in Drug Court. • Identify strategies for incorporating evidence based practices into your Drug Court. Speaker(s) Mary Kay Hudson Problem-Solving Court Administrator Indiana Judicial Center Indianapolis, Indiana • Review technology use highlights: Relationship between technology use and relapse rates. • Learn how the program integrated client and staff feedback into project operations and program improvements. • Understand key summary of findings and sustainability challenges. 53 Setting the Standard MONDAY Annual Training Conference SESSION SB-33 • Trauma-informed services. Gender Matters: Creating Trauma Services for Women and Men • Gender differences in terms of risk and response. Maryland 1-3 • Emotional development. While research and clinical experience indicate a high incidence of co-occurring disorders in women’s lives, counselors and clinicians often struggle with the realities of providing treatment. This workshop is based on a woman-centered trauma treatment curriculum, Beyond Trauma, designed for use in outpatient, residential, and criminal justice settings. Cognitive-behavioral techniques, mindfulness, expressive arts, and the principles of relational therapy are integrated in this strength-based approach. The curriculum also has a psycho-educational component that teaches women what trauma is, its process, and its impact on both the inner self (thoughts, feelings, beliefs, values) and the outer self (behavior and relationships, including parenting). The training includes interactive exercises that demonstrate techniques that counselors can use to help clients develop coping skills, as well as emotional wellness. In addition, there is a segment on specific issues in criminal justice settings. Topics • Developing gender-responsive services • Connection between trauma, mental health, and substance abuse. 54 NADCP 21st ANNUAL TRAINING CONFERENCE • Triggers and retraumatization. • Secondary traumatic stress. • Specific concerns and challenges in criminal justice settings. Objectives • Understand the historical background of trauma. • Explore the connection between addiction, trauma, and mental health. • Discuss gender differences. • Explicate the process of trauma. • Provide specific therapeutic interventions. • Develop strategies for work in criminal justice settings. Speaker(s) Twyla Peterson Wilson Licensed Clinical Social Worker Psychotherapy and Substance Abuse Services Durham, North Carolina Tuesday Schedule of Events July 28, 2015 7:00 a.m. – 7:20 a.m. Come to Your Senses (Facilitated Meditation) Chesapeake JKL Prince George’s Exhibition Hall DE 7:00 a.m. – 5:30 p.m. Registration (Closed During Opening Ceremony) Prince George’s Exhibition Hall DE 8:00 a.m. – 10:00 a.m. Opening Ceremony Potomac Ballroom 10:15 a.m. – 11:30 a.m. Concurrent Workshops Session A 11:30 a.m. – 12:30 p.m. Concessions for Purchase in Drug Court Expo Prince George’s Exhibition Hall DE Setting the Standard 12:30 p.m. – 1:45 p.m. Concurrent Workshops Session B 2:00 p.m. – 3:15 p.m. Concurrent Workshops Session C 3:30 p.m. – 4:45 p.m. Concurrent Workshops Session D Annual Training Conference 5:00 p.m. – 6:15 p.m. Concurrent Workshops Session E 6:30 p.m. – 8:00 p.m. Drug Court Expo with a Dessert Reception Prince George’s Exhibition Hall DE Tuesday 7:00 a.m. – 8:00 a.m. Drug Court Expo Opens with a Continental Breakfast Notes NADCP Washington, DC 2015 POTOMAC BALLROOM Tuesday, July 28 8:00 a.m. – 10:00 a.m. TUESDAY OPENING CEREMONY Presentation of the Colors United States Army Military District of Washington (MDW) Armed Forces Color Guard Pamela Hyde National Anthem Dr. Mark Rosekind (Invited) Cady Huffman Administrator Substance Abuse and Mental Health Services Administration Administrator National Highway Traffic Safety Administration Tony Award Winning Actress Welcoming Remarks Carolyn Hardin Interim CEO National Association of Drug Court Professionals Featured Speakers Michael Botticelli Director White House Office of National Drug Control Policy The Honorable Ruben Reyes Incoming Board Chair National Association of Drug Court Professionals The Honorable Pamela Gray Judge Washington, DC Family Treatment Court The Honorable Michael Kavanaugh Judge (ret) Senior Director National Center for DWI Court Loretta Lynch (Invited) Attorney General United States Department of Justice Special Presentations Parade of Transformation Denise O’Donnell Director Bureau of Justice Assistance Cultural Proficiency Award DWI Court Award 57 Setting the Standard TRACK SESSION A Tuesday, July 28 TUESDAY 10:15 a.m. – 11:30 a.m. SESSION A-1 A Team in Action Maryland D Drug Courts often succeed or fail based on their ability to bring all the various players into a collaborative team. Tulsa County COURTS Programs encompass the largest Drug Court program in Oklahoma and one of the four national mentor courts for Veterans’ Treatment Courts. Their success is due, in large part, to the effectiveness of their teamwork. The collective contributions of each team member at staffing and in court assure the highest level of team effectiveness which, in turn, leads to program excellence and effectiveness. The team will discuss and demonstrate the processes used in Tulsa County at staffing and at court. They will discuss the role of each team member and how they process information from various perspectives in a collaborative manner. Members of the pane will share personal experiences including some of the lessons learned through victories and mistakes. The workshop will cover principles of building an effective team and how these principles are implemented in the Tulsa Problem Solving Courts. Objectives • Gain ideas and tools to build a collaborative team. • Understand the importance of teamwork in the success of Problem Solving Courts. • Gain insight from demonstrations of teamwork at a mock staffing. Speaker(s) Rosie Andrews Supervision Officer Human Skills & Resources Tulsa, Oklahoma Lawrence Gilbert Executive Director/Clinical Director ActionSteps Counseling Tulsa, Oklahoma Ericka Jeffords Program Coordinator Community Service Council of Greater Tulsa Tulsa, Oklahoma 58 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference Corey Roberts Resource Coordinator Community Service Council Tulsa, Oklahoma Tammy Westcott Assistant District Attorney/Director of Alternative Courts Tulsa County District Attorney’s Office Tulsa, Oklahoma Debra Young-Allen Education Coordinator Tulsa COURTS Program Tulsa, Oklahoma SESSION A-2 A Look Inside The Nations Family Drug Courts National Harbor 11 Children and Family Futures has identified Family Drug Court (FDC) best practice models by creating nine mentorship sites across the nation that further the exchange of learning through peer-to-peer technical assistance. Peer Learning Courts host visiting FDC professionals to experience their court in action and share proven policies, practices and lessons learned. During this session, attendees will hear a brief overview of the Peer Learning Court program, including information on how to connect with a PLC site through sharing of resources and/or site visit. In addition, project leaders from each of the PLCs will provide an overview of their respective FDC and highlighted practice, including their implementation experience. The audience will have the opportunity to interact with each of the panel members as they discuss barriers and solutions experienced through the process of implementing FDC best practices. Presenters will also provide an overview of the Peer Learning Court (PLC) program, including information on how to connect with a PLC site through sharing of resources and/or site visit. Objectives • Learn about the Peer Learning Court Program and how to access this peer-to-peer technical assistance opportunity. • Hear from several different successful FDCs describing practice and policy highlights including how they have impacted their outcomes. • Explore solutions to common barriers experienced when implementing best practices in FDCs. NADCP Washington, DC 2015 TUESDAY Ninth Annual Breakfast For New NADCP Members and First Time Conference Attendees POTOMAC 1-3 Thursday, July 30 7:00 a.m. – 7:45 a.m. NADCP members and first time conference attendees are invited to join the NADCP Board of Directors and the Executive Committee for a breakfast on Friday. If you are a first time attendee, but not yet a member, we encourage you to join the NADCP. Speaker(s) Alexis Balkey FDC TTA Program Manager Children and Family Futures Irvine, California Penny Clodfelter Family & Juvenile Drug Court Program Manager Jackson County Family Drug Court Kansas City, Missouri Jocelyn Gainers Executive Director The Family Recovery Program, Inc. Baltimore, Maryland Suzanne Muir Program Director Treatment Alternatives for Safer Communities University of Alabama Birmingham, Alabama SESSION A-3 Seven Habits of Highly Effective Practices When Addressing Adolescent Drug Abuse in Juvenile Drug Courts National Harbor 13 The phrase evidence-based treatment practice (EBPs) gets used frequently in both the juvenile justice and adolescent treatment fields. But, what does EBP really mean and what does it mean to use EBPs. Words like fidelity, adolescent development, treatment dosage, brief intervention, comorbidity are often used in conjunction with EBPs…again, what does all that really mean to juvenile justice professionals? In this session, the presenter will clearly define “7 habits” that will increase effectiveness in your Juvenile Drug Court. Objectives Jill Murphy Program Supervisor King County Family Treatment Court King County, Washington • Participants will learn about the current research Hon. William S. Owens Associate Juvenile Judge Wapello County Courthouse Ottumwa, Iowa • Participants will learn how to integrate these 7 habits Joni Strange Family Dependency Treatment Court (FDTC) Coordinator Chatham County Family Dependency Treatment Court Chatham County, Georgia around teen-friendly approaches. • Participants will learn about treatment dosage for youth. into their programs. Speaker(s) Ken Winters Professor Department of Psychiatry, University of Minnesota Reno, Nevada 59 Setting the Standard Annual Training Conference SESSION A-5 TUESDAY From Compliance to Alliance: Using Recovery and Procedural Justice Principles to Improve Outcomes in Co-Occurring Disorder Cases Chesapeake GHI SESSION A-4 Mental Health Courts A-Z National Harbor 12 This session will teach participants about the history and research base for Mental Health Courts and discuss key issues in deciding whether to start a Mental Health Court, designing a Mental Health Court, and operating and sustaining a Mental Health Court. The session will utilize the CSG Justice Center’s experience in providing training and technical assistance to Mental Health Court grantees for over a decade, and the Justice Center’s online, free curriculum, “Developing A Mental Health Court: An Interdisciplinary Curriculum”, which includes online presentations and resources and live group as well as to help jurisdictions interested in Mental Health Courts. A recently released companion resource, the Handbook for Facilitators, provides further information on how to utilize the content and resources within the Curriculum and will also be discussed in this session. Objectives • Describe the essential elements of a Mental Health Court. • Identify key issues in deciding to start, design, and sustain a Mental Health Court. • Understand the research base for Mental Health Courts, particularly compared to Drug Courts. • Utilize online resources to help learn more about planning and implementing a Mental Health Court. Speaker(s) Emily Harris Program Associate, Courts Program Council of State Governments Justice Center New York, New York 60 NADCP 21st ANNUAL TRAINING CONFERENCE Mental health treatment services are increasingly incorporating principles of recovery, defined by SAMHSA as a process of change through which individuals improve their health and wellness, live a self-directed life, and strive to reach their full potential. Recovery principles, reflected in federal, state and local mental health policies, are revolutionizing the way we look at mental illness and its treatment, offering greater hope and stronger client engagement. But these principles may seem foreign and even troubling to criminal justice practitioners, and treatment court teams may be reluctant to link individuals under court supervision to community-based programs that promote autonomy and empowerment. This workshop will explore the ways that recovery principles can not only be reconciled with Drug Court and Mental Health Court policies and procedures but also promote better outcomes for participants with mental illnesses. Topics will include (1) a summary of Mental Health Court research, which demonstrates a weak connection between traditional treatment of symptoms of mental illness and reductions in criminal behavior; (2) the importance of procedural justice – which emphasizes dignity, voice, understanding and neutrality in the court process – in reducing recidivism; (3) common treatment court practices that incorporate recovery principles; and (4) adaptations of recovery principles for individuals under court supervision that bridge the potential gaps between treatment courts and recovery-oriented treatment providers. The panelists will bring perspectives and examples from multiple disciplines and states. Objectives • Identify SAMHSA’s recovery principles and understand the potential tensions with criminal justice system goals. • Understand the core principles of procedural justice, its impact on recidivism, and its relationship with recovery principles. • Learn strategies for incorporating recovery principles into treatment court policies and procedures to improve outcomes. NADCP Washington, DC 2015 Speaker(s) Norma D. Jaeger Statewide Drug Court and Mental Health Court Coordinator Idaho Supreme Court Boise, Idaho SESSION A-6 Race, Culture, Bias, Treatment, and the Courts: Cultural Competency 101 Chesapeake ABC Cultural Competency 101 is a strength-based interactive session, which provides strategies for professionals to work proactively to address complicated race and cultural issues potentially impacting their court. Concerns such as team members not being aware of bias, racial imbalance of participants, or teams not understanding behaviors of some participants that may be natural to their culture all may impede the retention and engagement of participants. Communication strategies such as, what to say and what not to stay will be addressed with basic respectful ways to respond. A closer look at implicit bias will be reviewed to assist court professionals to examine their own lens and to enhance their interaction with all clients. Objectives • Describe the potential impact of implicit bias. • Identify strategies and techniques to address challenging situations in Drug Court. Speaker(s) Susan James-Andrews President and CEO James-Andrews and Associates Mitchellville, Maryland SESSION A-7 Evaluation Challenges and Solutions in Family Drug Courts Maryland 4-6 This session will include a facilitated group discussion with Family Drug Courts related to evaluation challenges and solutions. Staff from NPC Research and Children and Family Futures will share their experiences with data challenges at multiple program sites. Topics to be covered include 1) the important role of partners, including staff from child welfare and the courts, particularly related to accessing data from different systems, 2) data quality, and 3) common technical assistance needs with regard to program evaluation. Family Drug Court staff members are invited to share their successful strategies and positive outcomes regarding developing partnerships and accessing data. Research staff will also present new findings from recent evaluation projects, discuss what research questions they were able to answer (and what further questions could be answered with additional data), and share some connections between evaluation and technical assistance. The panel will discuss how evaluation implementation and data collection can be used more directly in systems change work. Objectives • Understand the importance of data quality for program improvement and evaluation. • Learn about successes strategies programs have used to access data for evaluation. • Learn strategies programs have used to build partnerships between agencies that facilitated data access. Speaker(s) Juliette Mackin Executive VP & Sr. Research Associate NPC Research Portland, Oregon Chad Rodi Research and Evaluation Director Children and Family Futures Lake Forest, California 61 TUESDAY Carol Fisler Director, Mental Health Court Programs Center for Court Innovation New York, New York Setting the Standard SESSION A-8 Cocaine TUESDAY Maryland A Cocaine, used for centuries to alter consciousness, and popular since the 1980s in its rock or crack form, has been a plague on its users, criminal justice systems and the treatment community for years. However, in many jurisdictions, crack has been falling in popularity compared to meth and newer club drugs. Over the last century, cocaine has seen surges and ebbs in popularity. Research on cocaine dependence and cocaine’s impact on the brain has contributed greatly to the treatment of cocaine addiction. Come learn about cocaine, it’s impact on the brain, and the current strategies in treatment. Speaker(s) Steve Hanson Director Division of Treatment and Practice Innovation, Bureau of Addiction Treatment Centers Rochester, New York SESSION A-9 Critical Role of Risk/Need in Building Incentives and Sanctions Maryland C The research is clear: Drug Courts should focus on individuals with high prognostic risks and criminogenic needs. But how does dealing with someone who has high risk/needs impact how your court delivers incentives and sanctions? What if you mix lower risk and needs populations with higher risk and needs populations? Will your incentives and sanctions have the same impact? This session discusses the importance of risk/need assessment and its relationship to delivering effective incentives and sanctions in your Drug Court. Objectives • Identify the relationship between prognostic risk, criminogenic need, and incentives/sanctions. • Understand how to effectively deliver incentives and sanctions to a high risk/high need population. Speaker(s) Douglas Marlowe Chief of Science, Law, and Policy National Association of Drug Court Professionals Alexandria, Virginia 62 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference SESSION A-10 Search and Seizure and the Role of a Probation Officer National Harbor 10 Participants in a Problem Solving Court, individuals placed on probation or those in pre-adjudication court supervision programs do not lose all protections and rights guaranteed by the United States Constitution and the laws of the various jurisdictions. Specifically, the Fourth Amendment of the United States Constitution protects individuals from unreasonable searches and seizures and the extent of that protection has been addressed in a number of Supreme Court and other appellate court decisions. This session will provide an overview of the law relating to search and seizure in the context of supervised release programs such as probation and Problem Solving Courts with particular emphasis on the balancing of effective supervision and the due process rights of the participant. In addition to analyzing court decisions from different jurisdictions, there will be some discussion of best practices, tips and potential pitfalls to assist the officer in the field to properly consider and comply with the search and seizure rights of the participants Objectives • Analyze and comply with statutes and court decisions regarding search and seizure limitations in probation and Problem Solving Court supervision. • Evaluate the validity of monitoring procedures that impact on the due process protections relating to unreasonable searches and seizures. • Develop effective and constitutional supervision protocols that properly comply with the due process rights of participants. Speaker(s) Helen Harberts Deputy District Attorney (ret.) Chico, California Hon. Earl Penrod Judge Gibson Superior Court Princeton, Indiana NADCP Washington, DC 2015 SESSION A-12 Trauma Informed Judicial Decision Making HEAT Update Chesapeake 7-9 National Harbor 3 A large percentage of Drug Court participants suffer from one or a series of traumatic experiences. While there is an increased emphasis on trauma-informed care from the aspect of the treatment provider, the judge should also be aware of trauma and its impact on participants. In this session four judges who are national experts on trauma informed responses from the bench will address how they respond and talk with Latino participants who are suffering from trauma. This promising practice was introduced at the 2012 conference in Nashville and the preliminary results are in! Habilitation, Empowerment & Accountability Therapy (HEAT) applies a holistic, Afro centric, strength-based model that emphasizes a positive and engaging approach to treatment. It is closely modeled after Afro centric interventions that have previously been standardized and published in CSAP, CSAT and other publications (e. g., Burnett, 2008; Goddard, 1993; Philleo et al., 1997). Objectives • Understand the impact of trauma in Latino populations. • Identify strategies for integrating trauma informed responses from the bench. Speaker(s) Hon. Robert Anchondo Criminal Court Judge DWI Drug Court Intervention and Treatment Program El Paso County, Texas Hon. Jo Ann Ferdinand Judge Brooklyn Treatment Court Brooklyn, New York Objectives • This session provides an overview of this manualized approach to providing services in Drug Court. Speaker(s) Darryl Turpin President Darryl Turpin Consulting Louisville, Kentucky Guy Wheeler President Guy A. Wheeler Group Plantation, Florida Hon. Marcia Hirsch Judge Queens Treatment Court Kew Gardens, New York 63 TUESDAY SESSION A-11 Setting the Standard TUESDAY SESSION A-13 Annual Training Conference SESSION A-14 Gender Responsive Strategies and Trauma Informed Care in Community Treatment What Does My Drug Test Result Really Tell Me? National Harbor 4 Understanding what results really indicate. Is the THCA positive reuse or residual elimination. Did that donor test positive for cocaine due to use, accidental ingestion, dermal adsorption or passive inhalation. This program should assist the end user in better understanding the results they receive from the laboratory. We will also touch on new drugs, synthetic cannabinoids, synthetic stimulants and natural occurring plant materials. This workshop will provide information on the experiences of women journeying through the transition/ recovery process of the Drug Court program. Using evidence based principles the program will address the specific and unique needs of women. Trauma informed treatment play a vital role in the therapeutic process. Stepping stones of empowerment, self worth and building self esteem are explored through the process of treatment, as well. The paths women travel throughout the therapeutic experience, including obstacles, are shared. The women begin the journey searching for strength, courage, acceptance and wisdom in order to become confident and empowered to move forward in life overcoming adversity in order to live a life of sustained recovery. Objectives • To understand the purpose of gender responsiveness in the therapeutic environment. • To gain an understanding of barriers women face during reintegration into the community. • To gain an understanding of the journey to finding self in the therapeutic environment and to address trauma related issues. Speaker(s) Carol Berger Criminal Justice Liaison Community Education Centers, Inc. West Caldwell, New Jersey Angela Mims Treatment Provider Education & Health Centers of America, Inc. Trenton, New Jersey 64 NADCP 21st ANNUAL TRAINING CONFERENCE National Harbor 6-7 Objectives • Determining new use or residual elimination of THCA. • Cocaine positive from use, passive inhalation, dermal adsorption or accidental ingestion. • Understand the synthetic opiates. • Understand the truth about synthetic cannabinoids. • Learn about the new drugs on the streets. Speaker(s) Pat Pizzo Director of Toxicology Alere Toxicology Services Gretna, Louisiana NADCP Washington, DC 2015 SESSION A-15 TUESDAY Technology in YOUR Court: Learn How Web Based Case Management Can Support Performance Benchmarks and Best Practices Chesapeake 4-6 Accountability Court case management systems provide an efficient way to regain time for judicial decision making even as money and court staffs decrease. In addition, case management systems help the courts to meet nationally recognized best practices, and to gain 24/7 access to real-time participant status updates and progress. Conference attendees that participate in this training session will learn how Accountability Court case management systems address and assist the court to meet the Ten Key Components and Performance Benchmarks of Drug Courts. Attendees will also learn how web based case management can promote accuracy and accessibility to data, help to move the courts to a paperless system, and encourage just dispositions through accountability. Speaker(s) Libby Blackwell Director of Court Product Development Five Point Solutions Dacula, Georgia Taylor Jones Project Manager Five Point Solutions Dacula, Georgia SESSION A-16 The 10 Guiding Principles of DWI Courts Chesapeake 10-12 This session gives an overview of the principles which make DWI Courts different enough to merit specialized practices. The “Key Components of Drug Court” have not gone away in DWI Courts but rather have been supplemented by the Guiding Principles. Fidelity to the DWI Court model includes both documents as fundamental to the success of these programs. The presenters are national experts on DWI Courts and bring a wealth of knowledge and experience to the topic. Speaker(s) Hon. Michael Barrasse Presiding Judge Lackawanna County Veterans Treatment Court Scranton, Pennsylvania Hon. Michael Kavanaugh Judge (Ret) National Center for DWI Courts Alexandria, Virginia 65 Setting the Standard Annual Training Conference SESSION A-17 TUESDAY Keeping Kids Safely at Home: A Discussion on Legal Issues in an In-Home FDC Model Maryland 1-3 The Family Drug Court (FDC) model is characterized by court-based collaboration among child welfare, substance abuse treatment providers and the legal system. FDCs have emerged as a model of meaningful collaboration that address the specific needs of children and families affected by substance use by providing comprehensive services which allow children to remain safely at home while contributing to a parent’s recovery, and family well-being. This presentation will explore the legal issues associated with an In-Home FDC model and highlight outcomes from the Children Affected by Methamphetamine (CAM) Grant and Regional Partnership Grant Program outcomes. The presentation will highlight a Pre-Filing FDC model in Birmingham, Alabama, initiated as a way to bring child welfare, substance abuse treatment, and courts together to intervene early by offering preventive services in order to address the cycle of drug use and child abuse/neglect within their community. Objectives • Explore the legal issues associated with an In-Home FDC Model. • Discuss opportunities and challenges associated with children remaining in-home while participating in FDC. • Explores the lessons and experiences of an FDC site (Birmingham, AL) in addressing legal obstacles associated with the implementation of an In-Home FDC Model. Speaker(s) Phil Breitenbucher FDC TTA Program Director Children and Family Futures, Inc. Irvine, California Hon. Alan Summers Family Drug Court Judge Jefferson County Family Court Birmingham, Alabama 66 NADCP 21st ANNUAL TRAINING CONFERENCE SESSION A-18 The New ASAM Criteria: Implications for Drug Courts and Treatment Providers National Harbor 2 The ASAM Criteria are the most widely used guidelines for intake, assessment, service planning and placement, continued stay and discharge of patients with addictive disorders. This presentation will highlight what treatment providers should know about ASAM Criteria principles, assessment and treatment levels. There will be discussion of how to use The ASAM Criteria to shift drug and other Problem-Solving Courts from a program-driven to outcomes-driven model and achieve lasting change. Objectives • Identify the guiding principles of The ASAM Criteria and how it interfaces with criminal justice settings. • Apply ASAM Criteria multidimensional assessment to individualize treatment and move from programdriven treatment to outcomes-driven services. • Discuss how treatment providers can collaborate with court personnel through the common language of The ASAM Criteria to achieve lasting change. Speaker(s) David Mee-Lee Senior Vice President The Change Companies Carson City, Nevada NADCP Washington, DC 2015 SESSION A-19 Working Effectively with Native Participants National Harbor 5 Objectives • Learn about the history of tribes and Tribal Healing to Wellness Courts. • Learn strategies for collaboration between sovereigns. • Learn strategies for working with Native participants within State Drug Court. Speaker(s) Hon. Joseph Flies-Away Chief Justice Hualapai Court of Appeals Hon. Lawrence Lujan Judge Ysleta del Sur Pueblo El Paso, Texas Mark Panasiewicz Treatment Provider Keweenaw Bay Indian Community West Hollywood, California Five Ways to Wreck Your Career: Ethics for Treatment Providers Maryland B Treatment professionals are tasked with assisting individuals whose substance involvement has left them temporarily vulnerable to exploitation, coercion, enmeshment, and a variety of other perils. In many respects those involved in the criminal justice system are especially at-risk as the power balance between participant and helper is tilted heavily to the helper. This reality places a special burden on practitioners to structure programs and practices to encourage ethical conduct. However even the well-intentioned may find themselves in sticky situations that threaten careers, families, and reputations. This interactive presentation will provide strategies for recognizing and resolving vexing ethical dilemmas. Objectives • Understand the dynamics of ethical conduct and misconduct when providing Drug Court treatment. • Identify the five most common ethical pitfalls facing providers and how to navigate around them. • Identify how treatment providers can ethically collaborate and communicate with Drug Court team members, while respecting the privacy and confidentiality of participants. Speaker(s) Terrence Walton Chief of Standards NADCP Alexandria, Virginia 67 TUESDAY State and tribal courts stem from separate sovereigns and different histories, enforce different laws, and serve different, yet often overlapping populations. Similarly, Native participants have different histories and worldviews. Recognition of these differences, however, can strengthen rather than diminish the services that we provide. This workshop/plenary will explore the history that informs Tribal Healing to Wellness Courts, potential benefits to both Tribal Wellness Courts and State Drug Courts from collaboration, and will explore strategies for working with Native participants within a State Drug Court, including cultural competency and strategies for effectively incorporating culture and tradition into the Healing to Wellness Court/Drug Court. SESSION A-20 TUESDAY Setting the Standard Annual Training Conference SESSION A-21 SESSION A-22 Building Bridges between Drug Treatment Courts and the Addiction Recovery Community Matrix Model for Criminal Justice Settings Chesapeake JKL The presentation will provide attendees information on the Matrix Model for Criminal Justice Settings. Local addiction recovery communities are a resource for drug court participants and drug treatment court professionals. This workshop will introduce the Association of Recovery Communities (ARCO), which represents over 100 local recovery community organizations as well as national organizations representing recovery schools and recovery residences. Workshop participants will be provided with a case study on how the Henrico Drug Treatment Court and the McShin Foundation, a Richmond, Virginia based peer recovery community organization, built an effective working relationship. Objectives • Learn about ARCO and how its members can be a local recovery resource. • Learn how to build and sustain working relationships with your local recovery community. • Understand what the challenges and opportunities are in developing relationships with the local recovery community. Moderator Carol McDaid Principal Capitol Decisions Washington, D.C. Speaker(s) Honesty Liller CEO McShin Foundation Richmond, Virginia Patricia Shaw Administrator Henrico County Drug Treatment Court Henrico, Virginia 68 NADCP 21st ANNUAL TRAINING CONFERENCE Chesapeake DE Programs and clinicians will find this treatment model to be a valuable tool for Drug Court programs, correctional and jail programs, reentry and outpatient programs treating justice involved populations. The program includes the treatment of substance use disorders and the thinking errors that lead to criminal behaviors in a comprehensive integrated approach. Programming of the model includes two types of populations: • Individuals who meet criteria for substance use disorders who commit crimes or become involved in the criminal justice system as a result of their use. • Individuals who meet criteria for anti-social personality disorder and use substances. The program will address strategies for both populations and inclusive of best practices that will lead to improved clinical and overall program outcomes. An adjustment section is also included to address issues specific to justice involved populations, such as employment/ housing barriers and family reintegration. Objectives • How to provide a comprehensive integrated clinical program that works with a Drug Court phase system. • How to adjust treatment addressing 2 different types of justice involved populations. • Discuss the adjustment phase of treatment specific to issues typical of justice involved clients such as employment/housing. Speaker(s) Donna Johnson CEO Addiction Solutions Inc Cartersville, Georgia NADCP Washington, DC 2015 TRACK SESSION B Tuesday, July 28 12:30 p.m. – 1:45 p.m. TUESDAY SESSION B-1 Ten Key Components and the Research Maryland D How can you use the Ten Key Components as a foundation for building a more successful Drug Court? What research has been done on the effectiveness of Drug Court and the use of the Ten Key Components? Come hear how to integrate the Components into the court structure and how to help your court conform to best practices, along with examples of forms and documents utilized by the Drug Court. Objectives • Gain awareness of the Ten Key Components, how they provide the structure for a court and what documents and forms are necessary for Drug Courts to achieve the performance benchmarks connected to the Components. • Learn about the research done on the Ten Key Components and Drug Court effectiveness. Speaker(s) Hon. Christine Carpenter Circuit Court Judge 13th Judicial Circuit Columbia, Missouri Juliette Mackin Executive VP & Sr. Research Associate NPC Research Portland, Oregon SESSION B-2 Collaborative Approaches to Drug Endangered Children National Harbor 11 This presentation by the National Alliance for Drug Endangered Children (National DEC) focuses on how to implement the DEC Approach which is a comprehensive strategy based on collaboration between various disciplines and agencies that has proven to be effective in improving the likelihood of better outcomes for drug endangered children. This presentation will provide insights about how various practitioners— including child welfare professionals, law enforcement officers, court/judicial professionals, prosecutors, probation/parole, medical personnel, educators and treatment providers—are in a position to identify, protect, and serve drug endangered children and their families. As a significant expansion of the collaborative approach utilized by drug courts, the DEC approach leads to better communication and more informed decisions among a wide array of practitioners who are in a position to help drug endangered children. The presenters will discuss the identification of risks to drug endangered children and what all disciplines can look for when collecting evidence and information on drug endangered children. Presenters will utilize pictures and video of real DEC scenarios to assist professionals in understanding what to look for regarding the “life of the child”. 69 Setting the Standard Objectives TUESDAY • Gain insight about how our own experience, attitudes, values and emotions impact effective collaboration under the DEC Approach. • Gain insight about our collaborative partners to decrease frustrations when utilizing the DEC Approach. • Understand how utilizing collaboration leads to more informed decisions and increased likelihood of better outcomes on behalf of drug endangered children and their families under the DEC Approach. • Implement change in identification of children, mandatory reporting, and evidence and information collection in our respective practices on behalf of drug endangered children. Speaker(s) Eric Nation Director of Training and Development National Alliance for Drug Endangered Children Westminster, Colorado Stacee Read Director of DEC Network Development National Alliance for Drug Endangered Children Westminster, Colorado SESSION B-3 Assessing Fidelity to a Logic Model: The National Cross-Site Evaluation of JDC/RF Experience National Harbor 13 Logic models are an important component of program planning and assessment. They are a unified method to operations that link the problem at hand with associated goals, objectives, program activities, outputs, and outcomes. Logic models also serve as a yardstick against which evaluators measure a program’s progress, and can be used by programs to measure their own progress. But how can a logic model be effectively used to assess program implementation? Further, does a program’s fidelity to the logic model even matter? Using experiences from their work on the National Cross-Site Evaluation of Juvenile Drug Courts (JDC) and Reclaiming Futures (RF), the presenters will describe the utility of logic models when conducting a process evaluation. Specifically, the presenters will discuss their methodology used to develop a scale that examines the extent to which participating evaluation 70 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference sites adhered to the JDC/RF logic model and implemented the model with fidelity. This process involved the evaluation team creating measures for logic model components and scoring sites in accordance with these measures. The presentation will also provide a brief overview of logic models and how to develop them, lessons learned from this piece of the evaluation, and explore the linkages between model fidelity for particular activities and aggregate outcomes. Objectives • Understand how logic models can be used as an evaluation tool to assess program implementation. • Learn how to assess program fidelity to a logic model. • Discover if program fidelity to a logic model effects program activities and outcomes. Speaker(s) Alison Greene Director of Adolescent Research and Services University of Arizona Southwest Institute of Research on Women (SIROW) Tucson, Arizona Raanan Kagan Senior Policy Analyst Carnevale Associates Gaithersburg, Maryland Erika Ostlie Managing Director Carnevale Associates, LLC Gaithersburg, Maryland NADCP Washington, DC 2015 SESSION B-4 TUESDAY Solving the “Rubik’s Cube” of Mental Health Courts: Effective Strategies for Establishing Statewide Standards National Harbor 12 Research indicates that there is an overrepresentation of offenders with serious mental illness and/or co-occurring disorders in our jails and correctional facilities. In the past few years, this concern has led a number of Arizona courts (including Limited and General Jurisdiction Courts) to establish some form of Mental Health Court to process criminal cases involving people with serious mental illnesses. These locally developed problemsolving courts strive to reduce the incarceration and recidivism of people with mental illnesses by linking them to appropriate mental health services and supports. But is it that easy? The Arizona Supreme Court has been tasked with establishing statewide standards for Mental Health Courts but, how do you solve the puzzle of developing consistencies across programs and jurisdictions while ensuring program effectiveness, procedural fairness, and adherence to evidence based-practices? Objectives • Understand the challenges of establishing statewide standards. • Identify key partners to serve on the advisory group. • Develop the framework for establishing statewide standards. Speaker(s) Susan Alameda State Coordinator AZ Supreme Court: Adult Probation Services Phoenix, Arizona Mark Stodola NHTSA/APPA Probation Fellow American Probation and Parole Association Lexington, Kentucky Nicole Waters Principal Court Research Consultant National Center for State Courts Williamsburg, Virginia SESSION B-5 Co-Occurring Disorders in Mental Health Courts Chesapeake GHI This session will discuss how to identify the most appropriate courts for individuals with co-occurring substance use and mental health disorders in communities with multiple Problem Solving Courts, as well as how to work with individuals with co-occurring disorders who are participating in a Mental Health Court program. Participants will learn about treatment modalities for clients with co-occurring disorders, and receive handouts to help identify resources and treatment options in their community. Objectives • Understand the Risk-Needs-Responsivity Principle and its application in a Problem-Solving Court. • Identify appropriate treatment modalities for individuals with co-occurring substance use and mental health disorders. • Understand methods for working more effectively with individuals with co-occurring substance use and mental health disorders in a Mental Health Court. • Utilize handouts and resources to help identify treatment options and community resources for clients with co-occurring needs in their jurisdiction. Speaker(s) Sarah Wurzburg Policy Analyst National Initiatives New York, New York 71 Setting the Standard Annual Training Conference SESSION B-7 TUESDAY The Pathway to Minnesota’s Drug Court Expansion: Using Statewide Research as Leverage for Expansion Maryland 4-6 SESSION B-6 What Your Mama Didn’t Teach You (For Men Only) Chesapeake ABC Women and girls often present with multiple issues that many men may not always feel comfortable responding to. Unintentionally men can sometimes exacerbate problems when working with females by what they say and often what they don’t say. Male court professionals with good intentions can often create an unsafe situation for themselves and sometimes the client. From the bench to the community being gender responsive to the unique needs of females can support positive outcomes for the client as well as ensuring the safety for males interacting with females who have experienced trauma. Objectives • Identify challenges for men working with women and girls. • Discuss realistic strategies to maintain safety for the team and the client. Speaker(s) Susan James-Andrews President and CEO James-Andrews and Associates Mitchellville, Maryland 72 NADCP 21st ANNUAL TRAINING CONFERENCE This session will describe Minnesota’s strategy for expanding Drug Courts across the state, focusing on how it is using recent statewide Drug Court (adult substance abuse and DWI) research to support the expansion effort. Beginning with a Statewide Drug Court Evaluation (adult substance abuse courts) in 2012 and additional follow up analysis in 2014, together with a Statewide DWI Court Study released in September 2014, Minnesota’s Drug Court Initiative (DCI) crafted, and began implementing, a five year expansion plan. The DCI is also leveraging the research to engage Judicial, Executive, and Legislative Branch leadership in further policy, funding and implementation discussions and for developing peer mentoring and performance-based funding, all with eye toward statewide implementation and improvement. Objectives • Learn how to use research effectively to develop and promote Drug Court expansion. • Understand challenges in expansion efforts (it’s not just the funding). • Learn effective strategies for engaging Judicial, Executive, and Legislative Leadership in expansion efforts. Speaker(s) Michelle Cern Statewide Drug Court Coordinator Minnesota Judicial Branch Saint Paul, Minnesota Hon. Shaun Floerke Judge Minnesota Judicial Branch Duluth, Minnesota NADCP Washington, DC 2015 SESSION B-8 Alcohol Maryland A Objectives • Identify the neurochemical actions of alcohol in the brain. • Identify the symptoms of the acute use of alcohol, its chronic use consequences and withdrawal symptoms. • Understand Evidence-Based Treatment Implication. Speaker(s) Kenneth Robinson President Correctional Counseling, Inc. Germantown, Tennessee Hon. William Meyer Judge/Senior Judicial Fellow Judicial Arbiter Group Denver, Colorado TUESDAY Neuroimaging has yielded new evidence about the effects on the brain of alcohol use. This presentation will focus on those new findings as well as describe the psychopharmacology of alcohol use from both an acute and chronic use perspective. The session will also discuss the implications of this research on the treatment for alcohol dependency. Speaker(s) SESSION B-10 The Smoking Gun: The Role of Law Enforcement and Ethical Issues in a Drug Court Setting National Harbor 10 Police and Probation Officers face unique challenges in Drug Court. Some of these challenges present as ethical dilemmas. Officers are often aware of treatment information which they may not be able to reveal. Sometimes officers are aware of criminal justice investigations which they cannot reveal. When are you at risk for an ethical breach? What will you do? Objectives • Learn how to identify ethical problems in a Drug Court context. • Identify methods of dealing with ethical issues in the Drug Court. • Learn common ethical problems officers and police SESSION B-9 Fundamentals of Incentives and Sanctions in Adult Drug Court Maryland C Incentives and sanctions are essential tools of the Drug Court team. However, many Drug Court teams do not base their responses on scientific strategies. Over the past years, the National Drug Court Institute (NDCI) has offered topic-specific training programs for Drug Court teams after the completion of a thorough literature review of over 100 articles pertaining to shaping behavior. This session will offer an in-depth analysis of the ten science-based principles every Drug Court should consider before responding to client behavior. face in Drug Court. Speaker(s) Vanessa Price Law Enforcement Inspector, Ret. Chair – Oklahoma Pardon and Parole Board Oklahoma City, Oklahoma Objectives • Identify practical applications of the ten science based principles in developing a comprehensive strategy on incentives and sanctions. • Identify successful strategies for using incentives and sanctions in an Adult Drug Court . • Learn the ten science-based principles of changing behavior. 73 Setting the Standard Annual Training Conference SESSION B-12 From the Needle to the Pen: Telling it Like it is! -Addicted to Drugs or Addicted to the Lifestyle TUESDAY National Harbor 3 SESSION B-11 Cultural Proficiency with Latinos in Drug Court Practice Chesapeake 7-9 Achieving behavior change can be extremely difficult for Latino client populations when adhered to cultural values challenge or contrast the strategies used by the Drug Court professionals and desired program outcomes. Further, practitioners are not always privy to the cultural nuances that can impact behavior change with Latinos/as. This presentation will offer a cultural competent modality that practitioners can tap into and elicit the adhered to Latino cultural facets that impact behavior change, and essentially forge a successful recovery process for this diverse population. Objectives • Identify at least two culturally based questions that can be added to traditional client assessment tools. • State that integrating the Latino client’s culture can help lead to effective and sustainable behavior change. • List at least two points of Drug Court program and client contact where the cultural competence modality can be integrated. Speaker(s) Diana Padilla Program Manager NDRI USA / NeC ATTC New York, New York 74 NADCP 21st ANNUAL TRAINING CONFERENCE Substance abusing and criminal justice clients are not just addicted to drugs but are often addicted to a lifestyle that court teams continue to miss or even begin to understand. Without discussing these dynamics, clients continue to fail, especially from a cultural perspective. The author discusses and shares through his writings, how he manipulated and conned various professionals, and how the pen became his salvation in the midst of his addiction to fight for sanity in the unforgiving insanity of the drug world. This session further identifies what Drug Court practitioners can do to address these dynamics to support success for racially and culturally diverse participants. Objectives • Define the lifestyle of addiction and how it impacts success. • Explain the relationships between addiction to the drug and addiction to the lifestyle and the implications for Drug Courts. • Identify strategies for practitioners to use from peer coaching to recognizing unrealistic expectations. Speaker(s) Timothy James Author “From the Needle to the Pen” Atlanta, Georgia Guy Wheeler President Guy A. Wheeler Group Co-Chair: Thurgood Marshall Action Coalition Plantation, Florida NADCP Washington, DC 2015 SESSION B-13 SESSION B-14 Target 25: Pennsylvania’s Nationally Recognized DUI Reduction Initiative National Harbor 4 National Harbor 6-7 Justice system involved and substance abusing individuals historically experience incidents of trauma. Trauma means experiencing, witnessing, or being threatened with an event or events that involve actual serious injury, a threat to the physical integrity of one’s self or others, or possible death. If individuals suffering from trauma do not receive specialized intervention from trained staff, prospects for long-term recovery are diminished. Substance abusing individuals with misidentified or misdiagnosed trauma-related symptoms often have difficulty seeking help for their addiction and engaging in treatment, which makes relapse more likely. A trauma informed approach in Drug Courts and substance abuse treatment programs is essential to effectively address the multiple and unique needs of trauma survivors. Target 25 is the early identification, placement, and pretrial supervision of second and subsequent offense DUI offenders. Started in 2010 in York County, Pennsylvania, Target 25 uses 24/7 concepts and is designed to be a complement to DUI Treatment Courts. Target 25 runs as a collaborative program in partnership with the District Attorney’s office, the Court of Common Pleas, the minor judiciary, local law enforcement, the Sheriff’s Department, Adult Probation, the Clerk of the Courts, and the local defense bar. In the last year Target 25 and its founder, the Honorable John S. Kennedy, have been nationally recognized by NHTSA and the Governor’s Highway Safety Association for its unprecedented results, including reductions in the number of repeat drunk driving offenses; crashes resulting in injury or fatality due to a drinking driver; and the rates of re-arrest, failures to appear, and revocation. This session assumes prior knowledge of trauma informed care principles and primarily will focus on ideas and practical solutions for implementing traumainformed care principles into an existing Drug Court or program. Objectives • Provide a brief refresher on Trauma Informed Care Principles. • Identify areas where individuals can be re-traumatized in criminal justice settings. • Brainstorm ideas and practical solutions for implementing trauma-informed care principles. Speaker(s) Joseph Madonia Project Director Brooklyn Treatment Court Brooklyn, New York Sky Pena-Davis Project Manager, Office of Policy and Planning NYS Unified Court System New York, New York Christina Ruffino Project Manager, Drug Court Programs Center for Court Innovation New York, New York Objectives • Learn how the Target 25 program came to be and what the most recent statistics show in terms of local impact. • Hear from leaders in the York County criminal justice community about how to engage, develop, and coordinate a multi-departmental program like Target 25 in order to improve outcomes. • Learn about the specific requirements of the program, including methods to promote early intervention and treatment, 24/7 alcohol monitoring, and more. Speaker(s) Tim Barker Chief Deputy Prosecutor York County DA’s Office York, Pennsylvania Hon. John S. Kennedy Judge York County Treatment Courts York, Pennsylvania 75 TUESDAY Implementing Trauma-Informed Care Principles into Your Program Setting the Standard SESSION B-15 TUESDAY Alcohol Monitoring and Testing Technologies: A Primer for New Programs, a Refresher on Policies Chesapeake 4-6 Drug Courts are on the front line of providing encouragement when offenders succeed, and holding them accountable when they fail to meet their obligations. Sobriety is a major obstacle for many offenders. In fact, a survey of 1.2 million prisoners in state correctional facilities found that one-third had been using alcohol at the time of their offense. Ensuring offenders stay sober while released to community supervision has many positive effects. Criminal justice officials can effectively use rapidly evolving technology to track alcohol consumption by Drug Court participants. This workshop is for agencies considering an alcohol monitoring program. Objectives • Attendees will learn the basics of alcohol testing methods and devices, including continuous alcohol monitoring, the benefits of adding a program, key considerations, and how to begin with a focus on policy development. • This workshop is geared to professionals and administrators who are new to alcohol testing and electronic monitoring and/or considering implementing such a program within their agency. • It will also offer program administrators a refresher on policy and program development. Speaker(s) Joseph Johnson Account Executive Specializing in Offender Monitoring BI Incorporated Boulder, Colorado Annual Training Conference SESSION B-16 The Computerized Assessment and Referral System (CARS) - Identifying Mental Health Disorders Among DUI Offenders Chesapeake 10-12 Repeat DUI offenders often suffer from a number of psychiatric disorders and other psychosocial risks, suggesting that untreated mental health and behavioral issues likely contribute to the persisting rate of DUI. However, treatment for DUI offenders most commonly consists of alcohol education and alcohol treatment only. This presentation describes an innovative assessment in the final stages of development, the Computerized Assessment and Referral System (CARS), for use in DUI treatment and court settings. CARS packages a powerful mental health assessment with a user-friendly interface, increased flexibility, treatment referrals, and immediate personalized output, to create a tool that can be used easily by DUI programs to screen DUI offenders and target comorbid mental health issues. CARS is being evaluated through a randomized controlled trial at two separate DUI treatment locations. The study compares a screener, full, and self-administered version of the CARS tool. We are collecting both staff and client impressions, as well as data from CARS and follow-up information from clients, courts, and aftercare providers post-treatment to determine the usability of CARS, its efficacy as a brief intervention, and the relationship between psychiatric comorbidity and outcome among first-time and repeat DUI offenders. This session will present the latest findings from this study. Objectives • Gain a better understanding of the mental health profiles of first-time and repeat DUI offenders. • Learn why it is important to screen for mental disorders in DUI populations and learn about a new screening tool. • Engage in discussion of how and where such screening could occur within the DUI court process. Speaker(s) Sarah Nelson Associate Director of Research Division on Addiction, Cambridge Health Alliance; Harvard Medical School Medford, Massachusetts 76 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 SESSION B-17 Indian Country Legal Implications Maryland 1-3 Objectives • Learn the applicable federal Indian law, including the Indian Civil Rights Act, TLOA, and VAWA. • Learn the applicable federal Drug Court law. • Explore state Drug Court case law for strategies in tribal court. Speaker(s) Hon. Joseph Flies-Away Chief Justice Hualapai Court of Appeals Phoenix, Arizona Unique Aspects of Behavioral Healthcare in Drug Treatment Courts National Harbor 2 Treatment providers working with drug treatment courts seldom have prior relevant formal education and only limited experience in working with the criminal justice system and court-based interventions, such as drug treatment courts. The differences between traditional and drug treatment court practice are numerous, unique, and profound. These include ethics, client choice, informed consent, confidentiality, duty to warn/protect, evidence-based treatments for this population, participation in a multidisciplinary team, motivational issues, behavior management, and the central if often neglected role of criminogenic risks and needs. Additionally, Drug Court participants typically present with a complex range of concerns, such as co-occurring disorders, trauma, and criminal thinking. Relying solely upon on-thejob learning extends the learning curve of clinicians, diminishes the potential benefits of treatment, and puts the clinician at risk to run afoul of the court and other elements of the criminal justice system. This presentation will assist both new and experienced treatment providers in identifying the similarities and distinctions from traditional practice and the appropriate adaptations to make in order to work successfully in the drug treatment court setting. Relevant research, practical experience, case vignettes, and discussion will be used as learning tools. Carrie Garrow Consultant Tribal Law and Policy Institute West Hollywood, California Objectives Lauren van Schilfgaarde Tribal Law Specialist Tribal Law and Policy Institute West Hollywood, California • Improved ability to function as a member of the • Understand the significant differences in ethical practice in traditional counseling and that employed in the Drug Court setting. multidisciplinary Drug Court team. • Acquire greater skill in implementing best practices in addressing those needs most related to criminal conduct. Speaker(s) Hartwell Dowling Coordinator of Specialty Dockets and Grants Administrative Office of the Courts Augusta, Maine Sonya Harper Project Director of NDCRC NDCI - The Professional Services Branch of NADCP Alexandria, Virginia 77 TUESDAY Tribal Healing to Wellness Courts function under a different legal framework compared to their State Drug Court counterparts. This workshop will explore that legal framework, including the Indian Civil Rights Act, the newly enacted Tribal Law and Order Act and the Violence Against Women Act, as well as potentially applicable tribal law. In addition, this workshop will examine the common legal structures that adult, family, and juvenile Healing to Wellness Courts adopt. Finally, this workshop will explore common legal issues faced by Healing to Wellness Courts, including state Drug Court case law, which while not authoritative, nevertheless offers insights into legal issues facing Healing to Wellness Courts. SESSION B-18 Setting the Standard SESSION B-19 TUESDAY Tribal Youth Wellness: Responses to Underage Drinking Among Native Youth National Harbor 5 The serious consequences of alcohol abuse among Native youth have been repeatedly affirmed though research. Studies including Monitoring the Future and the National Household Survey on Drug Abuse have consistently shown that that American Indian and Alaska Native youth are more likely to start drinking at a younger age, more likely to drink heavily, more likely to use drugs together with drinking, and more likely to suffer higher alcohol-related consequences than their non-Native peers. Considering that excessive alcohol consumption is a leading cause of death among American Indians and Alaska Natives, alcohol abuse among Native youth can be particularly devastating for many tribal nations. The Center for Court Innovation is currently working with the National Council of Juvenile and Family Court Judges and several tribes around the country to explore innovative responses to underage drinking. At this session, the Center for Court Innovation will share timely information about effective interventions currently being used in tribal courts and lessons learned from this project. The presenters will also facilitate a discussion among participants around the particular challenges faced by tribes as they seek to empower their youth and divert them from destructive alcohol-related behaviors. This session seeks to enable participants to develop effective responses to underage drinking among Native youth in their own communities. Objectives • Understand the nature and scope of underage drinking and its attendant consequences among Native youth. • Identify innovative strategies for addressing underage drinking in tribal Healing to Wellness Courts. • Engage with other tribal justice practitioners to discuss different approaches to addressing underage drinking. Speaker(s) Aaron Arnold Director, Drug Court Programs and Tribal Justice Exchange Center for Court Innovation New York, New York 78 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference Precious Bennally Senior Associate Drug Court Programs and Tribal Justice Exchange Center for Court Innovation New York, New York Adelle Fontanet Senior Associate, Tribal Justice Exchange Center for Court Innovation New York, New York SESSION B-20 The Zealous Advocate Maryland B As defense attorneys working in a treatment court we are in the unique situation as counselors for our clients, advocates within the legal system and members of a treatment team. At times each of these rolls seems to be in direct conflict with another. However, research has shown that having the defense attorney as a regular member of the Drug Court team helps to increase success rates among the participants. In this session we will explore how to help participants understand and feel comfortable with your role as their legal counsel and as a member of the treatment team. We will identify rules of conduct as they apply to Attorney ethical obligations. Finally we will discuss how being a member of a treatment team is different from traditional legal roles and ways in which to help other members of the team understand why your role as an advocate must be maintained even within the non adversarial approach of Drug Court. Objectives • Identify the unique role of the defense attorney in the treatment court setting. • Understand the defense attorney’s role in developing and applying evidence based standards within the treatment court process. • Explore ways to help participants and team members understand the role of the defense attorney as a team member and an advocate. Speaker(s) Melynda Benjamin Chief - Specialty Court Division Kane County Public Defender’s Office St. Charles, Illinois NADCP Washington, DC 2015 SESSION B-21 Bring Drug Court to Your State Legislators Chesapeake JKL Objectives • Learn how to organize and implement a successful State Capitol Hill Day. • Identify ways to work with state legislatures to support Drug Courts, DWI Courts and Veterans Treatment Courts. • Learn effective ways to get your message heard at your state capitol. Speaker(s) Hon. Brent D. Benjamin Judge West Virginia Supreme Court of Appeals Charleston, West Virginia Hartwell Dowling Coordinator Specialty Dockets and Grants Administrative Office of the Courts, Maine Augusta, Maine James M. Eberspacher Project Director National Center for DWI Courts Alexandria, Virginia SESSION B-22 Is “Fair Treatment” an Evidence-Based Practice? How to Measure the Presence and Effects of Procedural Justice Chesapeake DE A common theme has emerged from a number of recent studies of Drug Courts and other problem-solving courts: defendants’ perceptions of the judge and the court process are key. The NIJ’s Multi-Site Adult Drug Court Evaluation, published by the Urban Institute, RTI International, and the Center for Court Innovation, found that Drug Courts whose judges interacted with defendants in a fair, respectful, and knowledgeable way were more effective, i.e. reduced drug use and reduced future offending. Similar findings have been shown for There is a robust research basis to support these findings. The concept – called procedural justice – holds that when litigants perceive the process to be fair, they are more likely comply with court orders and the law generally. Procedural justice includes several key dimensions, including treating litigants with respect, ensuring their understanding of court procedures, and providing an opportunity to be heard. This presentation will provide an overview of relevant procedural justice research and its connection to the broader topic of improving justice system legitimacy. Faculty will highlight studies and demonstration projects nationally in various justice system contexts that have experimented with the approach. Faculty will also describe a multi-year project funded by the Department of Justice to help the field understand procedural justice, assess their capacity to improve litigant perceptions of fairness, and make concrete improvements The presentation will explain available self-assessment resources and how they are being tested in pilot jurisdictions around the country. Lastly, faculty will engage the audience in a discussion of promising practices that might enhance the primary dimensions of procedural justice - voice, understanding, respect, and neutrality of decision-making – in an effort to stimulate discussion. Objectives • Define the key elements of procedural justice, its connection to system legitimacy, and research supporting these concepts. • Identify and explore available tools to assess court users’ perceptions of fairness. • Consider promising practices for enhancing perceptions of voice, understanding, respect, and neutrality of decision-making. Speaker(s) Amanda Berman Project Director Red Hook Community Justice Center Center for Court Innovation Brooklyn, New York Michael Rempel Research Director Center for Court Innovation New York, New York 79 TUESDAY What better way to get your message heard than to bring Drug Court to your legislators? This session will give you the tools and resources needed to plan a Capitol Hill Day at your state capitol, and how to capitalize on the momentum of the event. community courts, Mental Health Courts, and even traditional courts that exhibit these practices. Setting the Standard TRACK SESSION C Tuesday, July 28 TUESDAY 2:00 p.m. – 3:15 p.m. Annual Training Conference SESSION C-2 Comprehensive Services: Lessons from the Prevention and Family Recovery Project National Harbor 11 SESSION C-1 Target Population Maryland D When implementing and operating a successful Drug Court, one of the first and most critical questions is “Who will the court serve?” The research is clear. Drug Courts are best designed and most successful when serving high risk/high need populations, that is, those participants with high criminogenic risk and high prognostic need. In fact, every component of your Drug Court program, from treatment to incentives/sanctions to case management will be integrally connected with targeting the appropriate population. But how do you identify high risk/high need participants? How do you ensure your program is targeting these individuals? This presentation will outline the research on high risk/ high need, and will further discuss and explain how to ensure your program targets the correct population. Objectives • Understand the research behind serving high risk/ high need populations in Drug Court. • Identify strategies for incorporating risk/need assessment into your Drug Court operations. Speaker(s) Douglas Marlowe Chief of Science, Law, and Policy National Association of Drug Court Professionals Alexandria, Virginia What does it take for a Family Dependency Treatment Court (FDTC) to effectively serve the whole family? Join us to learn about an innovative public-private partnership designed to promote larger-scale systems changes to provide effective, comprehensive familycentered treatment for families in FDTCs. The Prevention and Family Recovery (PFR) initiative seeks to advance the capacity of FDTCs to integrate and sustain evidence-based parenting services and developmental and therapeutic services for children into their larger FDTC program. Children and Family Futures, with the generous support of the Doris Duke Charitable Foundation and The Duke Endowment, is providing funding and intensive technical assistance to four grantees: Pima County Juvenile Court Center (AZ), Robeson Health Care Corporation (NC), San Francisco Superior Court (CA) and Tompkins County Department of Social Services (NY). This session will highlight important lessons learned from the grantees’ first year of operations. These lessons will address progress and challenges with implementing and monitoring evidencebased programming, building local cross-systems data collection and evaluation capacity, and undertaking the practice and larger systems changes needed to provide and sustain a family-centered approach in FDTCs. The presenters will discuss the implications of the lessons for the larger FDTC field. They will also highlight the unique characteristics of this venture and offer insights for future public-private partnerships seeking to advance systems change. Objectives • Discuss key lessons about the progress and challenges associated with implementing and integrating evidence-based parenting and children’s services into an established FDTC. Examine the context of each PFR site and the major mechanisms that appear to be associated with a FDTC’s readiness and capacity to provide and sustain comprehensive family-centered care for families. • Describe the relationships between leadership and cross-systems program development and improvements. 80 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 • Explore how comprehensive family-centered services influence FDTC participants’ family well-being as well as children’s permanency and safety outcomes. from the PFR initiative to other jurisdictions. Speaker(s) Rosemary Chalk Consultant Doris Duke Charitable Foundation Alexandria, Virginia Phil Redmond Associate Director Child Care Division Duke Endowment Charlotte, North Carolina Nancy Young Executive Director Children and Family Futures Lake Forest, California SESSION C-3 Using a Gated Assessment Process to Connect the Right Kid to the Right Intervention Objectives • Participants will learn key elements of risk / needs screening and assessment. • Be able apply the gated approach model JDC client selection, structured decision-making, and JDC case management and supervision. • Have a better understanding of evidence-based practices and programs as they relate to interventions for JDC-involved youth. Speaker(s) Jessica Pearce Training Manager National Council of Juvenile and Family Court Judges Reno, Nevada Douglas Thomas Senior Research Associate National Center for Juvenile Justice Reno, Nevada National Harbor 13 Matching the right youth to the right program at the right time and for the right amount of time is a key to successful Juvenile Drug Court interventions. This workshop will present a strategy and procedures for identifying, screening, assessing youth and making data-driven decisions regarding JDC referral, matching with appropriate interventions, case management, as well as case closing. Matching the “right youth” requires assessing both static and dynamic risk factors to determine if an individual is a good fit for Juvenile Drug Court, if he or she is amenable to treatment, and which treatment intervention is most appropriate. The “right program” or intervention will be evidence-based (to the extent possible), matched to the individual level of risk and needs of youth, and implemented with integrity. The “right time” refers to both the youth’s current amenability to treatment and to maximizing treatment duration (neither too short nor too long). The strategy presented in this workshop is a “gated approach” in which each of the critical decision points are seen as JDC gates through which juveniles pass if they match the criteria at each gate. Several processes will be discussed, including screening and 81 TUESDAY • Explore initial opportunities to apply lessons learned assessing youth for risk, needs, and substance abuse involvement; structured decision-making; applying risk/needs outcome data to effective case management, applying evidence based practices and matching youth to evidence based programming. Setting the Standard SESSION C-4 TUESDAY A Dozen Years, Two Dozen Courts: Lessons from New York’s Mental Health Courts National Harbor 12 Since 2002, close to 8,000 defendants have participated in New York’s Mental Health Courts, which operate in large cities, suburban communities, and small towns in rural areas. The courts vary widely in their staffing and funding for court operations and in the local resources for treatment and related supports. In collaboration with the New York State Unified Court System, the Center for Court Innovation has conducted a statewide policy survey of New York’s 25 adult Mental Health Courts, which has reviewed policies and practices for adult Mental Health Courts including eligibility criteria, clinical assessment procedures, risk/ needs assessment, range of available treatment and other social services, local collaborations, and strengths and challenges, based on staff reporting. The policy survey is supplemented by a review of administrative data and qualitative interviews with select sites to understand specific Mental Health Court practices and policies. The New York State Unified Court System and the Center for Court Innovation plan to use the study results and recommendations drawn from the national literature to identify common challenges, promising practices, and training needs, to spark discussion about policy and practice recommendations for Mental Health Courts in New York State, and to provide guidance to jurisdictions that are interested 82 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference in improving case processing and sentencing options for defendants with mental illnesses without creating a specialized court part. This workshop will present findings from the policy survey and highlight opportunities for strengthening Mental Health Court operations and other mental health/criminal justice collaborations. Objectives • Understand standard practices and trends across Mental Health Courts (e.g., definitions of success), based on study findings. • Understand common challenges across Mental Health Courts and learn how courts are addressing those challenges. • Identify policies and practices from Mental Health Courts that can be adapted for Drug Courts. Speaker(s) Carol Fisler Director, Mental Health Court Programs Center for Court Innovation New York, New York Josy Hahn Senior Research Associate Center for Court Innovation New York, New York Sky Pena-Davis Regional Project Manager Unified Court System Cohoes, New York NADCP Washington, DC 2015 SESSION C-5 Chesapeake GHI Assertive Community Treatment (ACT) is an evidencedbased practice designed to provide effective treatment and support services to the chronically mentally ill by extending services to individuals with the most needs. The Kentucky Administrative Office of the Courts has adapted the model to address the needs of an addicted population and implemented it in multiple Adult Drug Court jurisdictions. Along with the traditional Drug Court approach to supervision and case management, these participants receive intensive support and assertive outreach in their own living and working environments via ACT. ACT has an anticipatory approach and through this adaptation, provides for intensive, ongoing assessment of immediate and long term recovery related needs. Ideally, the implementation of ACT in Drug Court settings goes beyond the traditional focus to increase access to needed services and decrease the likelihood of relapse and related criminal activity. This presentation focuses on the adaptation of this evidence-based practice to meet the needs of participants in rural Drug Courts as well as discussing necessary collaborations to ensure implementation and sustainability as well as research examining effectiveness and lessons learned to help individuals understand how this model can be implemented in other jurisdictions. Specifically, this session will: 1) provide a brief overview of the ACT model, 2) show how the model can be adapted successfully to rural Drug Courts, 3) overview the roles/responsibilities of team members and allow key stakeholders to share perspectives, and 4) provide evaluation data to overview lessons learned, successes, challenges, and effectiveness associated with implementing this model in Adult Drug Courts. The target audience for this presentation includes individuals interested in an approach to help address fragmented systems of care by a more coordinated approach. Objectives • Understand the fundamentals of ACT as well as necessary modifications for implementing. associated with the implementation of the ACT model. Speaker(s) Connie Neal Chief Operating Officer Kentucky Administrative Office of the Courts Frankfort, Kentucky TUESDAY Enhancing the Continuum of Care and Expanding the Service Population via Assertive Community Treatment in Rural Drug Courts • Understand quantitative and qualitative outcomes Lisa Shannon Assistant Professor Morehead State University Morehead, Kentucky SESSION C-6 Real Men Wear Pink (For Women Only) Chesapeake ABC Sometimes we just need to get over ourselves! This session identifies the potential challenges for women working in Drug Court and how often their interaction with participants can take on the role of “mother” vs. professional; instigator vs. interventionist; display issues of transference, exhibit fear of failure amongst other areas gender responsive services and approaches to often focus on the unique needs of women and girls. While this is critically important boys and men are in need of a gender responsive approach as well. This session explores the issues facing males in recovery from trauma, to societal expectations and the impact women may have had in their lives. It also examines the dynamics of women who work with men and the challenges that may occur. Women need to reexamine their approach when working with boys, men as well as with women and girls (especially those of color)! Objectives • Identify approaches of women working with males that can impede success. • List three issues or potential areas that may impact boys/men in Drug Courts. Speaker(s) Susan James-Andrews President and CEO James-Andrews and Associates Mitchellville, Maryland • Understand the key roles/responsibilities of the ACT and Drug Court team members. 83 Setting the Standard SESSION C-7 TUESDAY Drug Court Peer Review: Implementation Successes and Lessons Learned Maryland 4-6 The peer review process is intended to create a statewide learning community among treatment court teams. The purpose is for peers to help each other identify ideas for program improvements and share successes and challenges. This allows treatment court community across the state access to information and support at a low administrative cost while building relationships between programs. It can also provide important information to the state about areas of needed technical assistance and training, and how to focus those resources most effectively. This panel will discuss the process of developing and implementing Drug Court peer reviews in Idaho, Georgia, Oregon, and Colorado. Staff from each state will share stories and information about their state roll-outs and what they have experienced. These states have now conducted peer reviews in multiple sites and will share highlights from their successes and lessons learned, as well as how they are using the information and process. Staff from NPC Research who helped these states develop their protocols will facilitate a discussion and question and answer period for interested sites and states to gain more information about having peer reviews. Objectives • What are the benefits of using peer reviews? What are the successes states that have implemented peer reviews have had? • What challenges have arisen and how did states overcome them? • What lessons have been learned by the states that have implemented peer reviews that will help states that are exploring? Speaker(s) Annual Training Conference Juliette Mackin Executive VP & Sr. Research Associate NPC Research Portland, Oregon Ryan H. Porter Behavioral Health and Quality Assurance Idaho Supreme Court Boise, Idaho Brenidy Rice State Drug Court Coordinator/Court Program Analyst Colorado Judicial Department Denver, Colorado Ben Wyatt Grant Coordinator Oregon Criminal Justice Commission Salem, Oregon SESSION C-8 Designer Drugs 101 Maryland A Designer drugs are chemically modified versions of therapeutic medications, which users take to alter their mental state. The physical and mental effects of designer drugs often prove unpredictable because the illegal manufacture of these substances. Different types of designer drugs have varying effects on users. This workshop will highlight several types of designer drugs, their effects, trends in use, legal issues, and treatment considerations. This workshop is a mixture of lecture format, video clips, case presentation, and group interaction. Target audience is social workers, physicians, nurses, counselors, psychologists, law enforcement, first responders, parents of teens and young adults, and anyone who works with individuals with substance abuse and mental health issues. Objectives • Distinguish designer drugs and how they are made. Joshua Becker Certification Program Officer, Accountability Courts Administrative Office of the Courts Atlanta, Georgia • Learn who uses these substances and treatment Shannon Carey Co-President & Sr. Research Associate NPC Research Portland, Oregon Kristine Nutt Treatment Provider Life Center of Galax Galax, Virginia 84 NADCP 21st ANNUAL TRAINING CONFERENCE considerations. • Know the legal issues involved with Designer Drug use. Speaker(s) NADCP Washington, DC 2015 SESSION C-9 Incentives and Sanctions in Juvenile Drug Court Maryland C Objectives • Learn about privilege-reduction strategies to gain compliance over a single behavior. Delivering a response every single time! • How to create individualized behavior contracts to reward and motivate for positive behavior change in other areas. • Learn about program-wide incentives to motivate families to engage in the program and promote a strength-based atmosphere. Speaker(s) Cassandra Kirk Associate Judge Romae T. Powell Juvenile Justice Center Reno, Nevada Wendy Schiller Site Manager National Council of Juvenile and Family Court Judges Reno, Nevada TUESDAY Behavior change is an important aspect of JDCs, and research tells us that to promote positive behavior change within a Juvenile Drug Court, incentives and sanctions should be given in a 4 to 1 ratio (i.e., four incentives for every one sanction). However, this is a difficult task to accomplish for juvenile and Adult Drug Courts. Recommended practice is to try to achieve a 1 to 1 ratio. Ultimately, this means JDC team teams may need to create opportunities to deliver more incentives than sanctions to the youth in the program. In addition, it is extremely important to provide incentives that are meaningful to the youth, and as much as possible, involve the youth in choosing their own incentive and/or sanction, so they have ownership in the process. This session will cover a three-prong approach to implementing incentives and promoting behavior change in youth. SESSION C-10 Role of Probation in the Drug Court: Best Practices National Harbor 10 Probation is a critical piece of a successful Drug Court. From administering drug tests to doing home visits, from performing random searches to asking participants about their successes and offering support, the probation officer provides accountability, supervision, and encouragement. This session will outline the role of the probation officer in a Drug Court and offer advice and insight on how to enhance participant outcomes with a strong probation presence. Objectives • Understand the critical role of the probation officer in Drug Court. • Identify ways to enhance Drug Court outcomes by incorporating effective supervision techniques. Speaker(s) Helen Harberts Deputy District Attorney (ret.) Chico, California Charles R. Robinson Chief Probation Officer - Director Travis County Community Supervision and Correction Department Austin, Texas 85 Setting the Standard Annual Training Conference SESSION C-12 What’s in it for me? Attracting African Americans to Drug Court TUESDAY National Harbor 3 In many jurisdictions across the U.S. African Americans are not accessing Drug Courts. Many of them claim that the lack of access is due to African Americans choosing not to participate in Drug Courts. Why are African Americans not choosing to be in Drug Court? What can Drug Courts due to make their programs more attractive to African American populations? Objectives • This session will discuss disparate numbers of African Americans accessing Drug Courts across the country. • Participants will examine how using culturally relevant incentives could make programs more attractive to African Americans. SESSION C-11 Immigration Consequences of Criminal Conduct: How Drug Courts Can Help Chesapeake 7-9 This session will focus on the what can happen to lawful permanent residents, and undocumented workers (and their families) who are facing immigration consequences for alleged criminal conduct. Drug Courts have proven to be an effective tool to help mitigate negative consequences for many of these individuals. Additionally, the DACA and President Obama’s Executive Orders on immigration and how criminal prosecution for those who might be eligible will be discussed. Objectives • Identify the types of crimes involved in Drug Court cases that might carry immigration consequences. • Explain what a “conviction” is under Federal immigration law. • Explain how a sentence to Drug Court can fall within that definition and constitute a conviction of the underlying crime for Federal immigration purposes. Speaker(s) Hon. Rogelio R. Flores Superior Court Judge Superior Court of California, County of Santa Barbara Santa Maria, California 86 NADCP 21st ANNUAL TRAINING CONFERENCE • This session will explore and discuss other barriers that keep African Americans from accessing Drug Courts. Speaker(s) Darryl Turpin President Darryl Turpin Consulting Louisville, Kentucky SESSION C-13 Vicarious Trauma & Vicarious Posttraumatic Growth Among Service Providers In ProblemSolving Courts National Harbor 4 Clients in substance abuse treatment often report histories of trauma, reflecting, in part, the use of substances to self-medicate. The co-occurrence of substance abuse and trauma-related symptoms is evident among Drug Court participants, all the more so in family treatment Drug Courts, where child abuse and neglect and parent-child separations increase the level of trauma experienced by family members, and in Veterans Treatment Courts, particularly for those returning from deployments. In order to be effective with these clients, there is a need to provide intercession for trauma-related symptoms as well as substance abuse. While the integration of treatment for trauma and substance abuse treatment has positive effects on clients, less is known about its impact on service providers. This exposure has been shown to NADCP Washington, DC 2015 Objectives • To understand what is meant by vicarious trauma, and vicarious post-traumatic growth, and factors associated with both. • To learn about staff perceptions of conducting trauma-informed treatment and factors specific to a Family Treatment Drug Court. • To understand the trauma-related challenges and growth opportunities treatment providers may have in a Veterans Treatment Court. Speaker(s) Merith Cosden Dean University of California, Santa Barbara Santa Barbara, California Justin Gauthier Researcher University of California Santa Barbara Santa Barbara, California Lauren Koch Graduate Student Researcher University of California, Santa Barbara Santa Barbara, California Amy Lopez Drug Court Coordinator County of Santa Barbara ADMHS Santa Maria, California SESSION C-14 Making Evidence-Based Decisions: Using Technology to Assess People, Cases, and Outcomes National Harbor 6-7 This workshop focuses on best practices in risk and needs assessment (RNA) for problem-solving courts and agencies. Since there are many different kinds of RNA, selecting the right system with the capacity and functionality to meet your agency goals can be a major challenge. To help sort through the literature, we’ll take a look at recent process evaluation studies on decision-support procedures like the Risk-Need-Responsivity principle and we’ll clarify the main correctional purposes, policies, and standards that an effective RNA system must support. Once selected, there are several challenges that can thwart an effective implementation of RNA, so we’ll review common errors, deficits, and challenges that may undermine your efforts. Topics will include: • Achieving effective supervision of RNA staff. • Ensuring staff competence and “buy-in.” • Achieving high data quality. • Managing staff overrides. • Avoiding errors. • Proper use of RNA in guiding decisions. • Coping with ambiguous cases. • and other common challenges… We will also explore how senior administrators, judges, prosecutors, and probation supervisors can use RNA to enhance agency effectiveness and support the RNR principles. This workshop aims to be completely open to audience participation and Q&A participation will be encouraged. Speaker(s) Tim Brennan Chief Scientist Northpointe Institute Simpsonville, South Carolina 87 TUESDAY have an untoward impact, activating psychological distress particularly if staff have had traumatic experiences themselves, but can also result in post-traumatic growth, providing staff with a stronger sense of self. The first presentation will focus on understanding factors associated with vicarious trauma and/or vicarious post-traumatic growth as a function of working with clients who have experienced trauma. The second presentation will focus on a survey of substance abuse treatment providers for a family treatment Drug Court and the personal impact on them of utilizing trauma-informed treatment. Staff experiences of vicarious trauma symptoms and vicarious posttraumatic growth subsequent to working with clients will be discussed. Additionally, factors associated with these outcomes, including personal history of trauma and substance abuse, education and training, and clinical supervision, will be reported. The third presentation will focus on veterans, who are exposed to a disproportionate amount of traumatic events compared to civilians and may experience traumatic ethical and spiritual challenges. Empirical and anecdotal evidence on vicarious trauma and vicarious posttraumatic growth among veterans’ treatment providers, and implication, will be discussed. Setting the Standard SESSION C-15 TUESDAY Improve Outcomes by Integrating On-site Drug Testing: A Collaborative Approach Chesapeake 4-6 This interactive session will focus on how to develop, fund, market, and sustain on-site drug testing. Learn how CoRR supports their community to reduce the social, health and economic impact on families and children from all types of substance abuse and behavioral health issues. Objectives • Improve treatment outcomes by integrating on-site automated drug testing into your program. Speaker(s) Warren Daniels CEO Community Recovery Resources Grass Valley, California Ariel King Lovett Deputy Director Community Recovery Resources Grass Valley, California Annual Training Conference including the Impaired Driver Assessment designed specifically for probation and parole personnel, supervision strategies, available technologies and alcohol treatment. As part of this continuum of resources, emphasis will also be placed on the use of DWI Courts. Modeled after Drug Courts, DWI Courts offer a post sentence alternative for alcohol dependent, high-risk, high-need offenders, providing treatment, quality supervision, testing, behavior modification, and long-term, recovery sustaining strategies. The focus of this presentation is to present the best practices in the assessment and supervision of impaired drivers. This includes discussion of available research and meta-analysis as it relates to assessments, technology (interlock, Transdermal Alcohol Devices etc.), DUI Courts, evidence based alcohol treatment and supervision strategies. Specific sources of research analysis includes The National Association of Drug Court Professionals (NADCP), The National Highway Safety Administration (NHTSA), Traffic Injury Research Foundation (TIRF) and the Substance Abuse Mental Health Services Administration (SAMHSA). Objectives • Participants will be able to identify evidence based approaches to the supervision of impaired drivers. SESSION C-16 Research Says......... Best Practices in Assessment, Management and Treatment of Impaired Drivers Chesapeake 10-12 In 2010, there were 1.4 million drivers arrested for driving under the influence and drunk drivers were responsible for over 10,000 fatalities. Probation and parole departments face unique challenges in assessing risk levels for these offenders and determining the most appropriate level and type of supervision to minimize the risk of a re-offense. This workshop will provide an overview and continuum of evidence based practices for the supervision of high risk impaired drivers from intake to discharge while helping participants understand how to maximize effectiveness with these offenders while reducing risk to the community. Class content will include the latest research on assessment tools, 88 NADCP 21st ANNUAL TRAINING CONFERENCE • Participants will identify how DUI assessments impact supervision strategies. • Participants will identify unique advantages of DWI Courts in the supervision of impaired drivers. Speaker(s) Hon. Michael Kavanaugh Judge (Ret) National Center for DWI Courts Alexandria, Virginia Nathan Lowe Research Associate American Probation and Parole Association Lexington, Kentucky Mark Stodola NHTSA/APPA Probation Fellow American Probation and Parole Association Lexington, Kentucky NADCP Washington, DC 2015 TUESDAY SESSION C-17 Felony Deferred Prosecution: A Court Monitored Alternative to Traditional Prosecution for Low Risk/Low Need Offenders Maryland 1-3 The Cook County State’s Attorney’s Office has long been an active member of the alternative prosecution and sentencing arena, at least as far back as the early 1970s. The Office has been a major participant in the expansion of alternative prosecution processes which has seen the number of alternative sentencing options (primarily treatment courts) in Cook County from three in 2003 to the current 21 and deferred prosecution options from one in 2009 to the current 12. The number of individuals involved in one of these options has risen from approximately 300 in any given month (in 2000) to the current monthly total of over 2,600. In 2011, State’s Attorney Anita Alvarez directed the Alternative Prosecution/ Sentencing Unit to develop a deferred prosecution program for non-violent offenders with limited criminal backgrounds. This led to the development and implementation of the Felony Deferred Prosecution Program. To date, that Program has admitted over 1,600 individuals charged with non-violent felony offenses, with over 75% successfully completing the requirements of the Program and having charges dismissed. The goals of the Program are: • to provide meaningful direction to participants in the areas of educational achievement, vocational activity, treatment referral (where indicated), and pursuit of a law-abiding lifestyle and • to allow eligible offenders an opportunity to avoid The Program tracks successful participants for re-arrests, in the first year post-case dismissal. Of the first 432 such participants, 85% have no subsequent arrest, 98% have no subsequent felony conviction (among results). It has proven to be a cost- effective alternative to traditional prosecution in a quasitreatment court setting while also effective in limiting additional criminal behavior and allowing participants the opportunity to avoid a felony criminal record. Objectives • Engaging Low Risk/Low Need offenders in a treatment court setting without requiring excessive supervision or program demands. • The involvement of the victim and the coordination of community partners in a deferred prosecution alternative. • The role that this Program has in the CCSAO matrix of alternatives to traditional prosecution. Speaker(s) Amrithrobin Aakre Assistant State’s Attorney Cook County (Il) States Attorney Office Chicago, Illinois Mark Kammerer Supv, Alternative Prosecution/Sentencing Unit Cook County (Il) States Attorney Office Chicago, Illinois Sarah Kaufman Felony Specialty Courts Coordinator Cook County (Il) States Attorney Office Chicago, Illinois a felony prosecution and the possibility of a felony conviction and all that entails. 89 Setting the Standard SESSION C-18 The Urgency of Hepatitis C in Drug Treatment TUESDAY National Harbor 2 Addiction counselors and mental health specialists are now encouraged by SAMHSA to screen and test for Hepatitis C infection, (HCV) since early detection is vital to treatment success and the client’s overall health. HCV chronic illness can deter and effect the process of behavior change which is the ultimate goal of Drug Courts. Many clients in substance abuse treatment settings have a history of injection drug use and/or are born between the years of 1945 and 1965, emphasizing high risk for HCV infection. This presentation will present basic information on hepatitis C and how the counselor can play a critical part in promoting screening and testing for HCV. Objectives • List 2 factors that put drug treatment clients potentially at risk for hepatitis C infection and disease complications. • Identify at least 2 HCV disease factors that can impact on the Drug Court client’s ability to focus on drug free behavior. • State at least 2 reasons why addressing HCV in drug treatment can increase Drug Court outcomes. Speaker(s) Diana Padilla Program Manager NDRI USA / NeC ATTC New York, New York 90 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference SESSION C-19 Honoring our Children by Honoring our Traditions National Harbor 5 Positive Indian Parenting is a model Indian parent training curriculum that can be utilized as part of the treatment and required coursework in both Adult and Family Healing to Wellness Courts. The general curriculum was developed by the National Indian Child Welfare Association (NICWA). This parenting curriculum draws on the strengths of historic Indian child-rearing patterns and blends old parenting values with modern skills. Storytelling, cradleboards, harmony, lessons of nature, behavior management, and the use of praise are discussed. Judge Lujan will discuss how they implemented this unique curriculum in their community and show how easy it is to tailor to one’s own community. Objectives • Describe a parenting resource that can be used in the community. • Learn how to modify the curriculum to fit your community. • Learn ways to engage in your parenting sessions. Speaker(s) Hon. Lawrence Lujan Judge Ysleta del Sur Pueblo El Paso, Texas NADCP Washington, DC 2015 SESSION C-20 TUESDAY Guess What? You’re a Family Court, Too (if your Clients have Children)—Legal Issues and Practical Considerations When Working with Families in Drug Courts Hon. Jeri Beth Cohen Circuit Judge State of Florida, Eleventh Judicial Circuit Miami, Florida Maryland B All collaborative courts are family courts if their clients include parents and children. Many clients have legal matters involving juvenile delinquency, dependency, family, and domestic violence matters. This workshop will offer judicial leaders and legal professionals working in Adult Drug Courts an overview of the dependency court and child welfare system and offer some practical strategies on how to work with parents who are involved in family courts. Participants will gain a greater understanding and awareness of how decisions in Adult Drug Court impact the child and family, even if the child is never seen in court. This presentation will make the case for why Adult Drug Courts should pay greater attention to children and families and why cross-system collaboration and communication are critical for family safety and recovery. National resources for legal education and training will also be provided. Objectives • Gain greater understanding of dependency and child welfare system and learn practical strategies on how to work with Adult Drug Court participants who are also child welfare involved. • Gain a greater understanding of the impact of substance use on children, and the importance of addressing the needs of children and the parent-child relationship as a critical part of family recovery. • Learn how cross-systems collaboration, communication, and community partnerships are critical in serving the complex needs of children and families in your Drug Court. Speaker(s) Phil Breitenbucher FDC TTA Program Director Children and Family Futures, Inc. Irvine, California Hon. Phillip Britt Drug Court Commissioner 35th Judicial Circuit Kennett, Missouri SESSION C-21 The A, B, Cs of Meeting with Your Members of Congress Chesapeake JKL You’ve scheduled a meeting with your Member of Congress. Now What? This session will cover what a typical meeting entails, what you should say, and how you can continue a relationship with your Members long after your meeting has ended. Objectives • Identify ways of connecting with your Members of Congress. • Learn what to expect at your meeting with your Members of Congress. • Discuss Do’s and Don’ts of meeting with your Members of Congress. Speaker(s) Judi Kosterman Senior Vice President WestCare Foundation Las Vegas, Nevada Connie Payne Executive Officer, Statewide Services Administrative Office of the Courts Frankfort, Kentucky Hon. John Schwartz Supervising Judge Rochester, New York 91 Setting the Standard SESSION C-22 TUESDAY Alcoholics Anonymous: How We Cooperate With Courts and the Legal Community Chesapeake DE This presentation will focus on the availability of A.A. to national court professionals involved in assessing, referring, treating, and rehabilitating alcoholics. Strategies will be provided in accessing A.A. assistance & involvement, transitioning or bridging between professional treatment and A.A. The judicial system often requires clients involved in alcohol related offenses to attend AA meetings. When offenders are required to attend A.A. meetings as a condition of their sentence, there may be a requirement that each offender offer proof that he/she attends the required number of meetings. How can courts cooperate with Alcoholics Anonymous in ways that does not violate A.A. principles? What local A.A. resources are available to help courts and other justice professionals obtain accurate A.A. information. This question will be addressed along with demystifying AA myths and misconceptions while providing an accurate and current view of A.A. today.Rationalization and denial are part of the alcoholic’s illness. Initial rejection of A.A. is part of the denial mechanism. A.A. members, having broken through their denial and faced the harm in their drinking, are particularly suited to helping others break through their denial.Alcoholics Anonymous is a fellowship of men and women who 92 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference share their experience, strength and hope with each other that they may solve their common problem and help others to recover from alcoholism.The only requirement for membership is a desire to stop drinking. There are no dues or fees for A.A. membership; we are self supporting through our own contributions. A.A. is not allied with any sect, denomination, politics, organization or institution; does not wish to engage in any controversy, neither endorses nor opposes any causes. Our primary purpose is to stay sober and help other alcoholics to achieve sobriety. The solution to understanding A.A. and its friends is to get to know them. Objectives • Singleness of Purpose: The Only Requirement is a Desire to Stop Drinking. • Spiritual but Never Religious. • Cooperation/Not Affiliation With the Professional Community- Local A.A. Resources. Speaker(s) Hon. Ivan Lemelle Judge Alcoholics Anonymous New York, New York NADCP Washington, DC 2015 TRACK SESSION D Tuesday, July 28 3:30 p.m. – 4:45 p.m. SESSION D-2 Effective Strategies to Support Families Through Reunification SESSION D-1 The Brain on Drugs Maryland D Alcohol and other drugs modify the body’s entire neurochemistry once they enter the body’s system. Alcohol and other drugs trigger a massive release of neurotransmitters within the brain’s pleasure centers, inhibiting its ability to replenish its chemical reservoirs. This session will provide practitioners with insight into why an individual continually uses drugs to replenish chemical reservoirs to feel good again. Objectives • Understand the effect of drug use on mind and body. • Identify the impact on the brain of initial and prolonged drug use. • Learn to distinguish behaviors associated with use and withdrawal of various drugs. Speaker(s) Steve Hanson Director Division of Treatment and Practice Innovation, Bureau of Addiction Treatment Centers Rochester, New York The accountable, time-limited mandate for achieving permanency for children set forth in the 1997 Adoption and Safe Families Act (ASFA) drove the demand for a better and coordinated system response to meet the needs of families affected by parental substance use. This workshop presentation will explore the impact of parental substance use on the on the parent-child relationship and the essential service components needed to address these issues, including ensuring quality visitation and contact, implementation of evidence-based services inclusive of parent education, therapeutic services and access to ongoing family recovery support. This workshop discussion will explore family readiness as a collaborative practice issue by raising the need for coordinated case plans and effective communication protocols across child welfare, treatment and court systems. Discussion will explore different program designs across sites including the timing and phasing of reunification, family maintenance supervision and case termination. Objectives • Understand the impact of parental substance use on the parent-child relationship and the essential service components needed to address these issues. • Understand family readiness as a collaborative practice issue and why “team” is just as important as any “tool” for assessing readiness. • Learn various case management strategies, including implementation of quality visitation and contact, evidence-based services, coordinated case plans and effective communication protocols across child welfare, treatment and court systems. Speaker(s) Alexis Balkey FDC TTA Program Manager Children and Family Futures Irvine, California Phil Breitenbucher FDC TTA Program Director Children and Family Futures, Inc. Irvine, California 93 TUESDAY National Harbor 11 Setting the Standard Annual Training Conference SESSION D-3 TUESDAY Engaging Family and Community in Juvenile Drug Court and Implications for Policy National Harbor 13 Families and the community are important aspects of adolescent substance abuse treatment (NIDA, 2014). Engaging the family as a valued partner in all program aspects and building partnerships with community organizations are two of the sixteen Juvenile Drug Court (JDC): Strategies in Practice (BJA, 2003). Family engagement is identified as an essential JDC goal as the quality of the relationship between JDC professionals and families is a significant predictor of case success (BJA, 2003). Yet effectively engaging families, formalizing community partnerships, and creating strong community linkages do not come easily. This session will examine how JDCs work to attain these goals and effectively translate family and community engagement into JDC operations, process, and programming. The presenters will draw on lessons learned from a national cross-site evaluation of JDCs that implemented Reclaiming Futures (RF). The integrated JDC/ RF approach emphasizes the importance of engaging family and community partners in substance abuse treatment for youth. As a result, data from this evaluation are particularly informative of how to translate family and community engagement into JDC operations, process, and programming and the challenges of doing so. The challenges/barriers and promising practices/strategies presented in this session will be relevant for any JDC seeking to improve family and community engagement. The presenters will illustrate a lively discussion by utilizing cross-site findings from diverse data sources (i.e., one-on-one interviews; group interviews; observational data; and community resource utilization assessment) and highlight considerations for involving, engaging, and retaining family and community partners in adolescent substance abuse treatment and JDC programming overall. Additionally, the presenters will provide recommendations to guide policy for JDCs that are seeking to improve family and community engagement. Objectives • Identify practices & strategies for JDCs to increase involvement and engagement of families. • Understand challenges and barriers associated with engaging families and the community in JDCs. 94 NADCP 21st ANNUAL TRAINING CONFERENCE • Learn recommendations to guide policy for JDCs seeking to improve family and community engagement. Speaker(s) Alison Greene Director of Adolescent Research and Services University of Arizona Southwest Institute of Research on Women (SIROW) Tucson, Arizona Raanan Kagan Senior Policy Analyst Carnevale Associates Gaithersburg, Maryland Randolph D. Muck Senior Clinical Consultant Advocates Youth and Family Behavioral Health Care Treatment Harpers Ferry, West Virginia NADCP Washington, DC 2015 SESSION D-4 National Harbor 12 There are approximately 400 Adult Mental Health Courts in operation, but to date there are not any universally adopted standards of best practices resulting in many different models being used. If Mental Health Courts are going to be successful, they need an evidence-based starting point from which to develop. Although Mental Health Courts differ significantly from Drug Courts, the overwhelming majority of Mental Health Courts have a high percentage of offenders with co-occurring substance abuse or dependence. We must utilize the evidence-based practices from Drug Court when treating addicted mentally ill offenders in order successfully to manage their addiction as well as their mental illness. For the past 25 years, Drug Courts have provided the best antidote for substance abuse, and by utilizing their best practices and lessons learned we can make Mental Health Courts equally successful. Since 2002, Orange County has operated Mental Health Courts utilizing Drug Court principles as their foundation. With less than 25% recidivism, this model is one that is working. Jim Mahar Collaborative Court Coordinator Superior Court of California, County of Orange Santa Ana, California TUESDAY How to Successfully Integrate Drug Court Evidence-Based Practices into Your Mental Health Court Speaker(s) Andrea Mahar Probation Officer Orange County Probation Department Santa Ana, California Lauren Saunders Treatment Provider Orange County Health Care Agency Costa Mesa, California Kimberly Stevens Deputy Public Defender Public Defenders Office Orange County, California Objectives • Understand how Orange County has successfully blended Drug Court principles of addiction treatment and accountability into Mental Health Court. • Understand the ingredients of Drug Courts that must be implemented for successful Mental Health Courts. • Learn how one program has continued to implement evidence based practices for mental health and substance abuse treatment. 95 Setting the Standard TUESDAY SESSION D-5 What Juvenile Drug Courts Need to Know About Providing Effective Treatment for Youth with Co-Occurring Disorders Chesapeake GHI Evidence suggests more than half of all youth in contact with the juvenile justice system have a diagnosable mental or substance use disorder, with the majority experiencing both. Youth with co-occurring disorders have multiple and complex symptom patterns and behaviors raising unique challenges for juvenile courts. These youth typically: are more difficult to engage in treatment and have higher treatment dropout rates; have more severe symptoms; use substances earlier, more frequently and over a longer period of time; and have more serious and complex family issues. This presentation will provide an overview of the research and describe the national context for the movement towards integrated treatment. The presenters will describe a real-world approach – the Integrated Co-occurring Treatment (ICT) model – to addressing the needs of court-involved youth with co-occurring disorders. ICT, an intensive communitybased method of service delivery, provides a comprehensive and integrated set of mental health and substance use treatments to youth with co-occurring disorders and their families. ICT has been implemented within juvenile specialty courts with promising results. Finally, this session will provide attendees with guidance on how to develop capacity in their own communities to provide integrated, effective treatment for youth in JDCs with co-occurring disorders. Objectives • Increase understanding and awareness of the impact co-occurring disorders in youth has on JDC participation. • Review the most current research on effective, integrated interventions for youth with co-occurring disorders. • Learn about an integrated treatment model that works with court-diverted youth, and identify steps to develop local capacity. Speaker(s) Robert Kinscherff Senior Project Associate National Center for Mental Health and Juvenile Justice Delmar, New York 96 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference Richard Shepler Senior Research Associate The Begun Center for Violence Prevention Research and Education, the Jack, Joseph, and Morton Mandel School of Applied Sciences, Case Western Reserve University Cleveland, Ohio SESSION D-6 Are You Connected? Collaborating in Communities of Color to Meet the Diverse Needs of Clients Chesapeake ABC In an effort to address client needs accountability courts often struggle to meet the challenge of working with diverse partners in the community and effectively engaging (or educating them) about Drug Courts. If clients are not receiving basic needs such as stable housing, health services, or food in an environment that they can relate to or If clients are not comfortable with the services than the likelihood of a client’s success may diminish. Identifying community partners who can engage and retain diverse clients can be even more challenging if you are not clear on cultural nuances, strengths and challenges. Do clients fail services or are we failing clients? This session explores strategies and identifies practical solutions to identify, engage, and collaborate with communities of color. Objectives • Explore factors that make effective engagement of community partners a challenge. • Learn how to identify and address beliefs, thoughts, or attitudes that serve to create barriers between themselves and their clients. • Learn practical tips to establish authentic relationships and build trust with diverse community partners and clients. Speaker(s) Kimm Campbell Deputy Director Broward County Health & Human Services Department Fort Lauderdale, Florida Josalyn Conley Drug Court Program Manager King County Superior Court Seattle, Washington NADCP Washington, DC 2015 Joel Johnson CEO Human Resource Development Inc. Chicago, Illinois SESSION D-7 Applying Quality Improvement Principles to Juvenile Drug Courts Maryland 4-6 Continuous Quality Improvement (CQI) is a process that can help juvenile justice organizations, including Juvenile Drug Courts, use their own data to continually improve services with the goal of achieving the best possible outcomes for youth. By incorporating CQI, Juvenile Drug Court professionals can define their purpose, processes, and programs; collect, process, analyze, and report relevant information; and make data-informed decisions to improve services and outcomes. Regularly assessing the organization’s performance is the only way to know how current conditions are impacting the quality of services and outcomes produced. This workshop describes a process for Juvenile Drug Courts to adopt and implement CQI principles into their services. The workshop provides guidance on how JDC’s can prepare staff and stakeholders for CQI implementation and steps to implement and sustain CQI. The practices discussed in this workshop are derived from high quality research and have been embraced by criminologists, other social scientists and experienced practitioners. From the early steps of organizational readiness to the ultimate goal of using data to make informed decisions, Juvenile Drug Court administrators, probation officers, case workers and substance abuse providers will find benefits to incorporating CQI both at the intervention level and system wide. Speaker(s) Douglas Thomas Senior Research Associate National Center for Juvenile Justice Reno, Nevada TUESDAY Hon. Rogelio R. Flores Superior Court Judge Superior Court of California, County of Santa Barbara Santa Maria, California SESSION D-8 Marijuana Maryland A Neuro-imaging has yielded new evidence about the effects on the brain of marijuana use. This presentation will focus on those new findings as well as describe the psychopharmacology of marijuana use from both an acute and chronic use perspective. This session will also highlight the impact of new findings in what works in treating those dependent on marijuana. Objectives • Identify the neurochemical actions of marijuana in the brain. • Identify the symptoms of the acute use of marijuana, its chronic use consequences and withdrawal symptoms. • Identify strategies for treating marijuana dependence. Speaker(s) Kenneth Robinson President Correctional Counseling, Inc. Germantown, Tennessee Objectives • Participants will learn the essential elements of CQI. • Participants will learn how to achieve organizational readiness to implement CQI. • Participants will learn how to apply six steps for implementing CQI to Juvenile Drug Courts. 97 Setting the Standard Annual Training Conference SESSION D-10 CBT for LEO (Part 1) TUESDAY National Harbor 10 SESSION D-9 Incentives and Sanctions in Family Drug Court Law enforcement officers (LEO), with the advantage of direct community contacts, have a unique opportunity to intervene in the addictions cycle. People suffering from addiction are in the right stage of change during contact with law enforcement, which creates a prime opportunity to effectuate change in unlearning harmful attitudes and behaviors. This session will combine humor with reality to support and encourage law enforcement officers as pro-social role models to address everyday situations by providing insight into how thought processes cause feelings and behaviors, not external factors. Understanding CognitiveBehavioral Treatment (CBT) methods will allow law enforcement officers in Problem Solving Courts to empower addicts to identify their own negative patterns of thinking and move towards responsibility. This session will focus on the personal and professional applications of Cognitive-Behavioral Treatment with interactive discussion and activities. Maryland C Objectives In order for Family Drug Court parents to change behaviors which put their children at risk, they must enter and complete treatment, complete their child protection case plans and follow the rules of the program. Learn how to respond to behavior through the use of incentives, sanctions and therapeutic responses to hold parents accountable and keep parents engaged in case plans. Find out what research says works, what doesn’t work, and how to effectively respond to participants so compliance and good choices are reinforced and non-compliance and negative choices minimized. • Understand and apply CBT principles to promote Speaker(s) Penny Clodfelter Family & Juvenile Drug Court Program Manager Jackson County Family Drug Court Kansas City, Missouri Meghan Wheeler Senior Consultant National Drug Court Institute, NDCI Lexington, Ohio 98 NADCP 21st ANNUAL TRAINING CONFERENCE lasting positive life changes, not temporary compliance with rules and laws. • Learn about excuses and patterns of thinking and provide information on self-reflection, role-modeling, and leadership. • Practice CBT based approaches & learn redirection techniques to address excuses by challenging thinking, not the individual. Speaker(s) Sara Toms Cognitive-Behavioral Programs Coordinator Wyandotte County Community Corrections Kansas City, Kansas NADCP Washington, DC 2015 SESSION D-11 Homophobia and Transphobia with Hispanic LGBTQ Participants For some, Hispanic culture and gender identity of Hispanic LGBTQ Drug Court participants can incur practitioner discord and consequently impede the participant’s recovery process. Culturally effective communication and ensuring a safe environment is key to engaging Hispanic LGBTQ participants and facilitate program completion. This presentation will define and explore homophobia & transphobia, Hispanic cultural influences, and provide culturally informed practices that can help Hispanic LGBTQ participants to embrace the opportunities that Drug Court programs offer. Objectives • Define homophobia and transphobia. • Identify impact of phobic attitudes on practice. • Strategies to effectively work with Hispanic LGBTQ participants. Speaker(s) Diana Padilla Program Manager NDRI USA / NeC ATTC New York, New York This session will focus on the special challenges of this population; boyz that want to be treated like men but refused to grow up. The participants will learn cognitive behavioral evidence based techniques that I have developed in my 20 plus years of working with this population in the field of treatment and corrections. After completing this session, the participants will be better equipped to help young African American males accept responsibility, “man up” and maintain a drug free lifestyle. The format that I use is a state-of-the-art power point with embedded videos and audio tapes along with handouts that are formatted and ready to use in groups or individually. Objectives • Learn three proven methods of getting the clients to use their ‘street hustler’ mentality to work their program of recovery. • Learn three effective ways to motivate the clients to avoid the negative pitfalls of the Hip Hop culture. • Learn successful strategies for being more effective SESSION D-12 From Boyz to Men: Saving Our Young African American Males from the Streets and from Themselves National Harbor 3 ‘Gangsta rap’ exploded onto the national scene in 1988 at the height of the crack epidemic. With it, came a tidal wave of hip hop values which glorified the hustler lifestyle, normalized the use of marijuana, while promoting materialism and a “pimp” mentality that degrades women. when working with African American males in groups or individually. Speaker(s) Wallace Green Probation Officer / Treatment Coordinator Greater Cleveland Drug Court Cleveland, Ohio That was 27 years ago. The young African American males that we are dealing with today are the second generation. These young men are caught between twisted images of manhood made popular by the hip hop culture and an outright rejection of education and political involvement; values fought long and hard for during the Civil Rights Era. The result of this selfimposed street mentality has lead to higher rates of drug 99 TUESDAY Chesapeake 7-9 and alcohol problems, as well as higher incarceration rates. The leaders of the rap industry have proven that it is easier to take advantage of young African American males than it is to educate them. As a result, gangsta rappers have amassed personal fortunes flaunting these values in music and videos at the expense of the black community as a whole. Setting the Standard TUESDAY SESSION D-13 SESSION D-15 Creating a Trauma Informed Juvenile Drug Court The Ultimate Chain of Custody Machine National Harbor 4 Chesapeake 4-6 This session will present how trauma – particularly complex trauma in childhood – can lead to a host of challenging behaviors associated with struggles in relationships, disengagement from school, and involvement in the justice system. Participants will learn how physiological responses to chronic stress can have a profound impact on brain development, how subsequent adaptive skills can push youth away from protective influences such as school, and how educational and allied systems can become more trauma-informed at all points of contact with children, youth, and families. This 75 minute presentation introduces attendees to a vision for chain of custody extending well past its traditional use. The fundamental legal requirement for chain of custody is well understood within the context of forensics. The advent of modern testing laboratories using automated equipment and sophisticated software to capture and report results has extended the boundaries for chain of custody. Today’s chain of custody obligations go beyond the need to track the physical transfer of fungible items used as evidence. The audit trail of evidence must now include the representation of client specimens as data captured by complex analyzers, transported across multiple networks, arranged into manageable data container by a set of controlled system users, transformed by software into easily understood reports, certified by scientific experts, and delivered to ordering entities that include court systems, physicians, hospitals, and others. At eLab, where laboratory scientists and software developers focus on faster, less expensive, more comprehensive drug testing within a corporate culture obsessed with legal compliance, chain of custody presented a challenge. In this presentation, we’ll review the problems you might encounter from the need for chain of custody reporting, understand the modern scientific management principles used by eLab in its QuikLIMS laboratory management software, and see the future it provides within Drug Courts, case management systems, and the criminal justice system. In the course of this tract, our objective will be to introduce the following topics, discuss their meaning and relationship to chain of custody. Objectives • Participants will learn key elements in creating trauma-informed juvenile justice systems. • Be able to identify best practice examples associated with key elements of trauma-informed juvenile justice systems. • Participants will have a better understanding of the crucial role of youth engagement in informing best practices. Speaker(s) Kelly Decker Service Systems Program Coordinator National Center for Child Traumatic Stress Los Angeles, California SESSION D-14 Stone County, Missouri: 5 years of Implementing VIVITROL® (naltrexone for extended-release injectable suspension) in their Specialty Courts. National Harbor 6-7 Attendees will hear from Stone County leaders on their use of VIVITROL® in their specialty court. Attendees will learn about programs implementing VIVITROL; and how it has been made available to appropriate participants. 100 Annual Training Conference • Traditional chain of custody in Evidence Law • History of workflow from Gantt to Deming • The Iron triangle of Project Management (aka Triple Constraint) • The Observer Effect on chain of custody systems • Modern Automated Business Process Management (BPM) Systems This promotional program is created and sponsored by Alkermes, Inc. • The need for In-transit visibility of data Speaker(s) • Chain of custody as a PROACTIVE tool Mark Boesen Associate Director of Government Affairs & Public Policy Alkermes, Inc. Waltham, Massachusetts • Extended capabilities using chain of custodtu within NADCP 21st ANNUAL TRAINING CONFERENCE case management • Complex Event Processing, Big Data, and you NADCP Washington, DC 2015 The presenter will provide ample opportunity for the audience to participate, encourage Q&A, and leave you breathless about the future of software in case management, Drug Courts, and the criminal justice system. Speaker(s) Richard Williams Director of Product Development eLab Solutions Corp. Huntsville, Georgia SESSION D-16 DWI Court Research and Best Practices: What’s the Latest Evidence? Chesapeake 10-12 What evidence do we have that DWI Courts truly reduce recidivism and protect public safety? Are DWI court participants really that different from Adult Drug Court participants? Who does DWI court work for? What do we know about DWI court best practices? What happens if you change the system and all repeat DWI offenders are monitored and held accountable by the Court? This session will discuss best practices, the characteristics of DWI Court participants and the latest results on DWI court outcomes (including studies in California, Colorado, Michigan and Minnesota). Objectives • What is the evidence that DWI courts work? • What kind of offenders does DWI court work best for? • What are some DWI court best practices? Paige Harrison Research Associate NPC Research Portland, Oregon TUESDAY We will also take a look at eLab’s QuikLIMS product, its current use and benefits within an existing statewide cloud-based deployment, the advantages QuikLIMS’ cloud-based system can provide now, and have a peek of eLab’s future Case Management software offering. Hon. Richard Vlavianos Judge San Joaquin Superior Court San Joaquin, California SESSION D-17 Immigration Consequences of Criminal Conduct: How Drug Courts Can Help Maryland 1-3 This session will focus on the what can happen to lawful permanent residents, and undocumented workers (and their families) who are facing immigration consequences for alleged criminal conduct. Drug Courts have proven to be an effective tool to help mitigate negative consequences for many of these individuals. Additionally, the DACA and President Obama’s Executive Orders on immigration and how criminal prosecution for those who might be eligible will be discussed. Objectives • Identify the types of crimes involved in Drug Court cases that might carry immigration consequences. • Explain what a “conviction” is under Federal immigration law. • Explain how a sentence to Drug Court can fall within that definition and constitute a conviction of the underlying crime for Federal immigration purposes. Speaker(s) Hon. Rogelio R. Flores Superior Court Judge Superior Court of California, County of Santa Barbara Santa Maria, California Speaker(s) Shannon Carey Co-President & Sr. Research Associate NPC Research Portland, Oregon Hon. Shaun Floerke Judge Minnesota Judicial Branch Duluth, Minnesota 101 Setting the Standard SESSION D-18 TUESDAY Improving Drug Court Outcomes for Young Adult Offenders National Harbor 2 A county in Southeastern Pennsylvania conducted a study funded by the Substance Abuse and Mental Health Services Administration to determine if Leading Everyone to Achieve Potential (LEAP), an enhancement of its existing Treatment Court, would improve participant outcomes for high-risk/high need offenders aged 18-25. This age group had proven hardest to engage in Treatment Court and experienced higher dropout rates than older participants. LEAP was specifically designed to break the cycle of substance use and criminal behavior by addressing trauma, criminogenic risks, and the educational /vocational needs of young adult offenders from assessment through treatment and community supervision. The purpose of this presentation is to describe LEAP and the outcomes of 150 participants from 2011 to 2014. LEAP improved retention in Treatment Court (80% retention rate) and achieved positive clinical and community outcomes for participants compared to participants in similar Drug Court studies nationally. These six-month outcomes include higher rate abstinence from alcohol and other drugs; higher rates of employment; lower rates of depression and anxiety; and fewer negative social consequences related to substance use and crime than the rates of those in the national Adult Drug Court study cohort. These outcomes are attributed to the design and implementation of LEAP. Objectives • Describe effective recovery supports for Drug Court Participants. • Design an enhanced employment/vocational program. • Describe the role of trauma in the lives of Drug Court participants. Speaker(s) Michele Anastacio Treatment Court Coordinator/Probation Supervisor Chester County Adult Probation and Parole West Chester, Pennsylvania Vince Brown Exec. Director, Dept. of Drug and Alcohol Services Chester County PA West Chester, Pennsylvania 102 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference Sara-Ann Steber Evaluator University of Pennsylvania Wyomissing, Pennsylvania SESSION D-19 Enablement Prevention Program National Harbor 5 Developed by Hope Works Counseling, the treatment providers for the Keweenaw Bay Indian Community Adult Healing to Wellness Court, the Enablement Prevention Program is an interactive program that involves education of family members to help create a united team between service providers and loved ones. The Enablement Prevention Program is based on existing programs such as Rational Emotive Behavioral Therapy (REBT), Dialectic Cognitive behavioral therapy and on evidence based research of the damaging effect that enablement has on recovery. Enablement Prevention has been in practice and an element of recovery for at least the last 20 years. It originated out of Group Guided Interaction and the 12 step program. EPP is a form of peer-group treatment similar to group interventions where individuals experiencing similar problems can come together in a safe environment to share and receive experiences and get support. Furthermore, it is a cost-effective form of mental health treatment when compared to individual-based therapy. The goal of the group is to develop interactions with the client and to prevent the further enablement of the client and the client’s criminal behavior. EPP also utilizes value-based and process-oriented treatment model. The freedom from enablement will encourage clients into maturity, pro-social behavior and attitudes, and manages to make the client answerable for their own negative, delinquent behaviors and attitudes. Objectives • Learn the basic of addiction and how triggers operate. • Learn the role of family as both enablers and healers. • Learn strategies for better engaging family members in a participant’s treatment. Speaker(s) Mark Panasiewicz Treatment Provider Keweenaw Bay Indian Community West Hollywood, California NADCP Washington, DC 2015 SESSION D-20 The Proactive Prosecutor Maryland B Objectives • Best Practices regarding Prosecutor participation in Staffing and Court Sessions. • Most effective use of the Prosecutor in Targeting Offenders. • The Prosecutors role as an integral part of the Team Process. Speaker(s) TUESDAY Stepping from the Adversarial System into the Drug Court Model presents Prosecutors with a number of challenges. What role will they play in the process? How involved must they be in the Staffing’s and Court Sessions? Who should the team be targeting for entry into the program? What are the common Constitutional issues that arise and how have court addressed them? Over the past several years a great deal of research has been done to explore these questions and from this several “Best Practices” have been developed. This presentation will offer some sound approaches to resolving these legal and ethical dilemmas based on the research. This presentation is not just for the Prosecutor who has just been assigned to Drug Court but is intended for even the Experienced Prosecutor who is looking to gain more in-depth information on their role in Drug Court. SESSION D-21 Raise Your Voice: How to be an Effective Advocate for your Drug Court Chesapeake JKL What is the best way to deliver your message to Members of Congress and State Legislators? Learn ways to engage your Member of Congress in your District, how to keep your Member informed of Drug Court issues, and how to work with NADCP to ensure your message is heard loud and clear. Interested in getting your state legislature to work for you? This session has you covered, too! Objectives • Learn how to develop a lasting relationship with your Members of Congress. Stephen Ward Assistant District Attorney (Retired) Mecklenburg County, NC District Attorney’s Office Charlotte, North Carolina • Discuss ways to make your legislators champions Tammy Westcott Assistant District Attorney/Director of Alternative Courts Tulsa County District Attorney’s Office Tulsa, Oklahoma Speaker(s) of Drug Court. • Identify key opportunities to involve legislators. Hon. Sue Bell Cobb Judge Montgomery, Alabama Hon. Stephen Manley Judge Santa Clara, California 103 Setting the Standard Annual Training Conference TUESDAY as well as Recovery Coaches to assist participants with community re-integration. Although the program only began operating in the spring of 2014, enrollment is high (on average, eight participants are referred monthly) and nearly all participants have successfully completed the residential program and are on track to graduate from BTC. The most innovative aspect of the 90-RRP program is the use of Recovery Coaches. Recovery Coaching applies the concepts of Life Coaching and Business Coaching to those seeking recovery from alcohol and other drugs. Semi-structured interviews with Recovery Coaches and program participants highlight the combination of social support, structured services, and guidance that lead to successful treatment completion and positive Drug Court outcomes. This presentation will highlight the innovative features of the 90-RRP program, from the perspectives of participants and their Recovery Coaches. SESSION D-22 Objectives • Recognize the unique needs of alcohol and opiate using Drug Court participants. Innovative Use of Recovery Coaching to Improve Community Re-Integration for Drug Court Participants • Understand the importance of community linkage for Chesapeake DE • Understand the roles Recovery Coaches can play in Problem Solving Courts provide a range of comprehensive services for participants, making use of local resources where available, and often creating or developing additional resources as needed. In 2012, the Brooklyn Treatment Court (BTC) recognized a number of unmet needs for opiate and alcohol using participants. First, existing inpatient treatment programs were not achieving a significant level of success with these participants, who often relapsed upon discharge. Second, existing programs did not have the resources to adequately link participants to services in the community, including medical care and assistance with benefits including housing and family support services. In partnership with Samaritan Village, and through funding from SAMHSA and BJA, we created the 90-day Residential Rehabilitation Program (90-RRP), an innovative residential treatment program that makes use of evidence-based treatment programs (MRT; Think for a Change; Seeking Safety) administered over three months 104 NADCP 21st ANNUAL TRAINING CONFERENCE alcohol and opiate using Drug Court participants. the treatment of Drug Court participants. Speaker(s) Jacqueline Degiso Resource Coordinator Brooklyn Treatment Court Brooklyn, New York Hon. Jo Ann Ferdinand Judge Brooklyn Treatment Court Brooklyn, New York Lloyd Goldsamt Senior Research Scientist New York, New York Joseph Madonia Project Director Brooklyn Treatment Court Brooklyn, New York NADCP Washington, DC 2015 TRACK SESSION E Tuesday, July 28 5:00 p.m. – 6:15 p.m. SESSION E-2 Is your FDC Built to Last? The Importance of Real Sustainability Planning SESSION E-1 Data, Evaluation and Outcomes: What You Should Collect and Why Maryland D The research is clear: Drug Court works. But does your Drug Court work? Is your program collecting data on participants? What data? And what can you do with it? This session will outline the best practices in collecting data and evaluating your Drug Court program, ensuring that your court is keeping fidelity to the Ten Key Components and Best Practice Standards, determine if you are having the impact on your participants that you want and how you can use data to help you obtain funding. Objectives • Understand the importance of collecting data and how you can use it to improve your program. • Understand what data to collect. • How you can use data and evaluation to obtain funding. Speaker(s) Shannon Carey Co-President & Sr. Research Associate NPC Research Portland, Oregon Charlene Zil Research Coordinator NPC Research Portland, Oregon If grant funding is the primary resource for funding your FDC, then your FDC may not have the infrastructure to sustain itself in this economic climate. Real sustainability planning involves moving beyond the boundaries of your FDC as a project towards a focus on systems thinking and change. During this workshop, we will present a sustainability planning framework, explore the impact of federal and state level policy changes on FDC sustainability, and give specific advice on what sustainable funding options exist. Tessa Richter from the Jefferson County Family Integrated Treatment Court will tell her story about starting and sustaining a FDC without grant funding by distilling key components of the sustainability planning process. Ms. Richter plans to focus on how she garnered and continues to build institutional support to secure stable funding sources. This workshop is only for professionals who do not accept barriers as status quo but rather use them as targets for change. Objectives • Identify common barriers for sustainability planning. • Explore financing options, practical “barrier-busting” strategies, and opportunities for change. • Understand the difference between “project thinking” vs. “systems thinking” and the key features of systems change. • Learn why issues of scale, targeting, local parallel initiatives, and institutionalization are critical for sustaining your FDC. Speaker(s) Tessa Richter Problem Solving Court Coordinator & Juvenile Programs Coordinator Family Integrated Treatment Court, 1st Judicial District Golden, Colorado Nancy Young Executive Director Children and Family Futures Lake Forest, California 105 TUESDAY National Harbor 11 Setting the Standard Annual Training Conference TUESDAY SESSION E-3 Mentoring in Juvenile Treatment Drug Courts: Strategies and Tips from OnSite TA and Focus Group Report National Harbor 13 This workshop presents results from on-site technical assistance visits to ten jurisdictions in seven states and a force field analysis conducted during a Focus Group conducted in Reno, NV. The U.S. Office of Juvenile Justice and Delinquency Prevention recognizes mentoring as “an effective way to prevent at-risk youth from becoming involved in delinquency” and as a way to help already delinquent youth change their lives for the better. Research has demonstrated that mentoring relationships can improve youth’s self-esteem, behavior, and academic performance. The site visits and focus group identified five critical features of an ideal circumstance for implementing Mentoring JDCs, including: a clear vision/mission, adherence to a strong model, gritty determination to make it work, effective programming, and a quality pool of mentors. Using mentors can be a valuable asset to Juvenile Drug Courts. Presenters will discuss the variations in mentoring Juvenile Drug Court models, provide examples of the five critical features, and discuss driving and restraining forces associated with those features. Objectives • Participants will learn how mentors can enhance Juvenile Drug Court activities. • Participants will learn five factors of a successful mentoring Juvenile Drug Court. • Participants will learn about “forces” that enhance success factors as well as forces that “restrain” the success factors. Speaker(s) Jessica Pearce Training Manager National Council of Juvenile and Family Court Judges Reno, Nevada Douglas Thomas Senior Research Associate National Center for Juvenile Justice Reno, Nevada 106 NADCP 21st ANNUAL TRAINING CONFERENCE SESSION E-4 Difficult Issues Faced by Mental Health Court National Harbor 12 This session will discuss the “difficult issues” faced by Mental Health Courts, including broad issues such as the nexus between a criminal charge and mental illness, utilizing incentives and sanctions, and responding to high profile events involving participants, as well as difficult “on-the-ground” issues such as identifying appropriate treatment providers and finding housing resources. This session will be discussion-based and attendees are encouraged to come with questions they would like to discuss. Objectives • Understand the difficult issues facing Mental Health Courts. • Identify potential solutions and strategies for handling these difficult issues and improving their courts. • Hear from peers about innovative solutions to various Mental Health Court problems that are being utilized nationwide. Speaker(s) Emily Harris Program Associate, Courts Council of State Governments Justice Center New York, New York Eric Olson District Manager Idaho Adult & Juvenile Mental Health Courts 7th Judicial District Idaho Falls, Idaho NADCP Washington, DC 2015 SESSION E-5 Chesapeake GHI Drug Court participants vary in their clinical presentation. While all court participants have clinically significant substance use, many present with co-occurring mental health issues as well as other social and emotional concerns. For many participants, exposure to traumatic events is an underlying cause of many of these issues, and trauma-focused therapies have been implemented in many treatment settings. In recognition of these issues, the Brooklyn Treatment Court (BTC) developed a trauma screening protocol for Drug Court participants presenting with co-occurring mental health issues. As of September 2014, 63 Drug Court participants have been screened for entry into the program. Of these, 23 (36.5%) were found to be ineligible, primarily due to severe mental health issues (these participants were referred to Mental Health Court) and/or no reported trauma history (referred to regular Drug Court programming). Trauma Symptom Inventories (TSIs) have been completed by 17 of the 40 remaining participants (42.5%); administration of the TSI is ongoing. When percentile scores are averaged across participants, the mean was above the 70th percentile on three of the four TSI factors: Self-Disturbance (73.0%), Post-Traumatic Stress (81.6%) and Externalization (70.2%). The Somatization factor, however, was relatively low (39.3%). Five of the 12 clinical scales also averaged higher than the 70th percentile: Depression (71.6%), Intrusive Experiences (82.1%), Defensive Avoidance (89.6%), Insecure Attachment (76.5%), and Tension Reduction Behavior (80.9%). These findings are consistent with participant reports and are incorporated into individual treatment planning. The TSI used in conjunction with diagnostic interviews allows for a more objective assessment of what each participant is actually experiencing. BTC staff uses the TSI to better understand the psychological consequences of the participants’ trauma experience and develop a unique treatment plan of specialized therapeutic services. • Participants will learn about the Trauma Symptom Inventory (TSI), including its factor and scale structure. • Participants will learn how to use the TSI as part of a comprehensive screening for trauma-related issues in Drug Court participants. • Participants will learn how to use TSI results to develop individually-tailored treatment plans for Drug Court participants. Speaker(s) Hon. Jo Ann Ferdinand Judge Brooklyn Treatment Court Brooklyn, New York Lloyd Goldsamt Senior Research Scientist New York, New York Joseph Madonia Project Director Brooklyn Treatment Court Brooklyn, New York Susan Sturges Mental Health Specialist Brooklyn Treatment Court Brooklyn, New York 107 TUESDAY Trauma Symptom Inventory for Treatment Planning among Drug Court Participants with Co-Occurring Mental Health Disorders Objectives Setting the Standard SESSION E-6 TUESDAY Gay Lesbian Bisexual Transgender Intersex (GLBTI): Does it Really Matter in Treatment Courts? Chesapeake ABC Culture focuses on a variety of aspects of a person life. What goes on in an individual’s “world” can impact their recovery (or lack of), if we as professionals don’t understand the various nuances that may impact their lives. The issues our clients face are not simply alcohol and drugs, or criminal behavior. Gender does matter, and it is not just male and females. How your clients identify themselves, what services they access, interactions in court, engage family members (or not), even what services clients access can influence treatment court success, This session goes beyond terminology and provides helpful strategies when working with the GLBTI client in juvenile, adult, veteran and family treatment courts. Objectives • Identify how implicit bias may impact interactions with GLBTI clients in treatment courts. • Identify practical tips and resources in the community that are “safe zones” for the GLBTI client. • Explore services for friends and family members to aid in success for treatment court clients. Speaker(s) Susan James-Andrews President and CEO James-Andrews and Associates Mitchellville, Maryland 108 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference SESSION E-7 Programmatic Factors Related to Outcomes in Juvenile Outpatient Treatment: Evaluating the Effectiveness of Juvenile Drug Courts Maryland 4-6 There is a dearth of literature that provides information about key elements of successful collaboration and coordination in Juvenile Drug Courts. In addition, it is unclear whether collaboration between youth-serving agencies and coordination of services actually translates into (1) better organization/system performance (e.g., quality; efficiency), and (2) improved client services and outcomes. This session will present findings from the National Cross-Site Evaluation of Juvenile Drug Courts and Reclaiming Futures (JDC/RF) that address these gaps in the literature. This National Cross-Site Evaluation of JDC/RF examines the outcomes and impact of implementing an integrated model of the Juvenile Drug Court: Strategies in Practice model and the Reclaiming Futures model (JDC/RF) at eight different Juvenile Drug Courts. To understand the effectiveness of these JDC/ RF programs, the National Cross-Site Evaluation of JDC/RF compared the outcomes and impact of these eight JDC/RF programs to the outcomes and impact of other Juvenile Drug Courts who have not implemented Reclaiming Futures (JDC-only) and of other adolescent intensive outpatient substance abuse treatment programs (IOP). Session presenters will discuss these three approaches (JDC/RF, JDC-only, and IOP) and will discuss the ways in which they are similar and different at the program level (use of reputable screening tools; frequent reviews of treatment plans, family engagement, etc.). Session presenters will also discuss the comparable effectiveness of these three approaches on client outcomes such as substance use and recidivism. Presenters will compare the effectiveness of Juvenile Drug Courts to IOP (JDC/RF and JDC-only vs. IOP) and will also compare each of the three approaches to each other approach (JDC/RF vs. JDC-only vs. IOP). Finally, presenters will discuss the impact of programmatic factors (e.g., use of reputable screening tools) on client outcomes, identifying key elements of effective Juvenile Drug Courts, as well as of adolescent substance abuse programs. NADCP Washington, DC 2015 Objectives • Understand the similarities and differences between • Learn about the comparable effectiveness of JDC/RF, JDC-only, and IOP approaches on client outcomes. • Learn about programmatic factors related to improved client outcomes in JDC and adolescent substance abuse treatment programs. Speaker(s) Pamela Baumer Research Associate Chestnut Health Systems Normal, Illinois Josephine Korchmaros Director-Research Methods and Statistics University of Arizona Southwest Institute for Research on Women Tucson, Arizona Sally Stevens Executive Director and Distinguished Outreach Professor Southwest Institute for Research on Women Department of Gender and Women’s Studies University of Arizona Tucson, Arizona Methamphetamine Maryland A Methamphetamine and its impact on the basic brain is a presentation designed for legal and professional individuals actively seeking a practical understanding of how methamphetamine and other stimulant drugs impact the brain and the body. Objectives • Better understand the pathological and physical consequences of using methamphetamine and stimulant drugs common to most abusers. • Review a current understanding of what regions of the brain and the body are directly impacted by the use of methamphetamine and stimulant drugs. • Review the current research and data regarding the use of methamphetamine and stimulant drugs and their distinctive impact on various multi-cultural populations. Speaker(s) Steve Hanson Director Division of Treatment and Practice Innovation, Bureau of Addiction Treatment Centers Rochester, New York 109 TUESDAY JDC/RF, JDC-only, and other IOP substance abuse treatment programs. SESSION E-8 Setting the Standard Annual Training Conference TUESDAY Hon. Peggy Hora Judge (Ret.) NDCI Sr. Judicial Fellow Walnut Creek, California SESSION E-10 CBT For Probation Officers (Part 2) National Harbor 10 SESSION E-9 Behavior Modification and The Seriously Mentally Ill or Functionally Impaired: Special Issues to Consider Maryland C Mental Health Courts have moved away from the concept of graduated rewards and sanctions -a key component of Drug Courts -in favor of a broad array of strategies to motivate participants to engage in treatment. In Mental Health Courts, each participant’s treatment plan must be highly individualized to address his or her specific clinical needs, each participant responds to incentives and sanctions in idiosyncratic ways, and mental health service providers acknowledge their clients’ right to make their own treatment decisions. In this context, Mental Health Courts have adapted tactics from Drug Courts but have also created a range of new strategies, both in their court operations and in their partnerships with providers, to help motivate treatment engagement. This workshop will present promising practices drawn from a wide range of Mental Health Courts in New York and California. Objectives • Gain information about specific strategies and tactics used by operational Mental Health Courts that help motivate participants to engage in treatment and comply with court supervised treatment plans. • Learn about factors that have been shown to improve or impair engagement in mental health treatment. Speaker(s) Hon. Christine Carpenter Circuit Court Judge 13th Judicial Circuit Columbia, Missouri 110 NADCP 21st ANNUAL TRAINING CONFERENCE As Drug Court professionals, we know that recovery is frequently compounded by the way addicts think about and react to their various problems. By developing a deeper understanding of erroneous thought patterns and incorporating cognitive-behavioral treatment (CBT) methods into your regular contacts with participants, responsible skills can be modeled, taught, practiced, and role-played by probation officers to reinforce pro-social attitudes and behaviors. Implementing CBT based techniques to enhance your community supervision efforts will lead your participants towards developing critical thinking skills, emotional analysis, and personal accountability and responsibility. As Wyandotte County Adult Drug Court graduate John B. said, who has regularly come back to the probation office to speak at new-probationer orientation, I didn’t have a drug problem or an alcohol problem, I had a thinking problem. With CBT approaches, your Drug Court will be better equipped overall to address thinking errors. This session will review and provide CBT based activities that can be used immediately. Make your contacts count! Objectives • Develop an understanding of thinking errors and cognitive-behavioral treatment (CBT) methodology. • Discuss leading participants to creatively solve problems on their own & become less dependent on others & illegal substances. • Gain practical information & a variety of CBT-based resources/exercises that can be used for your contact visits. Speaker(s) Sara Toms Cognitive-Behavioral Programs Coordinator Wyandotte County Community Corrections Kansas City, Kansas NADCP Washington, DC 2015 SESSION E-11 SESSION E-12 African Americans and Mental Health Chesapeake 7-9 National Harbor 3 This workshop will focus on Family Dependency Treatment Courts for Los Angeles County and will explore the barriers to treatment within the Latino/ Latina community. Emphasis on the effective collaboration of the treatment team to break down the barriers to drug dependency inherent in the Latino/Latina community in Los Angeles county and protect the children. The related problems that are inherent in the community and the benefit of Drug Court. Historical trauma has a major impact on African Americans that enhance cultural mistrust issues. Is it schizophrenia or healthy paranoia that the black experience can be misconstrued as mental illness? The impact of discrimination, racial profiling, and trauma are just a few of the areas that can impact our clients success. Mental illness not only enhances resistance in Drug Courts; but also can contribute to the lack of retention. For African American women the issues can be even be more profound. This session discusses how to identify cultural relevant services for African Americans in need of mental health services and support in Drug Court. Objectives • Barriers to treatment within the Latino community and the benefit of Family Drug Court for cohesion of treatment. • The Latino cultural challenges in dealing with the judicial system and agencies providing services, including gang related issue. • The relationship in the courtroom between the participants and the Drug Court team as it relates to the Latino community, and includes barriers. Speaker(s) Germeen Duplessis MSW, Project Director Latino Family Center Caliornia Hispanic Commission on Alcohol & Drug Abuse Inc. Montebello, California Objectives • Discuss the additional challenges of African American participants who have mental illness. • Identify strategies to identify community support. Speaker(s) Guy Wheeler President Guy A. Wheeler Group Plantation, Florida Michel Eisner Principal Deputy County Counsel Office of the County Counsel Los Angeles County Monterey Park, California Laura Luna Supervising Social Worker Los Angeles County Department of Children and Family Services Los Angeles, California Stephen Marpet Commissioner of the Superior Court Superior Court Monterey Park, California 111 TUESDAY Serving the Needs of Latino Population in a FDC Setting the Standard SESSION E-13 Addiction, Personality Disorders, and Trauma TUESDAY National Harbor 4 Professionals and organizations working with justice involved populations often see not only substance use disorders but the additional complications of trauma and personality disorders This training will discuss ways to reframe personality disorders and recommended treatment modalities. Trauma and assessment and treatment models will also be discussed and featured. This training has also been updated to include the recent changes with the DSM-V and the clinical implications for these disorders. Objectives • Understand why addiction, personality disorders and trauma are often co-occurring. • Changes and implications with DSM-V. • How understanding the link with these disorders and lead to better treatment outcomes. Speaker(s) Donna Johnson CEO Addiction Solutions Inc Cartersville, Georgia Annual Training Conference SESSION E-16 Judicial Leadership and Strong Treatment Voice and Response Chesapeake 10-12 Effective DWI/Drug Court intervention is a complex interplay of team dynamics (and personalities – let’s be honest), probation monitoring, treatment voice and response, targeting the right clients, incentives, sanctions, testing, data review, and implementing research findings and best practices. We (a judge and a treatment provider from a thriving and effective Felony - High Risk/High Need - DWI Court) will consider two key components to effective team work, process and outcomes: the role of the judge as the team leader and the role of the treatment provider. In addition, we will explore the nature of the connection and communication between the judge and treatment provider as critically essential to thoughtful process and good outcomes for the court. Judges must lead in a way that doesn’t overpower the team or abdicate decision-making. Judges must foster a collaboration wherein every voice on the team is heard. Judges must ensure that the treatment voice is heard and respected and that the treatment response essential to great outcomes AND public safety - thrives. Judges must know the research, their own data, and fearlessly pursue best practices. The treatment provider plays a critical role in informing and education the team. The provider must appropriately assess clients for entry, craft effective interventions and responses and must also provide ongoing assessment and response as clients move through the court. Moreover, they must guide the team in understanding addiction, mental illness and recovery and how to respond appropriately to violations given proximal and distal skills/goals for individual clients. The treatment voice must also be grounded in best practices, both in terms of interventions with clients, but also in guiding the team and making recommendations. We will work through research, scenarios, methods, and best-practice ideas that courts can take home and apply for more effective interventions and outcomes. 112 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 Objectives • Appreciate the methods whereby the judge can • Understand the key role of the treatment provider, both in client interaction and team decision making. • Consider the essential collaboration between the judge and treatment provider in implementing research and best practices. Speaker(s) Hon. Shaun Floerke Judge Minnesota Judicial Branch Duluth, Minnesota Julie Seitz Clinical Director; LADC, LSW Center for Alcohol and Drug Treatment Duluth, Minnesota Search and Seizure: Overview of the Law Maryland 1-3 The Fourth Amendment to the United States Constitution protects individuals from unreasonable searches and seizures. Although the Fourth Amendment generally is interpreted to mean that a reasonable search requires a warrant supported by probable cause, the United States Supreme Court and other appellate courts have authorized a number of exceptions to the warrant/probable cause requirement in a variety of circumstances. Individuals subject to supervision through probation, Problem Solving Courts or other monitoring programs are entitled to certain due process rights under state and federal law, including the Fourth Amendment protections against unreasonable searches and seizures. This session will provide an overview of significant U.S. Supreme Court cases and other appellate court decisions that analyze the Fourth Amendment’s protection against unreasonable searches and seizures in the context of court authorized supervision programs such as probation, Problem Solving Courts and pre-conviction monitoring. Objectives • Analyze significant United States Supreme Court opinions and other appellate court decisions regarding search and seizure in probation, Problem Solving Courts and other court monitoring programs. • Properly evaluate the constitutionality of search and seizure procedures utilized by probation officers/ problem solving court personnel in supervising participants. Speaker(s) Hon. Earl Penrod Judge Gibson Superior Court Princeton, Indiana 113 TUESDAY support and lead the team to continue to grow and improve outcomes. SESSION E-17 Setting the Standard TUESDAY SESSION E-18 The Importance of Universal Precautions: Effects of Trauma and Health Literacy on Health Outcomes in Drug Court National Harbor 2 Health Literacy has been hailed as the “missing element” researchers have sought to understand due to its strong prediction of health outcomes among those with chronic disease and is often a stronger predictor of treatment success than race, education, or socio-economic status. However, very few studies have assessed health literacy in adults suffering from addiction within the criminal justice system. While experts in the field propose that health literacy interventions may effectively diminish health disparities by reducing barriers and increasing access to health services, these studies did not address disparities in behavioral health outcomes related to health literacy among clients within criminal justice populations. There have also been no prior studies researching the interaction effects of Trauma and Health Literacy on treatment court outcomes. This presentation will discuss significant findings in the importance of not only addressing trauma within this population but also its interacting effects on outcomes with health literacy. Attendees will be introduced to evidence-based interventions in reducing the negative effects of trauma on program success (Gain’s center’s Trauma-Informed Care) and the Universal Precautions Toolkit for improving communication and cultural practices related to health literacy (Agency for Healthcare Research and Quality; AHRQ). Specific health outcomes measured will be a reduction in maladaptive behavioral health symptoms (using the Brief Symptom Inventory), improvements in treatment plan fulfillment, and improvements in client perceptions of program practices (Consumer Assessment of Healthcare Providers and Systems; CAHPS). Results from this study will provide data that are needed on concurrent health literacy and trauma interventions and their impact among substance abuse clients within treatment courts. The full research design and process will be discussed as well as a practical guide to measuring impacts of the interventions that can be incorporated into existing evaluation/quality improvement activities. 114 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference Objectives • Understand the prevalence and impact of trauma and health literacy on client outcomes. • Identify successful strategies for implementing universal precautions to mediate those effects and improve client outcomes. • Learn to measure the impact of health literacy and trauma interventions and incorporate them into the evaluation/quality improvement. Speaker(s) Isis Martel Evaluator/PI University of Arkansas for Medical Sciences Fayetteville, Arizona SESSION E-19 Juvenile and Family Healing to Wellness Courts National Harbor 5 Because substance abuse effects more than the individual, because a criminal referral is but only one avenue of entry for potential participants, and because healing involves the entire family, tribes are beginning to expand their target population and means for serving that population. This workshop will explore both the Juvenile and Family Healing to Wellness Court models, including differing legal options for entry points, the various additional agencies that should be involved, additional services that should be considered, and strategies for doing so effectively and cost-efficiently. Objectives • Learn the Juvenile and Family Healing to Wellness Court models. • Learn about the particular populations that benefit from these models, including how to effectively engage the whole family. • Learn about unique challenges and opportunities involved with these models. Speaker(s) Hon. Joseph Flies-Away Chief Justice Hualapai Court of Appeals Phoenix, Arizona Carrie Garrow Consultant Tribal Law and Policy Institute West Hollywood, California NADCP Washington, DC 2015 SESSION E-20 SESSION E-21 Identifying Federal Firearm Prohibitions in Drug Courts Taking Your State Association to the Next Level Maryland B Are you ready to take your state association to the next level? Go beyond hosting an annual state conference and learn from leaders of CSDCA on how to engage your membership, develop fundraising events and advocate for Drug Courts Objectives • Understand the requirements of the federal law prohibiting firearms for persons who abuse drugs. • Learn what is needed to properly document the case from the arrest to the conviction and after. • Understand what is required by the NICS and how the courts impact the process. Speaker(s) Roberta Hatcher Legal Administrative Specialist FBI CJIS Division NICS Section Legal Analysis Team Clarksburg, West Virginia Objectives • Explore how states have utilized the power of the association to support Drug Courts, DWI Courts and Veterans Treatment Courts with legislators. • Discuss how state associations have implemented statewide events to promote and educate the public and elected officials. • Learn how to grow and nurture your association membership. Speaker(s) Jennifer Grandal Senior Court Operations Consultant Florida Office of the State Courts Administrator Tallahassee, Florida Hon. J. Michael Joiner Judge Alabama Court of Criminal Appeals Montgomery, Alabama Karen MacKenzie Executive Director Michigan Association of Drug Court Professionals Northville, Michigan 115 TUESDAY The presentation will focus on United States Code, Title 18, Section 922 which identifies federal firearm prohibitions. The speaker will focus on the importance of documenting drug arrest, conviction, and all test information in court and arrest records and the specific federal drug prohibition for possession of firearms. The presentation will show how documenting this information will help the NICS Section prevent prohibited individuals from obtaining firearms. Chesapeake JKL Setting the Standard SESSION E-22 TUESDAY Building Effective Interventions for Young Adults in Adult Drug Courts Chesapeake DE The Center for Court Innovation has released a monograph entitled “Young Participants in Adult Drug Courts: Practitioner Perspectives in Addressing Key Challenges.” This document explores the reasons why young adults merit special focus in Drug Courts and describes the specialized treatment interventions and service strategies used in three Adult Drug Treatment Courts: Brooklyn Treatment Court, Denver Treatment Court and King County (Seattle) Drug Diversion Court. In this session, practitioners from these three jurisdictions will describe how they developed and implemented specialized, developmentally appropriate interventions to serve young adult offenders. By promoting promising practices for young adults, these practitioners hope to motivate other Adult Drug Courts to modify their practices with the goal of improving services to young adults in Drug Court. This session will also address issues related to disproportionate minority contact among young adults in Adult Drug Courts. 116 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference Objectives • Learn about promising approaches to serving young adults in Adult Drug Courts. • Learn about the development of best practices and their replicability in other Drug Court settings. • Provide an opportunity to discuss the challenges of serving young adults in Adult Drug Courts. Speaker(s) Lilas Rajaee-Moore Director of TASC and Treatment Courts Denver Juvenile and Family Justice TASC Project Denver, Colorado Dennis Reilly Deputy Director, Drug Court Programs Center for Court Innovation New York, New York Mary Taylor Drug Court Program Manager King County Drug Court Seattle, Washington Wednesday Schedule of Events July 29, 2015 7:00 a.m. – 7:20 a.m. Come to Your Senses (Facilitated Meditation) Chesapeake JKL 7:00 a.m. – 8:00 a.m. Drug Court Expo Opens with a Continental Breakfast Prince George’s Exhibition Hall E 7:00 a.m. – 2:00 p.m. Registration Prince George’s Exhibition Hall D 2:00 p.m. – 5:30 p.m. Registration Convention Center Pre-Function 8:00 a.m. – 9:00 a.m. Capitol Hill Day Kick Off 9:00 a.m. – 10:30 a.m. SAMHSA Treatment Drug Court Grantee Meeting Potomac Ballroom 9:30 a.m. – 10:45 a.m. Concurrent General Sessions 11:00 a.m. – 12:15 p.m Concurrent General Sessions 12:15 p.m. – 2:00 p.m Lunch on your Own 2:00 p.m. – 3:15 p.m. Concurrent General Sessions Setting the Standard Annual Training Conference 2:00 p.m. – 3:30 p.m. Superior Court Drug Intervention Program All Rise! Mock Drug Court Session Maryland 1-3 3:30 p.m. – 4:45 p.m. Concurrent General Sessions 6:30 p.m. – 11:30 p.m. Washington DC Night Tour (See page 27 for more information) Buses depart from Woodrow Wilson Bus Loop 7:00 p.m. – 8:30 p.m. The Anonymous People Documentary Maryland D Wednesday Maryland B Notes NADCP Washington, DC 2015 WEDNESDAY SAMHSA Treatment Drug Court Grantee Meeting Wednesday, July 29 9:00 a.m. – 10:30 a.m. Maryland B This is a mandatory meeting for all SAMHSA grant project directors. While project directors must attend, they may also choose up to two additional grant staff to attend with them. This session will be an information exchange between SAMHSA grant project directors and SAMHSA grant project officers with both dialogue and Q/A sessions. This session is limited to SAMHSA grantees only. CONCURRENT GENERAL SESSIONS CG-1 THROUGH CG-8 Wednesday, July 29 9:30 a.m. – 10:45 a.m. • Provide guidance for FDC practice, including the importance of structured, timely and integrated risk and clinical assessments and linking clients with appropriate services. • Explore policy and practice implications on the scale SESSION CG-1 Matching Service to Need: Exploring What “High Risk/High Need” Means for FDCs National Harbor 11 As an adaptation of the Adult Drug Court model, Family Drug Courts have used Adult Drug Court literature and research to guide development and implementation of its model to serve families in the child welfare system affected by parental substance use. A significant amount of drug court research has addressed eligibility criteria and which populations these programs can serve most effectively – namely high-risk, high- need offenders. This plenary discussion between Dr. Douglas Marlowe and Dr. Nancy Young will explore the high-risk, high-need principle and how this applies to FDCs. Implications for FDC practice and policy will be offered, including the need for timely, structure, and integrated risk and clinical assessments and need to re-examine its target population to ensure that FDCs are serving a greater proportion of the CWS population. This plenary presentation is an ongoing discussion between two national experts, whose translation of these key principles will advance policy and practice for the entire FDC field going forward. Objectives and scope FDC as a result of serving high-risk high need clients. Speaker(s) Douglas Marlowe Chief of Science, Law, and Policy National Association of Drug Court Professionals Alexandria, Virginia Nancy Young Executive Director Children and Family Futures Lake Forest, California Stanley M. Goldstein Drug Court Hall of Fame Tomorrow morning we will induct a new individual or individuals into the Stanley M. Goldstein Drug Court Hall of Fame. Be on hand for the Closing Session and Featured Keynote Speaker at 10:30 a.m. • Explore how high-risk, high need are defined in the Family Drug Court model. 119 Setting the Standard WEDNESDAY SESSION CG-2 Revisiting Phases: Risk Matters National Harbor 12-13 This presentation will apply the latest research on risk and need to assist Drug Courts with revisiting their current phase structure to ensure its consistent with best practices. Objectives • Learn the two types of phases. • Learn about the typical phase requirements based on risk and need level. • Review examples of typical phase requirements as a participant progresses through the program. Speaker(s) Carolyn Hardin Interim Chief Executive Officer Senior Executive Director NDCI - The Professional Services Branch of NADCP Alexandria, Virginia Annual Training Conference SESSION CG-3 Impacts on Health Care Reform for Offender Populations: What Works to Enhance Collaboration National Harbor 2-3 In 2013, the County of San Diego was awarded a grant allocation to partner with community-based organizations to coordinate outreach and enrollment activities that focus on criminal justice populations, including inmates in jail custody and persons under the supervision of the Probation Department. Discussion will focus on San Diego County’s development and implementation plan of enhancing collaboration between health care services and the criminal justice system to take advantage of expanded health care under the Affordable Care Act (ACA). Specifically what worked, lessons learned and planning/implementation steps will be outlined. Discussion will also focus on the role of community corrections in providing an opportunity for health care services to a justice involved population. Objectives • Gain understanding of the relevance and potential resources of the Affordable Care Act to the criminal justice system. • Learn concrete examples for successful collaboration and links between the criminal justice and health care systems to assist. • Learn the part your organization can have in enrolling justice-involved individuals in Medicaid coverage. Speaker(s) Lorraine Fernandez Probation Director San Diego County Probation Department San Diego, California Sonya Harper Project Director of NDCRC NDCI - The Professional Services Branch of NADCP Alexandria, Virginia Clara Lapastora Senior Probation Officer San Diego County Probation San Diego, California 120 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 SESSION CG-4 National Harbor 4-5 Judges in Drug Courts face a variety of unique ethical situations. This session discusses some of the ethical issues that rise for the judge working in a Drug Court. Objectives • Identify ethical concerns for judges working in Drug Court. Steve Hanson Director Division of Treatment and Practice Innovation, Bureau of Addiction Treatment Centers Rochester, New York WEDNESDAY Ethics for Judges Speaker(s) Valerie Raine Director, Drug Court Programs Center for Court Innovation New York, New York • Discuss scenarios of potential ethical dilemmas raised in Drug Court. Speaker(s) Hon. Peggy Hora Judge (Ret.) NDCI Sr. Judicial Fellow Walnut Creek, California SESSION CG-5 Confidentiality National Harbor 10 This session will explore federal confidentiality laws and their impact on Drug Treatment Courts. Session content will include a breakdown of the two major statutes involved; and a detailed discussion of proper consents to Release Confidential Information. The Laws covered will be 42 C.F.R. Part 2 and the Health Insurance Portability and Accountability Act (HIPAA). The presentation will be about who is protected, what is protected, who must comply and exceptions to rules of disclosure. Objectives • Understand Consents to Release Confidential Information. • Special Considerations for the Criminal Justice Population. • Understand Revocable vs. Irrevocable Consents. • Understand Requirements for Proper Written Consent. SESSION CG-6 Designer Drugs: What Drug Court Practitioners Need to Know Maryland C Using the recently released NDCI Fact Sheet on designer drugs (URL: http://www.ndci.org/publications/fact-sheets) as a platform, this session will discuss the threat posed by designer drugs on Drug Court practitioners. The presentation will cover the new abuse trends and the new control challenges created by designer drugs. Because drug detection methods and laws associated with designer drugs often lag behind their appearance, well-chosen monitoring approaches are imperative. Attendees will learn about synthetic cannabinoids, “bath salts” and what’s coming next. This session is designed for both new and seasoned Drug Court team members. Objectives • Gain fundamental knowledge about designer drugs. • Understand the history and development of designer drugs. • Describe the two major categories of current designer drugs and how their differ. • Illustrate knowledge regarding approaches to controlling designer drugs in your court. Speaker(s) Paul Cary Director Toxicology and Drug Monitoring Lab University of Missouri Columbia, Missouri 121 Setting the Standard Annual Training Conference WEDNESDAY SESSION CG-7 Prescription Drug Abuse Screening and Treatment, and Dealing with Chronic Pain without use of Narcotics: A Judge’s Guide Maryland A This presentation will provide information on four classes of prescribed medications that are often misused (opioids/narcotics, stimulants, tranquilizers, and sedatives) and strategies for screening and treating substance use disorders. Topics covered include the definition and extent of prescription drug abuse (PDA), attributes and mechanisms of action of commonly-abused drugs, and side effects, toxicity, and characteristics of those who are most likely to misuse them. Speakers will suggest methods to help drug court professionals handle complex cases that involve PDA. Objectives • Identify commonly-abused prescription drugs and effective ways to screen for their misuse and abuse. • Understand strengths and weaknesses of alternative treatment approaches for prescription drug misuse. • Guide development of plans for controlling chronic pain while treating prescription opioid abuse. • Identify effective ways to treat chronic pain without use of opioids. Speaker(s) Sandra Lapham Director Behavioral Health Research Center of the Southwest A center of the Pacific Institute for Research and Evaluation Albuquerque, New Mexico Ted R. Miller Director Pacific Institute for Research and Evaluation Principal Investigator US Substance Abuse and Mental Health Services Administration’s Preventing Prescripton Abuse in the Workplace Technical Assistance Center Calverton, Maryland 122 NADCP 21st ANNUAL TRAINING CONFERENCE SESSION CG-8 Are All Drug Courts Collecting Reliable and Valid Data to Examine Potential Racial or Ethnic Disparities in Their Programs? Maryland D In the early 2000s, Drug Courts were credited with helping to alleviate unfair disparities in the incarceration of racial and ethnic minority citizens for drug-related offenses. Since then, the Drug Court model has expanded its scope (e.g., Veterans Treatment Courts, DUI/DWI Courts, Mental Health Courts, Family Drug Courts, Etc.) and locations. In NADCP’s efforts to recognize Drug Courts alleviating unfair disparities in the incarceration of racial and ethnic minority citizens for drug-related offenses, it appears that not all Drug Courts can prove that racial and ethnic minority candidates and participants may be experiencing relatively lower rates of admission and graduation than non-minorities, and that some Drug Courts have not adopted evidence-based, culturally proficient interventions to help other Drug Courts significantly improve admission and other outcomes for minority participants. NADCP Washington, DC 2015 Objectives • Explore why collecting reliable and valid data • Examine different database programs, and how to modify some databases to collect reliable and valid data. • Explore lessons learned and potential next steps to advance NADCP policy and practice. • Learn the significance of the Cultural Leadership Award for all Problem Solving Courts. Speaker(s) Hon. R. Eagleye Johnny Judge (Ret.) JD, NREMT & Nevada AEMT Nixon, Nevada Susan James-Andrews President and CEO James-Andrews and Associates Mitchellville, Maryland Hon. B.J. Jones Chief Judge and Court Administrator Sisseton-Wahpeton Oyate Sisseton, South Dakota Pedro Oliveros Deputy Public Defender County of Marin, Office of the Public Defender San Rafael, California Hon. Robert Russell Presiding Judge Buffalo Veterans Treatment Court Buffalo, New York Terrence Walton Chief of Standards NADCP Alexandria, Virginia Wednesday, July 29 11:00 a.m. – 12:15 p.m. SESSION CG-9 Collaborative Justice in All Treatment Courts: The PD and the Prosecutor: An Unlikely Couple (Joint NADCP and Vet Court Con Session) Chesapeake 10-12 The prosecutor and public defender who practice in treatment courts including Drug Court, DUI Court, Mental Health Court and Veteran’s Treatment Court will join together to discuss the challenges and the rewards of collaborating to see justice served through the Treatment Court programs. This atypical scenario requires the PD (or private defense counsel) to shed traditional roles and learn new ones while respecting each other’s alternative role. Research findings and principles derived from best practices will be woven into the discussion about the interplay of advocacy and prosecution in selecting participants, encouraging compliance, and requesting termination when necessary. This requires that both parties wear various hats and know the appropriate times to wear them. Objectives • Learn about setting aside traditional roles while still being and advocate for the client and a protector of public safety. • Learn about how to refer appropriate defendants to the Treatment Court programs and encourage compliance during the program. • Learn about the various hats worn by both parties and the appropriateness of these at various points in the process. Speaker(s) Kimberly Stevens Deputy Public Defender Public Defender’s Office Orange County, California Tammy Westcott Assistant District Attorney/Director of Alternative Courts Tulsa County District Attorney’s Office Tulsa, Oklahoma 123 WEDNESDAY examining potential racial or ethnic disparities is critical for all Problem Solving Courts to mitigate racial/ethnic disparities. CONCURRENT GENERAL SESSIONS CG-9 THROUGH CG-16 WEDNESDAY Setting the Standard Annual Training Conference SESSION CG-10 SESSION CG-11 Crossover Youth: The Power of Treatment Courts to Impact the School to Prison Pipeline Criminal Justice Reform and Drug Courts National Harbor 10 Drug Courts are the backbone of criminal justice reform. Drug Court professionals have transformed the justice system’s response to addicted offenders to one of compassion from one of incarceration. But we need to ensure that the system does not lose sight of the treatment needs of addicted individuals entering the justice system. Without sufficient treatment and supervision, too many addicted persons will remain in a downward spiral. This session discusses ongoing reforms in the justice system, such as Proposition 47 in California, and how Drug Court professionals can ensure that high risk, high need offenders can continue to access much-needed treatment and supervision. Juvenile Treatment Courts in its design can aid our most vulnerable population, those in both the child welfare and juvenile justice system. These populations are higher at risk due to limited family, education and community support. Juvenile Treatment Courts continue to evolve and many are addressing the disparities in the school to prison pipeline that impact youth of color disproportionately. From a national and local perspective the courts and community discuss how they have come together to provide a systematic approach to work collectively in the best interest of the child with limited support. Alarming facts regarding disparities are provided as well as strategies from the Juvenile Treatment Court in Seattle and the High Fidelity Wrap Around Case Management Services pilot in Broward County as well as services available for young adults leaving the foster care system. Moderator: Susan James-Andrews Chair; Thurgood Marshall Action Coalition (TMAC) President and CEO James-Andrews and Associates Mitchellville, Maryland Speaker(s) Kimm Campbell Deputy Director Broward County Health & Human Services Department Fort Lauderdale, Florida Joel Johnson CEO Human Resource Development Inc. Chicago, Illinois Hon. J Wesley Saint Clair Judge Seattle Juvenile Treatment Court Seattle, Washington 124 NADCP 21st ANNUAL TRAINING CONFERENCE National Harbor 4-5 Moderator Mack Jenkins Chief Probation Officer San Diego County San Diego, California Speaker(s) Andy Cummings Consultant Mary Covington Special Programs Manager - Harris County Veterans’ Court Harris County Criminal District Courts Houston, Texas Helen Harberts Deputy District Attorney (ret.) Chico, California NADCP Washington, DC 2015 SESSION CG-12 Maryland C The ramifications of a positive drug test (i.e. sanction, program expulsion, imprisonment, etc.) combined with the denial component of substance abuse often create circumstances whereby clients feel the need to “beat the drug test” by tampering with their urine sample. Diluted urine samples, designed to produce falsely negative drug testing results, represents the single most common form of specimen tampering. Negative testing results preclude therapeutic intervention and diminish client engagement in recovery. This session will discuss why creatinine testing is important, how to interpret creatinine results and how to use creatinine measurements in a therapeutic context. This session is designed for both new and seasoned Drug Court team members. Objectives • Gain fundamental knowledge about urine specimen tampering. • Understand the importance of urine creatinine measurements and the best way to use these results in a therapeutic context. • Describe two sanction approaches that can be utilized to remedy tampering behavior. Speaker(s) Paul Cary Director Toxicology and Drug Monitoring Lab University of Missouri Columbia, Missouri SESSION CG-13 Role of Law Enforcement in Drug Court National Harbor 2-3 This course is designed to educate law enforcement officers on Drug Court programs and the role law enforcement plays on the Drug Court team. Law enforcement officers will learn the core knowledge, skills and information necessary to effectively monitor, supervise and participate on a Drug Court team. The course is designed to educate you on how to effectively respond to individuals with mental health and trauma and to educate you on “why people can’t stop using drugs.” • To educate law enforcement officers about Specialty Court Programs and their role as a member of the team. • To identify effective ways of supervising program participants from a law enforcement perspective. • To understand how mental health and trauma play a role in supervision of participants. Speaker(s) Vanessa Price Law Enforcement Inspector, Ret. Chair – Oklahoma Pardon and Parole Board Oklahoma City, Oklahoma SESSION CG-14 The New ASAM Criteria: Implications for Drug Courts Maryland D The ASAM Criteria are the most widely used guidelines for intake, assessment, service planning and placement, continued stay and discharge of patients with addictive disorders. This presentation will highlight what judges and court personnel should know about ASAM Criteria principles, assessment and treatment levels. There will be discussion of how to use The ASAM Criteria to shift drug and other Problem-Solving Courts from a program-driven to outcomes-driven model and achieve lasting change. Objectives • Identify the guiding principles of The ASAM Criteria and how it interfaces with criminal justice settings. • Apply ASAM Criteria multidimensional assessment to individualize treatment and move courts from program-driven treatment to outcomes-driven services. • Discuss how to achieve accountable change in court participants through the common language of The ASAM Criteria and the clinical use of incentives and sanctions. Speaker(s) David Mee-Lee Senior Vice President The Change Companies Carson City, Nevada 125 WEDNESDAY Dilute Urine Samples: Courts Response to Low Creatinine Specimens Objectives Setting the Standard WEDNESDAY SESSION CG-15 Annual Training Conference SESSION CG-16 Medically Assisted Treatment Legal Eagle Maryland A National Harbor 11 Medically assisted treatment (MAT) is recognized by the federal government as an evidence based adjunct to drug/alcohol treatment. The NADCP board of directors issued a position statement in 2012 supporting the use of MAT, and the Adult Drug Court Best Practice Standards includes support for MAT as an adjunct to treatment. As of 2015, grant solicitations from SAMHSA and BJA have included language addressing the administration of MAT, along with funding availability for MAT. This session will outline the research on MAT, the history of MAT use (including the scope of FDA approval for these medications), and a brief description of the most common medications used in MAT. Drug Courts present a myriad of legal and constitutional issues, many of which are unique and of first impression at the appellate level. Adult Drug Court Best Practices addresses many of these issues. This session will provide an overview of the Best Practices and further discuss other legal issues impacting Drug Courts and as yet unresolved in the appellate courts. Objectives • Understand the basis for MAT use as an adjunct to treatment. • Identify the medications most commonly used in MAT. Speaker(s) Douglas Marlowe Chief of Science, Law, and Policy National Association of Drug Court Professionals Alexandria, Virginia Laurence Westreich Addiction Psychiatrist, President American Academy of Addiction Psychiatry East Providence, Rhode Island 126 NADCP 21st ANNUAL TRAINING CONFERENCE Objectives • Identify the legal Best Practicies in Adult Drug Courts. • Understand the major constitutional and legal issues impacting Drug Courts. • Identify trends in appellate decisions impacting Drug Courts. Speaker(s) Hon. William Meyer Judge/Senior Judicial Fellow Judicial Arbiter Group Denver, Colorado NADCP Washington, DC 2015 CONCURRENT GENERAL SESSIONS CG-17 THROUGH CG-24 WEDNESDAY Wednesday, July 29 2:00 p.m. – 3:15 p.m. SESSION CG-17 Matching Service to Need: Exploring What “High Risk/High Need” Means for FDCs National Harbor 11 One of the most important decisions faced by each Family Drug Court is determining its target population and what resources are needed to serve them. What criteria should drive these decisions? A significant amount of research in the adult criminal Drug Court setting has addressed eligibility criteria and which populations these programs can serve most effectively – namely high-risk, high- need offenders. This workshop presentation will explore the high-risk, high-need principle and how this applies to FDCs. A working definition of these concepts will be offered along with implications on key FDC processes, including screening and assessment, staff training, and partnerships needed to provide the scope of services needed to match services to needs. This workshop will serve as a work-group discussion which will advance FDC policy and practice for the entire field going forward. Objectives • Explore how high-risk, high need are defined for child welfare clients, including families affected by parental substance use. • Explore a collaborative framework for determining target population in FDC, which include identifying clients, matching needs with services, and monitoring progress. • Explore lessons learned from Adult Drug Courts and potential next steps to advance FDC policy and practice. Speaker(s) Douglas Marlowe Chief of Science, Law, and Policy National Association of Drug Court Professionals Alexandria, Virginia SESSION CG-18 Revisiting Phases: Risk Matters National Harbor 12-13 This presentation will apply the latest research on risk and need to assist Drug Courts with revisiting their current phase structure to ensure its consistent with best practices. Objectives • Learn the two types of phases. • Learn about the typical phase requirements based on risk and need level. • Review examples of typical phase requirements as a participant progresses through the program. Speaker(s) Carolyn Hardin Interim Chief Executive Officer Senior Executive Director NDCI - The Professional Services Branch of NADCP Alexandria, Virginia Nancy Young Executive Director Children and Family Futures Lake Forest, California 127 Setting the Standard Annual Training Conference WEDNESDAY SESSION CG-19 Impacts on Health Care Reform for Offender Populations: What Works to Enhance Collaboration National Harbor 2-3 In 2013, the County of San Diego was awarded a grant allocation to partner with community-based organizations to coordinate outreach and enrollment activities that focus on criminal justice populations, including inmates in jail custody and persons under the supervision of the Probation Department. Discussion will focus on San Diego County’s development and implementation plan of enhancing collaboration between health care services and the criminal justice system to take advantage of expanded health care under the Affordable Care Act (ACA). Specifically what worked, lessons learned and planning/implementation steps will be outlined. Discussion will also focus on the role of community corrections in providing an opportunity for health care services to a justice involved population. Objectives • Gain understanding of the relevance and potential resources of the Affordable Care Act to the criminal justice system. • Learn concrete examples for successful collaboration and links between the criminal justice and health care systems to assist. • Learn the part your organization can have in enrolling justice-involved individuals in Medicaid coverage. Speaker(s) Lorraine Fernandez Probation Director San Diego County Probation Department San Diego, California Sonya Harper Project Director of NDCRC NDCI - The Professional Services Branch of NADCP Alexandria, Virginia Clara Lapastora Senior Probation Officer San Diego County Probation San Diego, California SESSION CG-20 Ethics for Judges National Harbor 4-5 Judges in Drug Courts face a variety of unique ethical situations. This session discusses some of the ethical issues that rise for the judge working in a Drug Court. Objectives • Identify ethical concerns for judges working in Drug Court. • Discuss scenarios of potential ethical dilemmas raised in Drug Court. Speaker(s) Hon. Peggy Hora Judge (Ret.) NDCI Sr. Judicial Fellow Walnut Creek, California SESSION CG-21 Confidentiality National Harbor 10 This session will explore federal confidentiality laws and their impact on Drug Treatment Courts. Session content will include a breakdown of the two major statutes involved; and a detailed discussion of proper consents to Release Confidential Information. The Laws covered will be 42 C.F.R. Part 2 and the Health Insurance Portability and Accountability Act (HIPAA). The presentation will be about who is protected, what is protected, who must comply and exceptions to rules of disclosure. 128 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 Speaker(s) • Understand Consents to Release Confidential Paul Cary Director Toxicology and Drug Monitoring Lab University of Missouri Columbia, Missouri Information. • Special Considerations for the Criminal Justice Population. • Understand Revocable vs. Irrevocable Consents. • Understand Requirements for Proper Written Consent. Speaker(s) Steve Hanson Director Division of Treatment and Practice Innovation, Bureau of Addiction Treatment Centers Rochester, New York Valerie Raine Director, Drug Court Programs Center for Court Innovation New York, New York SESSION CG-22 Designer Drugs: What Drug Court Practitioners Need to Know Maryland C Using the recently released NDCI Fact Sheet on designer drugs (URL: http://www.ndci.org/publications/fact-sheets) as a platform, this session will discuss the threat posed by designer drugs on Drug Court practitioners. The presentation will cover the new abuse trends and the new control challenges created by designer drugs. Because drug detection methods and laws associated with designer drugs often lag behind their appearance, well-chosen monitoring approaches are imperative. Attendees will learn about synthetic cannabinoids, “bath salts” and what’s coming next. This session is designed for both new and seasoned Drug Court team members. Objectives • Gain fundamental knowledge about designer drugs. • Understand the history and development of designer drugs. • Describe the two major categories of current designer drugs and how their differ. • Illustrate knowledge regarding approaches to controlling designer drugs in your court. WEDNESDAY Objectives SESSION CG-23 Prescription Drug Abuse Screening and Treatment, and Dealing with Chronic Pain without use of Narcotics: A Judge’s Guide Maryland D This presentation will provide information on four classes of prescribed medications that are often misused (opioids/narcotics, stimulants, tranquilizers, and sedatives) and strategies for screening and treating substance use disorders. Topics covered include the definition and extent of prescription drug abuse (PDA), attributes and mechanisms of action of commonly-abused drugs, and side effects, toxicity, and characteristics of those who are most likely to misuse them. Speakers will suggest methods to help drug court professionals handle complex cases that involve PDA. Objectives • Identify commonly-abused prescription drugs and effective ways to screen for their misuse and abuse. • Understand strengths and weaknesses of alternative treatment approaches for prescription drug misuse. • Guide development of plans for controlling chronic pain while treating prescription opioid abuse. • Identify effective ways to treat chronic pain without use of opioids. Speaker(s) Sandra Lapham Director Behavioral Health Research Center of the Southwest A center of the Pacific Institute for Research and Evaluation Albuquerque, New Mexico Ted R. Miller Director Pacific Institute for Research and Evaluation Principal Investigator US Substance Abuse and Mental Health Services Administration’s Preventing Prescription Abuse in the Workplace Technical Assistance Center Calverton, Maryland 129 Setting the Standard WEDNESDAY SESSION CG-24 Are All Drug Courts Collecting Reliable and Valid Data to Examine Potential Racial or Ethnic Disparities in Their Programs? Maryland A In the early 2000s, Drug Courts were credited with helping to alleviate unfair disparities in the incarceration of racial and ethnic minority citizens for drug-related offenses. Since then, the Drug Court model has expanded its scope (e.g., Veterans Treatment Courts, DUI/DWI Courts, Mental Health Courts, Family Drug Courts, Etc.) and locations. In NADCP’s efforts to recognize Drug Courts alleviating unfair disparities in the incarceration of racial and ethnic minority citizens for drug-related offenses, it appears that not all Drug Courts can prove that racial and ethnic minority candidates and participants may be experiencing relatively lower rates of admission and graduation than non-minorities, and that some Drug Courts have not adopted evidencebased, culturally proficient interventions to help other Drug Courts significantly improve admission and other outcomes for minority participants. Objectives • Explore why collecting reliable and valid data examining potential racial or ethnic disparities is critical for all Problem Solving Courts to mitigate racial/ethnic disparities. • Examine different database programs, and how to modify some databases to collect reliable and valid data. • Explore lessons learned and potential next steps to advance NADCP policy and practice. • Learn the significance of the Cultural Leadership Award for all Problem Solving Courts. Speaker(s) Hon. R. Eagleye Johnny Judge (Ret.) JD, NREMT & Nevada AEMT Nixon, Nevada Susan James-Andrews President and CEO James-Andrews and Associates Mitchellville, Maryland 130 NADCP 21st ANNUAL TRAINING CONFERENCE Annual Training Conference Hon. B.J. Jones Chief Judge and Court Administrator Sisseton-Wahpeton Oyate Sisseton, South Dakota Pedro Oliveros Deputy Public Defender County of Marin, Office of the Public Defender San Rafael, California Hon. Robert Russell Presiding Judge Buffalo Veterans Treatment Court Buffalo, New York Terrence Walton Chief of Standards NADCP Alexandria, Virginia 2:00 p.m. – 3:30 p.m. Superior Court Drug Intervention Program All Rise! Mock Drug Court Session Maryland 1-3 This unique session provides a glimpse into one of the nation’s largest and longest running Drug Courts. The DC Drug Court will provide information about their court, conduct a mock staffing and Drug Court session, and then offer attendees the opportunity to ask questions of the team members. If you would like to see a Drug Court in action, this session is not to be missed! Objectives • Understand the success and operations of the DC Drug Court. • Identify the importance of staffing in preparation for Drug Court. • Identify the roles of each Drug Court team member in operating a successful program. Hon. Gregory E. Jackson Associate Judge Superior Court Drug Intervention Program Pretrial Services Agency Washington, DC Sloane Johnston Public Defender Service Superior Court Drug Intervention Program Pretrial Services Agency Washington, DC NADCP Washington, DC 2015 CONCURRENT GENERAL SESSIONS CG-25 THROUGH CG-32 Michelle McCall-Harris Courtroom Clerk Superior Court Drug Intervention Program Pretrial Services Agency Washington, DC SESSION CG-25 Tyrene Wilson-Sweetney Courtroom Clerk Superior Court Drug Intervention Program Pretrial Services Agency Washington, DC Chesapeake 10-12 The Anonymous People Documentary Presentation and Discussion 7:00 p.m. – 8:30 p.m. Maryland D Wednesday, July 29 3:30 p.m. – 4:45 p.m. Collaborative Justice in All Treatment Courts: The PD and the Prosecutor: An Unlikely Couple (Joint NADCP and Vet Court Con Session) The prosecutor and public defender who practice in treatment courts including Drug Court, DUI Court, Mental Health Court and Veteran’s Treatment Court will join together to discuss the challenges and the rewards of collaborating to see justice served through the Treatment Court programs. This atypical scenario requires the PD (or private defense counsel) to shed traditional roles and learn new ones while respecting each other’s alternative role. Research findings and principles derived from best practices will be woven into the discussion about the interplay of advocacy and prosecution in selecting participants, encouraging compliance, and requesting termination when necessary. This requires that both parties wear various hats and know the appropriate times to wear them. Objectives • Learn about setting aside traditional roles while still being and advocate for the client and a protector of public safety. • Learn about how to refer appropriate defendants to the Treatment Court programs and encourage compliance during the program. • Learn about the various hats worn by both parties and the appropriateness of these at various points in the process. Speaker(s) 4TH DIMENSION PRODUCTIONS PRESENTS “THE ANONYMOUS PEOPLE” A GREG WILLIAMS FILM FEATURING KRISTEN JOHNSTON CHRIS HERREN PATRICK KENNEDY TARA CONNER WILLIAM COPE MOYERS WILLIAM WHITE LAURIE DHUE EXECUTIVE PRODUCER PAUL MCCULLEY OF THE MORGAN LE FAY DREAMS FOUNDATION CO-EXECUTIVE PRODUCER JOHN SILVERMAN EDITOR JEFF REILLY DIRECTORY OF PHOTOGRAPHY CRAIG MIKHITARIAN ORIGINAL SCORE BRENDAN BERRY SOUND BUD MIKHITARIAN THEANONYMOUSPEOPLE.COM Kimberly Stevens Deputy Public Defender Public Defender’s Office Orange County, California Tammy Westcott Assistant District Attorney/Director of Alternative Courts Tulsa County District Attorney’s Office Tulsa, Oklahoma 131 WEDNESDAY Terry Keeney Assistant U.S. Attorney Superior Court Drug Intervention Program Pretrial Services Agency Washington, DC Setting the Standard Annual Training Conference WEDNESDAY SESSION CG-26 Crossover Youth: The Power of Treatment Courts to Impact the School to Prison Pipeline National Harbor 10 Juvenile Treatment Courts in its design can aid our most vulnerable population, those in both the child welfare and juvenile justice system. These populations are higher at risk due to limited family, education and community support. Juvenile Treatment Courts continue to evolve and many are addressing the disparities in the school to prison pipeline that impact youth of color disproportionately. From a national and local perspective the courts and community discuss how they have come together to provide a systematic approach to work collectively in the best interest of the child with limited support. Alarming facts regarding disparities are provided as well as strategies from the Juvenile Treatment Court in Seattle and the High Fidelity Wrap Around Case Management Services pilot in Broward County as well as services available for young adults leaving the foster care system. Moderator: Susan James-Andrews Chair; Thurgood Marshall Action Coalition (TMAC) President and CEO James-Andrews and Associates Mitchellville, Maryland Speaker(s) Kimm Campbell Deputy Director Broward County Health & Human Services Department Fort Lauderdale, Florida Joel Johnson CEO Human Resource Development Inc. Chicago, Illinois Hon. J Wesley Saint Clair Judge Seattle Juvenile Treatment Court Seattle, Washington SESSION CG-27 Criminal Justice Reform and Drug Courts National Harbor 4-5 Drug Courts are the backbone of criminal justice reform. Drug Court professionals have transformed the justice system’s response to addicted offenders to one of compassion from one of incarceration. But we need to ensure that the system does not lose sight of the treatment needs of addicted individuals entering the justice system. Without sufficient treatment and supervision, too many addicted persons will remain in a downward spiral. This session discusses ongoing reforms in the justice system, such as Proposition 47 in California, and how Drug Court professionals can ensure that high risk, high need offenders can continue to access much-needed treatment and supervision. Moderator Mack Jenkins Chief Probation Officer San Diego County San Diego, California Speaker(s) Andy Cummings Consultant Mary Covington Special Programs Manager - Harris County Veterans’ Court Harris County Criminal District Courts Houston, Texas Helen Harberts Deputy District Attorney (ret.) Chico, California 132 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 SESSION CG-28 WEDNESDAY Dilute Urine Samples: Courts Response to Low Creatinine Specimens Maryland C The ramifications of a positive drug test (i.e. sanction, program expulsion, imprisonment, etc.) combined with the denial component of substance abuse often create circumstances whereby clients feel the need to “beat the drug test” by tampering with their urine sample. Diluted urine samples, designed to produce falsely negative drug testing results, represents the single most common form of specimen tampering. Negative testing results preclude therapeutic intervention and diminish client engagement in recovery. This session will discuss why creatinine testing is important, how to interpret creatinine results and how to use creatinine measurements in a therapeutic context. This session is designed for both new and seasoned Drug Court team members. SESSION CG-29 Objectives Role of Law Enforcement in Drug Court • Gain fundamental knowledge about urine specimen tampering. • Understand the importance of urine creatinine measurements and the best way to use these results in a therapeutic context. • Describe two sanction approaches that can be utilized to remedy tampering behavior. Speaker(s) Paul Cary Director Toxicology and Drug Monitoring Lab University of Missouri Columbia, Missouri National Harbor 2-3 This course is designed to educate law enforcement officers on Drug Court programs and the role law enforcement plays on the Drug Court team. Law enforcement officers will learn the core knowledge, skills and information necessary to effectively monitor, supervise and participate on a Drug Court team. The course is designed to educate you on how to effectively respond to individuals with mental health and trauma and to educate you on “why people can’t stop using drugs.” Objectives • To educate law enforcement officers about Specialty Court Programs and their role as a member of the team. • To identify effective ways of supervising program participants from a law enforcement perspective. • To understand how mental health and trauma play a role in supervision of participants. Speaker(s) Vanessa Price Law Enforcement Inspector, Ret. Chair--Oklahoma Pardon and Parole Board Oklahoma City, Oklahoma 133 Setting the Standard WEDNESDAY SESSION CG-30 The New ASAM Criteria: Implications for Drug Courts Maryland A The ASAM Criteria are the most widely used guidelines for intake, assessment, service planning and placement, continued stay and discharge of patients with addictive disorders. This presentation will highlight what judges and court personnel should know about ASAM Criteria principles, assessment and treatment levels. There will be discussion of how to use The ASAM Criteria to shift drug and other Problem-Solving Courts from a program-driven to outcomes-driven model and achieve lasting change. Objectives • Identify the guiding principles of The ASAM Criteria and how it interfaces with criminal justice settings. • Apply ASAM Criteria multidimensional assessment to individualize treatment and move courts from program-driven treatment to outcomes-driven services. • Discuss how to achieve accountable change in court participants through the common language of The ASAM Criteria and the clinical use of incentives and sanctions. Speaker(s) David Mee-Lee Senior Vice President The Change Companies Carson City, Nevada Annual Training Conference Objectives • Understand the basis for MAT use as an adjunct to treatment. • Identify the medications most commonly used in MAT. Speaker(s) Douglas Marlowe Chief of Science, Law, and Policy National Association of Drug Court Professionals Alexandria, Virginia Laurence Westreich Addiction Psychiatrist, President American Academy of Addiction Psychiatry East Providence, Rhode Island SESSION CG-32 Legal Eagle National Harbor 11 Drug Courts present a myriad of legal and constitutional issues, many of which are unique and of first impression at the appellate level. Adult Drug Court Best Practices addresses many of these issues. This session will provide an overview of the Best Practices and further discuss other legal issues impacting Drug Courts and as yet unresolved in the appellate courts. Objectives • Identify the legal Best Practicies in Adult Drug Courts. • Understand the major constitutional and legal issues impacting Drug Courts. • Identify trends in appellate decisions impacting SESSION CG-31 Medically Assisted Treatment Maryland D Medically assisted treatment (MAT) is recognized by the federal government as an evidence based adjunct to drug/alcohol treatment. The NADCP board of directors issued a position statement in 2012 supporting the use of MAT, and the Adult Drug Court Best Practice Standards includes support for MAT as an adjunct to treatment. As of 2015, grant solicitations from SAMHSA and BJA have included language addressing the administration of MAT, along with funding availability for MAT. This session will outline the research on MAT, the history of MAT use (including the scope of FDA approval for these medications), and a brief description of the most common medications used in MAT. 134 NADCP 21st ANNUAL TRAINING CONFERENCE Drug Courts. Speaker(s) Hon. William Meyer Judge/Senior Judicial Fellow Judicial Arbiter Group Denver, Colorado Thursday Schedule of Events July 30, 2015 7:00 a.m. – 7:20 a.m. Come to Your Senses (Facilitated Meditation) Chesapeake JKL 7:00 a.m. – 8:00 a.m. Continental Breakfast Convention Center Pre-Function 7:00 a.m. – 10:30 a.m. Registration Convention Center Pre-Function 7:15 a.m. – 8:15 a.m. Discipline Specific Breakouts See Page 7 8:30 a.m. – 10:00 a.m. General Session Adult Drug Court Best Practice Standards Potomac Ballroom Potomac Ballroom Setting the Standard Annual Training Conference Thursday 10:30 a.m. – 12:30 p.m. NADCP/Vet Court Con Closing Ceremony Notes NADCP Washington, DC 2015 POTOMAC BALLROOM THURSDAY Thursday, July 28 8:30 a.m. – 10:00 a.m. Presentation of the Science Giant Award Carolyn Hardin Interim Chief Executive Officer Senior Executive Director NDCI - The Professional Services Branch of NADCP Alexandria, Virginia Douglas Marlowe Chief of Science, Law, and Policy National Association of Drug Court Professionals Alexandria, Virginia GENERAL SESSION Adult Drug Court Best Practice Standards The Adult Drug Court Best Practice Standards Volume II: The Wait is Over! In 2013, the National Association of Drug Court Professionals published Volume I of the ground-breaking Adult Drug Court Best Practice Standards Volume I. Volume I provides practical, implementable, and enforceable guidance on how Drug Courts are to operate in 5 critical areas: Target Population, Historically Disadvantaged Groups, Roles and Responsibilities of the Judge, Incentives, Sanctions, & Therapeutic Adjustments, and Substance Abuse Treatment. The highly-anticipated Adult Drug Court Best Practice Standards Volume II is ready and being distributed for the first time during the NADCP 21st Annual Training Conference! This presentation provides a succinct summary of Volume II, which includes 5 new standards—Complementary Treatment and Social Services, Drug and Alcohol Testing, Multidisciplinary Team, Census and Caseloads and Monitoring and Evaluation. Participants will: • Receive a summary of each standard in Volume II and some of the fascinating research on which they are based; • Understand why adherence to Best Practice Standards are essential for the continued success of the Drug Court Model; and • Learn about the Drug Court practice areas likely to be the focus of future standards. Speaker Douglas Marlowe Chief of Science, Law, and Policy National Association of Drug Court Professionals Alexandria, Virginia 137 Setting the Standard Annual Training Conference POTOMAC BALLROOM THURSDAY Thursday, July 28 10:30 a.m. – 12:30 p.m. CLOSING CEREMONY Featured Speakers Special Presentations Tommy Rieman Justice For Vets Mentor Corps Swearing-In Executive Director The Independence Fund Chris Matthews Host Hardball with Chris Matthews, MSNBC Travis Howard Award Winning Country Singer-Songwriter The Honorable Keith Starrett Board Chair National Association of Drug Court Professionals Carolyn Hardin Interim CEO National Association of Drug Court Professionals Carson Fox Chief Operating Officer National Association of Drug Court Professionals Melissa Fitzgerald Senior Director Justice For Vets 138 NADCP 21st ANNUAL TRAINING CONFERENCE Justice For Vets Champion Award Justice For Vets Media Award Stanley M. Goldstein Drug Court Hall of Fame Exhibitors and Maps Setting the Standard and Maps Exhibitors Annual Training Conference Notes NADCP Washington, DC 2015 Drug Court Expo Prince George’s Exhibition Hall DE 11th Judicial Circuit Drug Court CourtView Justice Solutions Booth Number: 209 Booth Number: 208 3M Electronic Monitoring DeKalb County C.L.E.A.N Program Booth Number: 237 ACT Booth Number: 412 Alcoholics Anonymous World Services Booth Number: 511 DWI Drug Court Intervention and Treatment Program Booth Number: 235 eLab Solutions Alkermes Booth Number: 228 American Court & Drug Testing Services Booth Number: 506 American Drug Screen Booth Number: 224 American Screening Corporation Booth Number: 436 Athens/Clarke County DUI/Drug Court Program Fairbault, Martin, Jackson Counties SA Court Booth Number: 219 537 535 439 437 435 342 340 338 336 341 339 335 333 242 240 236 234 Booth Number: 202 Family Drug Court Peer Learning Courts Booth Number: 204 Five Point Solutions Booth Number: 307 Hazelden Publishing Avertest Booth Number: 510 Booth Number: 303 Immunalysis BI Incorporated Booth Number: 316 Booth Number: 400 Infinite Trading Inc. Billings Adult Municipal Tx Court Booth Number: 501 321 239 237 235 231 227 401 413 411 407 312 308 306 Integrated Management Solutions 224 222 315 313 311 309 307 303 214 212 210 208 204 202 200 225 223 221 219 215 213 211 209 207 203 201 199 299 Registration Booth Number: 402 Orange County Veterans Treatment Court Social Solutions Booth Number: 199 Stone County Circuit Court Orasure Booth Number: 222 Oxford House Booth Number: 531 Ramsey County Adult SA Court Booth Number: 211 Recovery Healthcare Corporation Booth Number: 314 Center for Court Innovation Matrix Institute on Addictions Booth Number: 203 Booth Number: 413 Booth Number: 411 Roxbury Treatment Center Central Recovery Press Narcotics Anonymous World Services Booth Number: 528 Booth Number: 332 National Association for Children of Alcholics (NACoA) Booth Number: 240 Booth Number: 430 Redwood Toxicology Laboratory Booth Number: 506 San Diego Adult Drug Treatment Court Booth Number: 227 Savannah-Chatham County Drug Court Booth Number: 514 Booth Number: 213 StreeTime Technologies Booth Number: 432 The Change Companies Booth Number: 312 The National Judicial College Booth Number: 311 The Ranch at Dove Tree Booth Number: 214 Thermo Fisher Scientific Booth Number: 414 Total Court Services Booth Number: 234 Treatment Research Institute Booth Number: 333 Tulsa Veterans Treatment Court Booth Number: 200 USDiagnostice Booth Number: 406 USDTL National Center on Substance Abuse and Child Welfare Booth Number: 207 Booth Number: 338 Booth Number: 212 SCRAM Systems Wendell’s Booth Number: 299 Booth Number: 408 SecurManage White Deer Run/Cove Forge/ Bowling Green Brandywin National Council of Juvenile and Family Court Judges Booth Number: 407 Nez Perce County Drug Court Booth Number: 223 399 216 SoberLink, Inc Booth Number: 335 Intoxalock 499 300 Booth Number: 231 Rochesters Veterans Treatment Court Booth Number: 512 502 500 501 Orange County DUI Court Marker Test Diagnostics Council of State Governments Justice Center 402 400 Booth Number: 216 CAWSO, Inc. Booth Number: 308 505 Smart Start, Inc Booth Number: 431 Corrisoft 507 408 406 Booth Number: 315 KidLink Treatment Services Booth Number: 399 511 412 Norchem Booth Number: 306 Correctional Counseling, Inc. 506 504 314 Registration Call2Test Booth Number: 221 508 228 Booth Number: 330 Cook County WRAP 510 316 431 332 330 Booth Number: 201 Booth Number: 210 512 414 DANCE FLOOR Buffalo Veterans Treatment Court Children and Family Futures 514 531 432 430 Booth Number: 401 Booth Number: 340 STAGE 526 Family Drug Court Peer Learning Courts Booth Number: 239 Booth Number: 225 539 442 440 438 436 Drug Testing Program Management Booth Number: 236 Booth Number: 321 541 Booth Number: 215 Food/Beverage 4th Judicial District Adult DWI Court Food/Beverage Booth Number: 309 542 540 538 536 534 532 530 528 Booth Number: 435 Siemens Healthcare Diagnostics Booth Number: 313 Booth Number: 300 141 Setting the Standard Annual Training Conference Exhibitor Listing 3M Electronic Monitoring Alkermes Booth: 309 Booth: 321 3M’s solutions in GPS tracking, home curfew RF monitoring, and alcohol monitoring aid law enforcement and corrections in empowering justice, maximizing efficiency and improving safety. For more information about Alkermes and its innovative medicines designed to help people living with serious, chronic diseases, including addiction disorders, please visit www.alkermes.com Contact: Contact: Kerri Ryan, Marketing Supervisor 1838 Gunn Hwy Odessa, FL 33556 jtmcclain@mmm.com www.mmm.com Jeff Harris, Senior Director Government Affairs and Policy 852 Winter Street Waltham, MA Jeffrey.Harris@alkermes.com ACT Booth: 508 Booth: 412 ACT currently provides DCCM, a web-based drug court case management solution, to over 300 courts. They also provide Paracelsus, a drug testing laboratory information system, in over 17 different states. Contact: Greg Brannon, Vice President 101 Market Place, Suite 200 Montgomery, AL 36117 greg@actinnovations.com Alcoholics Anonymous World Services Booth: 236 Alcoholics Anonymous: A fellowship of sober alcoholics; no dues or fees, self-supporting, no outside funds; unaffiliated; primary purpose: carry the A.A. message to alcoholic who still suffers. Contact: A.A.W.S., C.P.C. Coordinator 475 Riverside Drive 11th Floor New York, NY 10115 cpc@aa.org Tel: 212-870-3107 Fax: 212-870-3003 www.aa.org 142 NADCP 21st ANNUAL TRAINING CONFERENCE American Bio Medica Corporation ABMC is a manufacturer of accurate, simple, costeffective point of collection tests that detect the presence or absence of abused drugs in urine or oral fluid, including a line of CLIA waived drug tests. Our products are manufactured in the US ensuring the highest quality. Contact: Scott Hutton, 122 Smith Road Kinderhook, NY 12106 shutton@abmc.com Tel: 800-227-1243 Fax: 518-758-8171 www.abmc.com American Court & Drug Testing Services Booth: 506 American Court Services put the element of surprise back in random testing with i-samson.net, and this year introduces i-OnTrack.net, a companion web application for specialized dockets to objectively evaluate and track incentives and sanctions. Contact: Adam Dedrick, 200 S. Columbus Street Lancaster, OH 43130 adam.dedrick@americancourtservices.com Tel: 740-687-6156 Fax: 866-741-8523 www.americancourtservices.com NADCP Washington, DC 2015 American Drug Screen Avertest Booth: 224 Booth: 303 The American Drug Screen Corporation is a fast growing company bringing change and innovation to accommodate your drug testing needs. We are convenient, reliable, and cost effective. We offer top of the line Drug of Abuse testing products, such as, our integrated cups, the Eco Cup, Eco II Cup, Eco III Cup, and Push-Button Cup. ADS carries numerous configurations of Dip Cards and quality Forensic Use Only saliva tests like the Swab Cube and the Oral Cube. Our products are widely used in drug courts, correctional facilities, behavioral health treatment centers, and law enforcement. With over 2 million dollars worth of inventory in stock, we always keep a handy supply of products that you need. Avertest provides best-in-class, evidenced-based drug testing services, that include random schedule management, same gender collections, laboratory testing, expert testimony, test results analysis, and treatment court team training and consultation. Contact: BI Incorporated James Cinsneros, Inside Sales Rep 5358 Irwindale Ave. Irwindale, CA 91706 sseferovich@hemosure.com Tel: 626-443-8480 www.hemosure.com American Screening Corporation Booth: 436 A manufacturer of ONESCREEN and Reveal MultiPanel Drug Tests, American Screening Corporation is the pioneer in the drug testing market. ASC is your first choice for quality CLIA Waived drug tests and excellent customer service. ASC is an ISO 13485 certified distributor for a wide range of clinical rapid tests and point of care devices. Contact: Ron Kilgarlin, CEO 7607 Fern Ave. Shreveport, LA 71105 ron@americanscreeingcorp.com Tel: 318-798-3306 Fax: 318-798-3386 www.americanscreeningcorp.com Contact: Jason Herzog, CEO 1700 Bayberry Court, Suite 105 Richmond, VA 23226 jherzog@avertest.com Tel: 804-955-5246 Fax: 804-767-8693 www.avertest.com Booth: 400 BI provides a full continuum of offender monitoring technologies & community reentry services for parolees, probationers, pretrial defendants & illegal aliens involed in the U.S. Contact: Todd Porter, Business Director 6400 Lookout Rd. Boulder, CO 80301 todd.porter@bi.com Tel: 303-218-1000 www.bi.com Call2Test Booth: 306 Randomized Drug Court call in service Contact: Ed Larson, CEO 7040 Avenida Encinas, Suite 104-391 Carlsbad, CA 92010 ed@call2test.com www.call2test.com 143 Setting the Standard Annual Training Conference CAWSO, Inc. Children and Family Futures Booth: 335 Booth: 210 We are Cocaine Anonymous World Service Office, Inc. (CAWSO, Inc) and a 12 Step Recovery program for those addicted to Cocaine and all other mind-altering substances. We have participated in Drug Court for the past 5 years or longer. The mission of CFF is to improve the lives of children and families, particularly those affected by substance abuse disorders. CFF consults with government agencies and service providers to ensure that effective services are provided to families. Contact: Contact: Linda L. Francisco, Director of Operations 21720 S Wilmington Ave., Suite 304 Long Beach, CA 90810 cawso@ca.org Tel: 310-559-5833 Fax: 310-559-2554 www.ca.org Sidney L. Gardner, President 25371 Commercenter Drive, Suite 140 Lake Forest, CA 92630 sgardner@cffutures.org Tel: 714-505-3525 Fax: 714-505-3626 www.cffutures.org Center for Court Innovation Correctional Counseling, Inc. Booth: 413 Booth: 399 Founded as a public/private partnership between the New York State Unified Court System and the Fund for the City of New York, the Center for Court Innovation seeks to aid victims, reduce crime, strengthen neighborhoods, reduce incarceration, and improve public trust in justice. The Center combines action and reflection to spark justice reform locally, nationally, and internationally. CCI offers training and treatment materials for Moral Reconation Therapy (MRT©), a cognitive skills model, in substance abuse, relapse prevention, anger management, domestic violence, codependence and other related areas. Contact: Aaron Arnold, Director, Drug Court Programs and Tribal Justice Exchange 520 8th Avenue, 18th Floor New York, NY 10018 aarnold@nycourts.gov Tel: 646-386-3100 Fax: 212-397-0985 Central Recovery Press Booth: 340 CRP provides books and other resources that encompass the best thinking on addiction [in all of its manifestations], recovery, and a range of behavioral health topics. Contact: John Davis, Special Sales Manager 3321 N Buffalo Drive Suite 275 Las Vegas, NV 89129 jdavis@centralrecovery.com Tel: 702-868-5830 Fax: 702-331-3098 www.centralrecoverypress.com 144 NADCP 21st ANNUAL TRAINING CONFERENCE Contact: Breathitt Robinson, Office Manager 2028 Exeter Road Germantown, TN 38138 ccimrt@aol.com Tel: (901) 360-1564 Fax: (901) 757-1995 www.ccimrt.com Corrisoft Booth: 308 Corrisoft’s Alternative to Incarceration via Rehabilitation (AIR) program, along with ERAM, has merged innovative monitoring technology with extensive support services in order to reduce recidivism. Contact: Jeff Milner, VP Sales and Marketing 1713 Jaggie Fox Way Lexington, KY 40511 jmilner@corrisoft.com Tel: 859-271-1190 www.corrisoft.com NADCP Washington, DC 2015 Council of State Governments Justice Center eLab Solutions Booth: 512 Booth: 228 The CSG Justice Center provides training and technical assistance to mental health courts around the country, and produces resources for communities interested in establishing a mental health court. We work with you to customize a testing program that is right for staff, patients and successful clinic operations. Contact: Emily Harris, Program Associates, Court and Behavioral Health 22 Cortland Street, 22nd Floor New York, NY 10007 eharris@csg.org Tel: 646-356-0054 Fax: 212-482-2344 CourtView Justice Solutions Booth: 208 CourtView Justice Solutions engineers, installs and supports justice information systems. Courts, prosecuting attorneys, public defenders, probation offices, detention operators and law enforcement agencies enhance their operations and improve public safety. Contact: Contact: Marty Smith, President/CEO 5009 Roswell Rd Sandy Springs, GA marty.smith@elabsolutions.com Tel: 675-756-3216 Fax: 770-988-9943 www.elabsolutions.com Five Point Solutions Booth: 307 FivePoint Solutions is a tech company that hasn’t forgotten why it exists. We make people’s lives EASIER by helping them work SMARTER. Our web based case management solutions are focused specifically on the individual objectives and requirements of Drug, DUI, Mental Health, and Veterans Treatment Courts; bringing them all the benefits of technology without the headache. Sue Humphreys, Director of Industry Solutions 4825 Higbee Avenue NW Canton, OH 44718 sue.humphreys@courtview.com Tel: 330-470-0618 Fax: 330-494-2483 www.courtview.com Contact: Drug Testing Program Management Hazelden Publishing Booth: 511 Booth: 510 DTPM provides any type drug testing product for drug courts, treatment centers, clinics and others needing drug testing solutions. Sets up laboratories, designs programs and sells point of care devices. Hazelden Publishing is the leading publisher of resources that help millions of people recognize, understand and conquer addiction and related life issues. Hazelden Publishing provides readers the tools and guidance needed to overcome adversity and grow in the areas of recovery, relationships, family, mental health and spirituality. Contact: Gene Cleckler, Executive Director 3022 Greenhill Blvd NE Fort Payne, AL 35968 genec@dtpm.com Tel: 256-845-1261 Fax: 888-317-1478 www.dtpm.com Ro Lucas, CEO/Co-Founde 905 Old Cherokee Road Lexington, SC 29072 Rlucas@myfivepoint.com Tel: 803-951-2094 www.myfivepoint.com Contact: Ashley Thill, Publishing Sales Director 15251 Pleasant Valley Road Center City, MN 55045 athill@hazeldenbettyford.org Tel: 651-213-4672 Fax: 651-213-4577 145 Setting the Standard Annual Training Conference Immunalysis Intoxalock Booth: 316 Booth: 330 With an expansive line of ELISA and Homogeneous Enzyme (HEIA™) assays, plus Quantisal™ – our proprietary oral fluid collection device, as well as automation tools and confirmation support, Immunalysis provides forensic toxicologists with powerful, comprehensive drug testing solutions. Intoxalock has been manufacturing ignition interlock devices (car breathalyzers) for over 20 years and today is an industry leader in reliability, customer service and technology. Contact: Greg Dowdeswell, Regional Account Manager 829 Towne Center Drive Pomona, CA 91767 gdowdeswell@immunalysis.com Tel: 828-279-2083 Fax: 909-482-0850 www.immunalysis.com Infinite Trading Inc. Booth: 501 Contact: Lourdes Nims, President 3651 Lindell Rd. D120 Las Vegas, NV 89103 lourdesinfinite@gmail.com Tel: 888-415-9964 Integrated Management Solutions Booth: 401 iMs provides integrated data and case management solutions for toxicology laboratories, specialty courts and therapeutic entities. For 10 years, iMs has provided this technology to 440 sites throughout the US. Contact: Kevin Nelson, Northwest Business Development Representative 10520 Hickman Des Moines, IA 50325 knelson@intoxalock.cim Tel: 253-509-0905 www.intoxalock.com KidLink Treatment Services Booth: 431 KidLink Treatment Services is a referral service for children and adolescents requiring residential behavioral healthcare. KTS provides assistance to parents, social service and court agencies by locating clinically appropriate treatment. Contact: Maggie Rhodes-Parsons, Service Advocate 110 Westwood Place Brentwood, TN 37027 margaret.rhodes-parsons@uhsinc.com Tel: 800-726-4032 Fax: 866-775-4208 www.kidlinktreatmentservices.com Marker Test Diagnostics Contact: Booth: 314 Ken Taylor, President and CEO 4900 Bradford Drive, NW Huntsville, AL 0 sales@ims-trident.com Tel: (256) 713-5232 Fax: (256) 864-9994 www.ims-dynetics.com/ Eliminate observed collections, false negative results and adulteration with UR Code, the accurate, secure and cost-effective solution from Marker Test Diagnostics. UR Code is an oral marker that internally “bar-codes” a subject’s urine and eliminates the need to supervise urine collection. Because UR Code makes sample substitution impossible, authorities can finally rely on truly accurate results. Contact: Kim Christensen, CEO 5891 West Orchid Lane Chandler, AZ 85226 christensen@markertest.com Tel: 480-710-2903 www.markertest.com 146 NADCP 21st ANNUAL TRAINING CONFERENCE NADCP Washington, DC 2015 Matrix Institute on Addictions Booth: 411 Matrix Institute on Addictions has been providing evidence-based, manualized treatment services for over 30 years. Matrix has also provided Matrix Model training to over 2,000 agencies worldwide. Contact: Donna Johnson, Trainer 1849 Sawtelle Blvd., Suite 670 Los Angeles, CA 90025 djohnson@matrixinstitute.org Tel: 877-422-2353 Fax: 818-704-8948 www.matrixinstitute.org Narcotics Anonymous World Services Booth: 332 Narcotics Anonymous is a global, community based organization with a multi-lingual and multicultural membership. NA members hold more than 63,000 meetings weekly in 132 countries. Contact: Jane Nickels, PR Manager 19737 Nordhoff Pl Chatsworth, CA 91311 PR@na.org Tel: 818-773-9999 Fax: 818-700-0700 www.na.org National Center on Substance Abuse and Child Welfare Booth: 212 The NCSACW provides consultation, technical assistance and training to local, state and tribal agencies seeking to improve outcomes for child welfare involved families affected by substance use disorders. Contact: Nancy K. Young, Director 25371 Commercenter Drive, Suite 140 Lake Forest, CA 92630 nkyoung@cffutures.org Tel: 714-505-3525 Fax: 714-505-3626 www.ncsacw.samhsa.gov National Council of Juvenile and Family Court Judges Booth: 407 Justice is a work in progress. It reflects our society’s ever-evolving belief system and our attempt to define what is right, what is wrong, and how to deal with the consequences of those choices. The National Council of Juvenile and Family Court Judges (NCJFCJ) works to ensure justice for every family and every child in every court throughout this country. The vital and important work of the NCJFCJ began in 1937 when a group of judges came together looking to improve the effectiveness of the nation’s juvenile courts. Contact: National Association for Children of Alcholics (NACoA) Booth: 240 NACoA’s Celebrating Families!™ - the whole-family, trauma-informed, skill building program – requested by one of the country’s first Dependency Drug Courts in 2003, and has continued to save families eversince. Wendy Schiller, Site Manager PO Box 8970 Reno, NV 89507 wschiller@ncjfcj.org Tel: 775-784-1550 Fax: 775-784-6160 www.ncjfcj.org Contact: Mary Beth Collins, CEO/President 10920 Conneticut Ave, Ste 100 Kensington, MD 20895 mbcollins@nacoa.org Tel: 301-468-0985 Fax: 301-468-0987 www.nacoa.org 147 Setting the Standard Annual Training Conference Norchem, A Cordant Forensic Solutions Company Recovery Healthcare Corporation Booth: 315 Since 1993, Recovery Healthcare Corporation has been the forerunner in delivering smart solutions to the criminal justice community in Texas, Louisiana, and Oklahoma. Our full range of services includes substance abuse assessment, education, intervention, treatment, and monitoring. We aim to keep communities safe, ensure compliance with court-ordered abstinence, and provide a sober start for the client. Norchem, is an industry-leading CAP FDT toxicology laboratory. We help you achieve better outcomes and lower overall costs by equipping you with effective case management tools. We provide forensic quality and legally defensible test results nationwide. Contact: Jefferson Warner, Sales Manager 1760 E. Route 66, Suite 1 Flagstaff, AZ 86004 jeffw@norchemlab.com Tel: 800-348-4422 Fax: 855-386-1088 www.norchemlab.com Orasure Booth: 430 Contact: Terry Fain, Chief Operating Officer 9090 N Stemmons Fwy, Suite A Dallas, TX 75247 terryf@recoveryhealthcare.com Tel: 214-819-1400 ext. 1478 www.recoveryhealthcare.com Booth: 222 Redwood Toxicology Laboratory OraSure Technologies is the pioneer of oral fluid drug testing, manufactures the Intercept® Oral Fluid Drug Test System collection device and diagnostic immunoassays. Booth: 506 Contact: June Fields, Regional Account Manager 220 East 1st Street Bethlehem, PA 18015 jfields@orasure.com Tel: 610-882-1820 www.orasure.com Oxford House Redwood Toxicology Laboratory is the government services division of Alere Toxicology and one of the nation’s largest drug and alcohol testing laboratories. Redwood provides reliable and innovative substance abuse screening products and lab services. Contact: Jennifer Camp, Client Relations Specialist 3650 Westwind Blvd Santa Rosa, CA 95403 jcamp@redwoodtoxicology.com www.redwoodtoxicology.com Booth: 531 Roxbury Treatment Center Oxford House, Inc., a service organization that serves as the umbrella organization for the worldwide network of Oxford Houses, is dedicated to establishing and maintaining disciplined self-help housing that supports long-term recovery from alcoholism, drug addiction and co-occurring mental illness. Booth: 528 Contact: Christina Sledzinski, Director of Business Development 601 Roxbury Rd. Shippensburg, PA 18257 christina.sledzinski@uhsinc.com www.roxburyhospital.com Kathleen Gibson, Chief Operating Officer 1010 Wayne Ave, #300 Silver Spring, MD 20910 kathleen.gibson@oxfordhouse.org Tel: 301-587-2916 Fax: 301-589-0302 www.oxfordhouse.org 148 NADCP 21st ANNUAL TRAINING CONFERENCE Roxbury provides inpatient substance abuse and mental health treatment to our Nation’s military and veterans. We are also the only contracted Tricare® provider for inpatient substance abuse in Pennsylvania. Contact: NADCP Washington, DC 2015 SCRAM Systems Smart Start, Inc Booth: 299 Booth: 216 SCRAM Systems is the world’s leading manufacturer and provider of alcohol and location monitoring technologies that includes SCRAM Continuous Alcohol Monitoring™, SCRAM Remote Breath™, SCRAM GPS, and SCRAM House Arrest™. Leader in alcohol monitoring with its ignition interlock and IN-HOM® alcohol testing devices and its SmarTox drug testing products and services. It provides fully integrated services encompassing design, manufacturing, installation, customer service, monitoring and administrative support. Contact: Jennifer Mill, Marketing Manager 1241 W. Mineral Avenue Suite 200 Littleton, CO jmill@alcoholmonitoring.com Tel: 303-791-7828 Fax: 303-791-4262 www.alcoholmonitoring.com SecurManage Booth: 435 SecurManage is a web based, software management tool designed for corrections, drug & alcohol rehab, mental health and veterans programs. Contact: Frank Genovese, President 25 Oakglen Drive Oakmont, PA 15139 fgenovese@securmanage.com Tel: 412-401-2432 Siemens Healthcare Diagnostics Contact: Felicia Thompson, Marketing Assistant 500 E Dallas Road Grapevine, TX 76051 Fthompson@smartstartinc.com SoberLink, Inc Booth: 402 The innovative SOBERLINK system simplifies the alcohol monitoring process and allows the lower-risk offender a discreet and portable solution. Contact: Andy Rothman, VP Sales and Marketing 10805 Holder Street #245 Cypress, CA 90630 ar@soberlink.net Tel: 714-975-7200 www.soberlink.net Social Solutions Booth: 514 When the stakes are too high to be wrong; turn to the experts in drug testing at Siemens Healthcare Diagnostics. Syva EMIT® is the world’s leading drug monitoring methodology. Siemens offers a comprehensive portfolio of products for drugs of abuse, specimen validity, point of care testing, and data management. Social Solutions Global (SSG), the creator of Efforts to Outcomes (ETO®) software, is the leading provider of outcomes management software for human services, turning good intentions into measurable outcomes while connecting people to social services. ETO equips organizations to drive performance by demonstrating the usefulness of data at all levels, including to the funding community. Contact: Contact: Amy Adkins 1717 Deerfield Road Deerfield, IL 60016 Kimberly.ruehl@siemens.com Kristin Brooks, Event Manager 425 Williams Ct, Suite 100 Baltimore, MD 21220 kbrooks@socialsolutions.com Booth: 300 149 Setting the Standard Annual Training Conference StreeTime Technologies The Ranch at Dove Tree Booth: 432 Booth: 214 We provide high value public safety and program compliance tools for supervision, corrections and addictions treatment markets. StreeTime Technologies designs, manufactures and markets various supervision products that are integrated into ongoing full service solutions to customers. The Ranch at Dove Tree provides detoxification, residential programs (including a specialty collegiate residential program) to individuals seeking help for substance dependency. Contact: John Diamond, VP of Sales 1127 Sport Hill Road Easton, CT 06612 jcdiamond@streetimetechnologies.com Tel: 877-727-7764 Fax: 888-223-6084 www.streetimetechnologies.com The Change Companies Contact: Michelle McCall Sandlin, Marketing and Community Relations Coordinator 1406 County Rd 5800 Lubbock, TX 79403 lsandlin@ranchatdovetree.com Tel: 800-218-6727 www.ranchatdovetree.com Thermo Fisher Scientific Booth: 414 Contact: Thermo Fisher Scientific supplies innovative quality products for drugs of abuse screening and offers system solutions with our MGC240 Bench top analyzer to meet your testing challenges. These assays can be used on a variety of clinical chemistry analyzers. Our MGC240 also provided a data management tool for keeping track of participant’s on-going information. Mike Judnick, Vice President of Justice Services Contact: 5221 Sigstrom Drive Larry Wilkie, Sales Supervisor 46500 Kato Road Fremont, CA 94538 kathy.ruzich@thermofisher.com Tel: 510-979-5000 Fax: 510-979-5002 Booth: 312 TCC is a training, consulting, publishing and multimedia company with an expertise in behavioral change, developing resources to support providers/practitioners in delivering evidence-based solutions. Carson City, NV 89706 mjudnick@changecompanies.net The National Judicial College Booth: 311 The National Judicial College is the nation’s leading provider of judicial education. NJC’s mission is the education – innovation – and advancing justice through judicial education Contact: Ashlei Neufeld, Program Attorney The National Judicial College Judicial College Bldg, MS 358 Reno, NV 89557 neufeld@judges.org Tel: 775-327-8245 Fax: 775-784-1253 judges.org 150 NADCP 21st ANNUAL TRAINING CONFERENCE Total Court Services Booth: 234 Total Court Services provides electronic, alcohol and drug monitoring services for drug courts and other agencies. These programs are either offender pay or self-run programs that are designed to their needs. Contact: Sultana Xhilaj, Office Manager 600 E 11 Mile Rd Royal Oak, MI 48067 sxhilaj@totalcourtservices.com Tel: 888-889-6989 Fax: 877-475-6535 www.totalcourtservices.com NADCP Washington, DC 2015 Treatment Research Institute USDTL Booth: 333 Booth: 338 Treatment Research Institute develops solutions for courts, treatment programs, families, and schools including its web-based RANT® Suite: evidencebased, science-derived tools to improve placement, monitoring, evaluation and outcomes for substanceinvolved offenders. USDTL is a leader in forensic toxicology and pilots the development of objective biomarker assays to effectively use alternative specimens in the analysis of substances of (ab)use. Contact: Salvatore Grasso, Chief Operating Officer 600 Public Ledger Bldg. 150 S. Independence Mall West Philadelphia, PA 19106 sgrasso@tresearch.org Tel: 215-399-0980 Fax: 215-399-0987 www.research.org USDiagnostics Booth: 406 Contact: Meghan Burke, Development Manager-Forensics Testing 1700 S Mount Propect Road Des Plaines, IL 60018 meghan.burke@usdtl.com Tel: 800-235-2367 Fax: 847-375-0775 Wendell’s Booth: 408 Wendell’s has been in business since 1882 and was the originator of the raised center anniversary medallion. Our staff will work with you to produce your own unique medallion. USDiagnostics is a leading provider of instant, on-site drug testing products designed for quick, accurate drug test results. USD provides the best drug testing devices you need at prices that work within your budget. USD drug testing products are engineered to give you the quickest and clearest-reading results available and are easy for clinicians to store, handle and administer. From correctional facilities to courts, staffing to transportation, schools to hospitals, a Fortune 500 company or a small business... USDiagnostics can provide the best on-site testing products to meet your needs. Contact: Contact: Booth: 313 Randy Frizzell, Account Executive 2 Parade Street Huntsville, AL 35806 larissa@usdiagnostics.com www.usdiagnostics.com WDR/Cove Forge BHS/ Bowling Green Brandywine is one of the leading providers of treatment for drug and alcohol addiction in Pennsylvania and have helped thousands of adults and adolescents. Wendy Johnson, Sales 6601 Bunker Lake Blvd NW Ramsey, MN 55303 wjohnson@wendellsinc.com Tel: 800-860-9355 Fax: 800-622-8894 www.wendellsinc.com White Deer Run/Cove Forge/Bowling Green Brandywine Contact: Maureen Wilk, Regional Service Coordinator 220 North Front Street, Suite 4 Philipsburg, PA 16886 mwilk@crchealth.com Tel: 814-861-6198 151 W E L C O M E T O OPTIONS in Alcohol Monitoring SCRAM Remote Breath® SCRAM Continuous Alcohol Monitoring® LOWER LEVEL L H HIGHER LEVEL Alcohol Misuse A Alcohol Dependence & Addiction A • 1st tim time DUI • Public order offenses • Low BAC at time of arrest • Earns reduced monitoring through program compliance Follow us at: scramsystems.com/OPTIONS • 800.557.0861 • Repe Repeat/Hardcore Drunk Drivers • Domestic violence • High BAC at time of arrest • Requires more intensive monitoring after a violation A91DX-9171-A1-4A00. © 2011 Siemens Healthcare Diagnostics Inc. All rights reserved. EMIT, Syva and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc. reserved. Recovery starts with a drug test. With answers from Siemens, drug courts can stop cycles of drug abuse. www.usa.siemens.com/drugtesting Drug court programs have proven remarkably effective at stopping substance abuse and diverting criminal activity to treatment and recovery. Seventy-five percent of graduates remain arrest-free. And for every dollar invested, more than three dollars are saved by the justice system. The Siemens Syva® EMIT® Drug Testing Solution supports drug courts by offering urine drug screening that’s fast, accurate, and defensible in court. In fact, the Syva EMIT assay has the only citation as a defensible technology in a Supreme Court ruling.1 Today, we’re not just helping drug courts be more effective – we’re empowering them to become more self-sufficient. On-site testing combined with data management and reporting eliminates manual, subjective testing methods to improve workflow and efficiency. Instant uploads of test results save time and prevent costly transcription errors. At Siemens, we’ve seen firsthand how drug tests that stand up in court help people stand proud. Visit our website at www.usa.siemens.com/drugtesting to learn how Siemens can support a successful drug rehabilitation program. Answers for life. 1. NationalTreasuryEmployeesUnionv.VonRaab, 109 S.Ct.1384 (1989) His opioid dependence got him here. VIVITROL® (naltrexone for extended-release injectable suspension) is a nonnarcotic, nonaddictive, once-monthly medication indicated for1: Prevention of relapse to opioid dependence, following opioid detoxification Treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL. Patients should not be actively drinking at the time of initial VIVITROL administration VIVITROL should be part of a comprehensive management program that includes psychosocial support For additional Important Safety Information, please see Brief Summary of Prescribing Information on adjacent pages. Now help him get on a path to treatment. Learn more about the only once-monthly FDA-approved medication that when added to counseling may help him prevent relapse to opioid dependence after detoxification.1 Call: 1-617-852-7356 E-mail: GovernmentAffairs@Alkermes.com Important Safety Information Contraindications VIVITROL is contraindicated in patients: Receiving opioid analgesics With current physiologic opioid dependence In acute opioid withdrawal Who have failed the naloxone challenge test or have a positive urine screen for opioids Who have exhibited hypersensitivity to naltrexone, polyactide-co-glycolide (PLG), carboxymethylcellulose, or any other components of the diluent Prior to the initiation of VIVITROL, patients should be opioid-free for a minimum of 7-10 days to avoid precipitation of opioid withdrawal that may be severe enough to require hospitalization. Reference: 1. VIVITROL [prescribing information]. Waltham, MA: Alkermes, Inc; 2013. Visit vivitrol.com to learn more about how VIVITROL can help. VIVITROL® (naltrexone 380 mg/vial Intramuscular for extended-release injectable suspension) The symptoms of spontaneous opioid withdrawal (which are associated with the discontinuation of opioid in a dependent individual) are uncomfortable, but they are not generally believed to be severe or necessitate hospitalization. However, when withdrawal is precipitated abruptly by the administration of an opioid antagonist to BRIEF SUMMARY See package insert for full prescribing information (rev. July 2013). an opioid-dependent patient, the resulting withdrawal syndrome can be severe INDICATIONS AND USAGE: VIVITROL is an opioid antagonist. VIVITROL should be enough to require hospitalization. Review of postmarketing cases of precipitated part of a comprehensive management program that includes psychosocial support. opioid withdrawal in association with naltrexone treatment has identified cases with Opioid-dependent patients, including those being treated for alcohol dependence, symptoms of withdrawal severe enough to require hospital admission, and in some must be opioid-free at the time of initial VIVITROL administration. VIVITROL is cases, management in the intensive care unit. To prevent occurrence of precipitated indicated for the treatment of alcohol dependence in patients who are able to withdrawal in patients dependent on opioids, or exacerbation of a pre-existing abstain from alcohol in an outpatient setting prior to initiation of treatment with subclinical withdrawal syndrome, opioid-dependent patients, including those being VIVITROL. Patients should not be actively drinking at the time of initial VIVITROL treated for alcohol dependence, should be opioid-free (including tramadol) before administration. In addition, VIVITROL is indicated for the prevention of relapse to starting VIVITROL treatment. An opioid-free interval of a minimum of 7–10 days is recommended for patients previously dependent on short-acting opioids. Patients opioid dependence, following opioid detoxification. transitioning from buprenorphine or methadone may be vulnerable to precipitation of CONTRAINDICATIONS: VIVITROL is contraindicated in: patients receiving opioid withdrawal symptoms for as long as two weeks. If a more rapid transition from analgesics, patients with current physiologic opioid dependence, patients in acute agonist to antagonist therapy is deemed necessary and appropriate by the healthcare opioid withdrawal, any individual who has failed the naloxone challenge test or provider, monitor the patient closely in an appropriate medical setting where has a positive urine screen for opioids, and patients who have previously exhibited precipitated withdrawal can be managed. In every case, healthcare providers should hypersensitivity to naltrexone, polylactide-co-glycolide (PLG), carboxymethylcellulose, always be prepared to manage withdrawal symptomatically with non-opioid or any other components of the diluent. medications because there is no completely reliable method for determining whether a patient has had an adequate opioid-free period. A naloxone challenge test may be WARNINGS AND PRECAUTIONS: Vulnerability to Opioid Overdose: After opioid helpful; however, a few case reports have indicated that patients may experience detoxification, patients are likely to have reduced tolerance to opioids. VIVITROL precipitated withdrawal despite having a negative urine toxicology screen or blocks the effects of exogenous opioids for approximately 28 days after tolerating a naloxone challenge test (usually in the setting of transitioning from administration. However, as the blockade wanes and eventually dissipates buprenorphine treatment). Patients should be made aware of the risks associated completely, patients who have been treated with VIVITROL may respond to lower with precipitated withdrawal and encouraged to give an accurate account of last doses of opioids than previously used, just as they would have shortly after opioid use. Patients treated for alcohol dependence with VIVITROL should also be completing detoxification. This could result in potentially life threatening opioid assessed for underlying opioid dependence and for any recent use of opioids prior to intoxication (respiratory compromise or arrest, circulatory collapse, etc.) if the initiation of treatment with VIVITROL. Precipitated opioid withdrawal has been patient uses previously tolerated doses of opioids. Cases of opioid overdose with observed in alcohol-dependent patients in circumstances where the prescriber had fatal outcomes have been reported in patients who used opioids at the end of a been unaware of the additional use of opioids or co-dependence on opioids. dosing interval, after missing a scheduled dose, or after discontinuing treatment. Hepatotoxicity: Cases of hepatitis and clinically significant liver dysfunction were Patients should be alerted that they may be more sensitive to opioids, even at lower observed in association with VIVITROL exposure during the clinical development doses, after VIVITROL treatment is discontinued, especially at the end of a dosing program and in the postmarketing period. Transient, asymptomatic hepatic interval (i.e., near the end of the month that VIVITROL was administered), or after a transaminase elevations were also observed in the clinical trials and postmarketing dose of VIVITROL is missed. It is important that patients inform family members and period. Although patients with clinically significant liver disease were not the people closest to the patient of this increased sensitivity to opioids and the risk systematically studied, clinical trials did include patients with asymptomatic viral of overdose. There is also the possibility that a patient who is treated with VIVITROL hepatitis infections. When patients presented with elevated transaminases, there could overcome the opioid blockade effect of VIVITROL. Although VIVITROL is a potent were often other potential causative or contributory etiologies identified, including antagonist with a prolonged pharmacological effect, the blockade produced by pre-existing alcoholic liver disease, hepatitis B and/or C infection, and concomitant VIVITROL is surmountable. The plasma concentration of exogenous opioids attained usage of other potentially hepatotoxic drugs. Although clinically significant liver immediately following their acute administration may be sufficient to overcome the dysfunction is not typically recognized as a manifestation of opioid withdrawal, competitive receptor blockade. This poses a potential risk to individuals who attempt, opioid withdrawal that is precipitated abruptly may lead to systemic sequelae on their own, to overcome the blockade by administering large amounts of exogenous including acute liver injury. Patients should be warned of the risk of hepatic injury opioids. Any attempt by a patient to overcome the antagonism by taking opioids is and advised to seek medical attention if they experience symptoms of acute especially dangerous and may lead to life-threatening opioid intoxication or fatal hepatitis. Use of VIVITROL should be discontinued in the event of symptoms and/or overdose. Patients should be told of the serious consequences of trying to overcome signs of acute hepatitis. Depression and Suicidality: Alcohol- and opioid-dependent the opioid blockade. Injection Site Reactions: VIVITROL injections may be followed patients, including those taking VIVITROL, should be monitored for the development by pain, tenderness, induration, swelling, erythema, bruising, or pruritus; however, in of depression or suicidal thinking. Families and caregivers of patients being treated some cases injection site reactions may be very severe. In the clinical trials, one with VIVITROL should be alerted to the need to monitor patients for the emergence patient developed an area of induration that continued to enlarge after 4 weeks, with of symptoms of depression or suicidality, and to report such symptoms to the subsequent development of necrotic tissue that required surgical excision. In the patient’s healthcare provider. Alcohol Dependence: In controlled clinical trials of post marketing period, additional cases of injection site reaction with features VIVITROL administered to adults with alcohol dependence, adverse events of a including induration, cellulitis, hematoma, abscess, sterile abscess, and necrosis, suicidal nature (suicidal ideation, suicide attempts, completed suicides) were have been reported. Some cases required surgical intervention, including infrequent overall, but were more common in patients treated with VIVITROL than in debridement of necrotic tissue. Some cases resulted in significant scarring. The patients treated with placebo (1% vs 0). In some cases, the suicidal thoughts or reported cases occurred primarily in female patients. VIVITROL is administered as an behavior occurred after study discontinuation, but were in the context of an episode intramuscular gluteal injection, and inadvertent subcutaneous injection of VIVITROL of depression that began while the patient was on study drug. Two completed may increase the likelihood of severe injection site reactions. The needles provided suicides occurred, both involving patients treated with VIVITROL. Depression-related in the carton are customized needles. VIVITROL must not be injected using any other events associated with premature discontinuation of study drug were also more needle. The needle lengths (either 1.5 inches or 2 inches) may not be adequate in common in patients treated with VIVITROL (~1%) than in placebo-treated patients every patient because of body habitus. Body habitus should be assessed prior to (0). In the 24-week, placebo-controlled pivotal trial in 624 alcohol-dependent each injection for each patient to assure that the proper needle is selected and that patients, adverse events involving depressed mood were reported by 10% of the needle length is adequate for intramuscular administration. Healthcare patients treated with VIVITROL 380 mg, as compared to 5% of patients treated with professionals should ensure that the VIVITROL injection is given correctly, and should placebo injections. Opioid Dependence: In an open-label, long-term safety study consider alternate treatment for those patients whose body habitus precludes an conducted in the US, adverse events of a suicidal nature (depressed mood, suicidal intramuscular gluteal injection with one of the provided needles. Patients should be ideation, suicide attempt) were reported by 5% of opioid-dependent patients treated informed that any concerning injection site reactions should be brought to the with VIVITROL 380 mg (n=101) and 10% of opioid-dependent patients treated with attention of the healthcare professional. Patients exhibiting signs of abscess, oral naltrexone (n=20). In the 24-week, placebo-controlled pivotal trial that was cellulitis, necrosis, or extensive swelling should be evaluated by a physician to conducted in Russia in 250 opioid-dependent patients, adverse events involving determine if referral to a surgeon is warranted. Precipitation of Opioid Withdrawal: depressed mood or suicidal thinking were not reported by any patient in either treatment group (VIVITROL 380 mg or placebo). When Reversal of VIVITROL Blockade Is Required for Pain Management: In an emergency situation in patients receiving VIVITROL, suggestions for pain management include regional analgesia or use of non-opioid analgesics. If opioid therapy is required as part of anesthesia or analgesia, patients should be continuously monitored in an anesthesia care setting by persons not involved in the conduct of the surgical or diagnostic procedure. The opioid therapy must be provided by individuals specifically trained in the use of anesthetic drugs and the management of the respiratory effects of potent opioids, specifically the establishment and maintenance of a patent airway and assisted ventilation. Irrespective of the drug chosen to reverse VIVITROL blockade, the patient should be monitored closely by appropriately trained personnel in a setting equipped and staffed for cardiopulmonary resuscitation. Eosinophilic Pneumonia: In clinical trials with VIVITROL, there was one diagnosed case and one suspected case of eosinophilic pneumonia. Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. Similar cases have been reported in postmarketing use. Should a person receiving VIVITROL develop progressive dyspnea and hypoxemia, the diagnosis of eosinophilic pneumonia should be considered. Patients should be warned of the risk of eosinophilic pneumonia, and advised to seek medical attention should they develop symptoms of pneumonia. Clinicians should consider the possibility of eosinophilic pneumonia in patients who do not respond to antibiotics. Hypersensitivity Reactions Including Anaphylaxis: Cases of urticaria, angioedema, and anaphylaxis have been observed with use of VIVITROL in the clinical trial setting and in postmarketing use. Patients should be warned of the risk of hypersensitivity reactions, including anaphylaxis. In the event of a hypersensitivity reaction, patients should be advised to seek immediate medical attention in a healthcare setting prepared to treat anaphylaxis. The patient should not receive any further treatment with VIVITROL. Intramuscular Injections: As with any intramuscular injection, VIVITROL should be administered with caution to patients with thrombocytopenia or any coagulation disorder (eg, hemophilia and severe hepatic failure). Alcohol Withdrawal: Use of VIVITROL does not eliminate nor diminish alcohol withdrawal symptoms. Interference with Laboratory Tests: VIVITROL may be cross-reactive with certain immunoassay methods for the detection of drugs of abuse (specifically opioids) in urine. For further information, reference to the specific immunoassay instructions is recommended. ADVERSE REACTIONS: Serious adverse reactions that may be associated with VIVITROL therapy in clinical use include: severe injection site reactions, eosinophilic pneumonia, serious allergic reactions, unintended precipitation of opioid withdrawal, accidental opioid overdose and depression and suicidality. The adverse events seen most frequently in association with VIVITROL therapy for alcohol dependence (ie, those occurring in ≥5% and at least twice as frequently with VIVITROL than placebo) include nausea, vomiting, injection site reactions (including induration, pruritus, nodules and swelling), muscle cramps, dizziness or syncope, somnolence or sedation, anorexia, decreased appetite or other appetite disorders. The adverse events seen most frequently in association with VIVITROL therapy in opioid dependent patients (ie, those occurring in ≥ 2% and at least twice as frequently with VIVITROL than placebo) were hepatic enzyme abnormalities, injection site pain, nasopharyngitis, insomnia, and toothache. Clinical Studies Experience: Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. In all controlled and uncontrolled trials during the premarketing development of VIVITROL, more than 1100 patients with alcohol and/or opioid dependence have been treated with VIVITROL. Approximately 700 patients have been treated for 6 months or more, and more than 400 for 1 year or longer. Adverse Events Leading to Discontinuation of Treatment: Alcohol Dependence: In controlled trials of 6 months or less in alcoholdependent patients, 9% of alcohol-dependent patients treated with VIVITROL discontinued treatment due to an adverse event, as compared to 7% of the alcoholdependent patients treated with placebo. Adverse events in the VIVITROL 380-mg group that led to more dropouts than in the placebo-treated group were injection site reactions (3%), nausea (2%), pregnancy (1%), headache (1%), and suicide-related events (0.3%). In the placebo group, 1% of patients withdrew due to injection site reactions, and 0% of patients withdrew due to the other adverse events. Opioid Dependence: In a controlled trial of 6 months, 2% of opioid-dependent patients treated with VIVITROL discontinued treatment due to an adverse event, as compared to 2% of the opioid-dependent patients treated with placebo. DRUG INTERACTIONS: Patients taking VIVITROL may not benefit from opioid-containing medicines. Naltrexone antagonizes the effects of opioid-containing medicines, such as cough and cold remedies, antidiarrheal preparations and opioid analgesics. USE IN SPECIFIC POPULATIONS: Pregnancy: There are no adequate and well-controlled studies of either naltrexone or VIVITROL in pregnant women. VIVITROL should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Pregnancy Category C: Reproduction and developmental studies have not been conducted for VIVITROL. Studies with naltrexone administered via the oral route have been conducted in pregnant rats and rabbits. Teratogenic Effects: Naltrexone has been shown to increase the incidence of early fetal loss when given to rats at doses ≥30 mg/kg/day (11 times the human exposure based on an AUC(0-28d) comparison) and to rabbits at oral doses ≥60 mg/kg/day (2 times the human exposure based on an AUC(0-28d) comparison). There was no evidence of teratogenicity when naltrexone was administered orally to rats and rabbits during the period of major organogenesis at doses up to 200 mg/kg/day (175- and 14-times the human exposure based on an AUC(0-28d) comparison, respectively). Labor and Delivery: The potential effect of VIVITROL on duration of labor and delivery in humans is unknown. Nursing Mothers: Transfer of naltrexone and 6ʹ-naltrexol into human milk has been reported with oral naltrexone. Because of the potential for tumorigenicity shown for naltrexone in animal studies, and because of the potential for serious adverse reactions in nursing infants from VIVITROL, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Pediatric Use: The safety and efficacy of VIVITROL have not been established in the pediatric population. The pharmacokinetics of VIVITROL have not been evaluated in a pediatric population. Geriatric Use: In trials of alcohol-dependent subjects, 2.6% (n=26) of subjects were >65 years of age, and one patient was >75 years of age. Clinical studies of VIVITROL did not include sufficient numbers of subjects age 65 and over to determine whether they respond differently from younger subjects. No subjects over age 65 were included in studies of opioid-dependent subjects. The pharmacokinetics of VIVITROL have not been evaluated in the geriatric population. Renal Impairment: Pharmacokinetics of VIVITROL are not altered in subjects with mild renal insufficiency (creatinine clearance of 50-80 mL/min). Dose adjustment is not required in patients with mild renal impairment. VIVITROL pharmacokinetics have not been evaluated in subjects with moderate and severe renal insufficiency. Because naltrexone and its primary metabolite are excreted primarily in the urine, caution is recommended in administering VIVITROL to patients with moderate to severe renal impairment. Hepatic Impairment: The pharmacokinetics of VIVITROL are not altered in subjects with mild to moderate hepatic impairment (Groups A and B of the Child-Pugh classification). Dose adjustment is not required in subjects with mild or moderate hepatic impairment. VIVITROL pharmacokinetics were not evaluated in subjects with severe hepatic impairment. OVERDOSAGE: There is limited experience with overdose of VIVITROL. Single doses up to 784 mg were administered to 5 healthy subjects. There were no serious or severe adverse events. The most common effects were injection site reactions, nausea, abdominal pain, somnolence, and dizziness. There were no significant increases in hepatic enzymes. In the event of an overdose, appropriate supportive treatment should be initiated. This brief summary is based on VIVITROL Full Prescribing Information (rev. July 2013) ALKERMES and VIVITROL registered trademarks of Alkermes, Alkermes® and VIVITROL® areare registered trademarks of Alkermes, Inc. Inc. ©2015 Alkermes, Inc. Manufactured and marketed by Alkermes, Inc. All rights reserved. VIV-001876 Printed in U.S.A. ©2014 Alkermes, Inc. VIV-001558 January 2014 www.vivitrol.com Printed in U.S.A. All rights reserved. Now Available from BI Incorporated The SOBERLINK SL2 helps offenders stay sober in the community. The SL2 is a sleek, cutting-edge, portable alcohol monitoring device that utilizes cellular and GPS technology. No ankle monitors to wear, no plugging into the wall—just accurate results every time to hold court participants accountable while they proceed through critical treatment. Count on the SL2’s reliability and convenience—make it a designated device when sobriety is on the line. Call 800.876.1105 to add the SL2 as a trusted monitoring option. You are Ignition interlocks save lives Read the words of those whose lives have been forever changed. “ ,W·VQRWWKHDOFRKROLFV RUWKHEDGSHRSOH WKDWWKLVNLQGRIWKLQJ KDSSHQVWR,WLVWKH HYHU\GD\SHRSOH “ “ “ ,ZDVQ·WWKHÀUVWLQ P\IDPLO\WRJUDGXDWH IURPFROOHJH«,ZDV WKHÀUVWLQP\IDPLO\ WRJRWRSULVRQ “ “ Once you’ve consumed \RXUÀUVWGULQN\RX·YH ORVWWKDWDELOLW\WRPDNH DVRXQGMXGJPHQW LEBRATING CE I NT O X A LO C K www.Intoxalock.com/SavingLives 0RUH,QIR#,QWR[DORFNFRP| (888) 283-6148 25371 Commercentre Drive, Suite 140 Lake Forest, CA 92630 714.505.3525 y 866.493.2758 contact_us@cffutures.org www.cffutures.org Children and Family Futures (CFF) is a not-for-profit organization supporting substance abuse treatment, child welfare, courts and the communities they serve since 1996 ł&RQVXOWLQJ łEvaluation ł6WUDWHJLF3ODQQLQJ łTechnical Assistance Real Solutions for Real Problems Electronic and Alcohol Monitoring Services 888.889.6989 www.totalcourtservices.com New screening solutions using Thermo Scientific CEDIA Oral Fluid Immunoassays. New Thermo Scientific CEDIA Oral Fluids Immunoassays are the newest tools available © 2011 Thermo Fisher Scientific Inc. All rights reserved. CEDIA is a registered trademark of Roche Diagnostics. All other trademarks are the property of Thermo Fisher Scientific and its subsidiaries. for drugs of abuse screening and monitoring. The observation of oral fluid collect is noninvasive, so the risk of adulterated samples is significantly minimized. Samples can also be collected during routine field visits or during regular check-ins. The CEDIA® Oral Fluids immunoassays, calibrators and controls have FDA clearance and are based on the reputable CEDIA technology. These new immunoassays offer new options for testing amphetamines, cannabinoids (THC), cocaine, methamphetamines, opiates and PCP. Moving science forward Part of Thermo Fisher Scientific For more information about these or other drugs of abuse testing products, from collection devices to confirmation tools, contact us be email at sales.diagnostics.com or call 1-800-232-3342 or visit our website at www.thermoscientific.com/diagnostics TRULY SECURE TRULY EASY TRULY COMPLIANT TRULY RANDOM AUTOMATED SCHEDULING. Start your free trial today or request a demo at call2test.com or call 888-972-9166. Integrated Management Solutions WinTOX Total Lab Management & Case Management System Fully Integrated Information and Services Drug Courts Judicial Systems Laboratories Probation & Parole Treatment Centers Pain Management Centers Software Innovation You Can Trust Phone: (888) 946-5227 Email: Sales@iMs-Trident.com www.iMs-Trident.com Tracking and Treatment Solutions Solutions for Criminal Justice 1-844-909-8555 www.getemsober.com info@recoveryhealthcare.com web-based VWDIÀQJ reports DQDO\WLFV fast HDV\ UHVXOWV 888.549.9880 www.ACTinnovations.com . Setting the Standard Annual Training Conference Session Tables SKILLS BUILDING WORKSHOPS MONDAY, JULY 27 • 9:00 A.M. – 12:00 P.M. MONDAY, JULY 27 • 2:00 P.M. – 5:00 P.M. SB-1 • Chesapeake ABC SB-17 • Chesapeake ABC Changing Behavior With 24/7 Alcohol Monitoring: NHTSA’s Newest Study on SCRAM Use, Recidivism Rates, and Characteristics Building the Right Team to Support Implementation of VIVITROL® (naltrexone for extended-release injectable suspension) SB-2 • Chesapeake GHI SB-18 • Maryland A Data, Evaluation, and Fidelity to the Model: Best Practices Drug Testing: Best Practices SB-3 • Chesapeake 4-6 SB-19 • Chesapeake GHI Drug Courts in Rural Areas—Our Strengths and Special Challenges Effective Strategies in Juvenile Drug Court SB-4 • National Harbor 2 SB-20 • National Harbor 2 DWI Court Forum DWI Court Forum SB-5 • National Harbor 10 SB-21 • Potomac Ballroom AB Family Drug Court: Best Practices Incentives and Sanctions: Best Practices (Joint NADCP and Vet Court Con Session) SB-6 • Maryland A SB-22 • Chesapeake 4-6 Target Population: Best Practices Other Problem-Solving Courts: Engaging the Community and Helping Victims SB-8 • Maryland 1-3 SB-23 • National Harbor 11 Supervision Case Planning and Recovery Support for Mental Health and Family Drug Courts SB-9 • Maryland B SB-24 • National Harbor 5 Heroin Resurgence and Prescription Opiates: Critical Issues in Diagnosis and Treatment Tribal Nations Forum SB-10 • Maryland C SB-25 • National Harbor 3 Everything You Always Wanted to Know about PTSD, Substance Abuse, and Co-Morbid Disorders: An Expert Answers Your Questions Reentry Court on Steroids SB-11 • Maryland D SB-26 • Maryland C Legal Issues in Adult Drug Court: Best Practices Dos and Don’ts of Becoming a DC Coordinator: Avoiding Pitfalls (Drug Court Coordinator Forum) SB-12 • National Harbor 5 SB-27 • Maryland B A Team Member’s Guide to Effective Drug Court Treatment: The Results are In! Health Care Reform: Understanding and Navigating the Affordable Care Act SB-13 • National Harbor 3 SB-28 • National Harbor 6-7 The Critical Role of the Team: Best Practices Historically Disadvantaged Groups SB-14 • National Harbor 11 SB-29 • National Harbor 10 Judicial Role and Ethics: Best Practices HEAT SB-15 • National Harbor 6-7 SB-30 • National Harbor 4 Grant Information from a Panel of Federal Experts The Dangers of Spice and the Science Behind It SB-16 • National Harbor 4 SB-31 • Maryland 4-6 Seeking Safety Using Technology in Problem-Solving Courts: Strategies for Tuning In and Turning On SB-32 • Maryland D Ancillary Services: Best Practices SB-33 • Maryland 1-3 Gender Matters: Creating Services for Women and Men 164 NADCP 21st ANNUAL TRAINING CONFERENCE A-1 • Maryland D A Team in Action A-2 • National Harbor 11 A Look Inside the Nation’s Family Drug Courts A-3 • National Harbor 13 Seven Habits of Highly Effective Practices When Addressing Adolescent Drug Abuse in Juvenile Drug Courts A-4 • National Harbor 12 Mental Health Courts A-Z A-5 • Chesapeake GHI From Compliance to Alliance: Using Recovery and Procedural Justice Principles to Improve Outcomes in Co-Occurring Disorder Cases A-6 • Chesapeake ABC Race, Culture, Bias, Treatment, and the Courts: Cultural Competency 101 A-7 • Maryland 4-6 Evaluation Challenges and Solutions in Family Drug Courts Track 1 Ready, Set, Go! Fundamentals of Implementing Your Drug Court Track 2 Raising the Bar: Taking Family Dependency Treatment Courts to the Next Level Track 3 Juvenile Drug Courts: Building on Our Success Track 4 Mental Health Courts: From Implementation to Operation Track 5 Participants with Co-Occurring Disorders: Advanced Issues Track 6 Ensuring Cultural Proficiency: More than Just Awareness Track 7 The Facts and Nothing but the Facts: Critical Role of Research 10:15 A.M. – 11:30 A.M. SESSION A TRACKS The Pathway to Minnesota’s Drug Court Expansion: Using Statewide Research as Leverage for Expansion B-7 • Maryland 4-6 What Your Mama Didn’t Teach You (For Men Only) B-6 • Chesapeake ABC Co-Occurring Disorders in Mental Health Courts B-5 • Chesapeake GHI Solving the “Rubik’s Cube” of Mental Health Courts: Effective Strategies for Establishing Statewide Standards Drug Court Peer Review: Implementation Successes and Lessons Learned C-7 • Maryland 4-6 Real Men Wear Pink (For Women Only) C-6 • Chesapeake ABC Enhancing the Continuum of Care and Expanding the Service Population via Assertive Community Treatment in Rural Drug Courts Applying Quality Improvement Principles to Juvenile Drug Courts D-7 • Maryland 4-6 Are You Connected? Collaborating in Communities of Color to Meet the Diverse Needs of Clients D-6 • Chesapeake ABC What Juvenile Drug Courts Need to Know About Providing Effective Treatment for Youth with Co-Occurring Disorders D-5 • Chesapeake GHI How to Successfully Integrate Drug Court Evidence-Based Practices into Your Mental Health Court A Dozen Years, Two Dozen Courts: Lessons from New York’s Mental Health Courts C-5 • Chesapeake GHI D-4 • National Harbor 12 Engaging Family and Community in Juvenile Drug Court and Implications for Policy D-3 • National Harbor 13 Effective Strategies to Support Families Through Reunification D-2 • National Harbor 11 The Brain on Drugs D-1 • Maryland D 3:30 P.M. – 4:45 P.M. SESSION D C-4 • National Harbor 12 Using a Gated Assessment Process to Connect the Right Kid to the Right Intervention Assessing Fidelity to a Logic Model: The National CrossSite Evaluation of JDC/RF Experience B-4 • National Harbor 12 C-3 • National Harbor 13 Comprehensive Services: Lessons from the Prevention and Family Recovery Project C-2 • National Harbor 11 Target Population C-1 • Maryland D 2:00 P.M. – 3:15 P.M. TUESDAY, JULY 28 SESSION C B-3 • National Harbor 13 Collaborative Approaches to Drug Endangered Children B-2 • National Harbor 11 Ten Key Components and the Research B-1 • Maryland D 12:30 P.M. – 1:45 P.M. SESSION B TRAINING TRACKSCONCURRENT WORKSHOP SESSIONS TUESDAY, JULY 28 • 8:00 A.M. – 10:00 A.M. Potomac Ballroom OPENING CEREMONY Programmatic Factors Related to Outcomes in Juvenile Outpatient Treatment: Evaluating the Effectiveness of Juvenile Drug Courts E-7 • Maryland 4-6 Gay Lesbian Bisexual Transgender Intersex (GLBTI): Does it Really Matter in Treatment Courts? E-6 • Chesapeake ABC Trauma Symptom Inventory for Treatment Planning Among Drug Court Participants with Co-Occurring Mental Health Disorders E-5 • Chesapeake GHI Difficult Issues Faced by Mental Health Courts E-4 • National Harbor 12 Mentoring in Juvenile Treatment Drug Courts: Strategies and Tips from Onsite TA and Focus Group Report E-3 • National Harbor 13 Is your FDC Built to Last? The Importance of Real Sustainability Planning E-2 • National Harbor 11 Data, Evaluation and Outcomes: What You Should Collect and Why E-1 • Maryland D 5:00 P.M. – 6:15 P.M. SESSION E NADCP Washington, DC 2015 165 166 C-9 • Maryland C Incentives and Sanctions in Juvenile Drug Court B-9 • Maryland C Fundamentals of Incentives and Sanctions in Adult Drug Court A-9 • Maryland C Critical Role of Risk/Need in Building Incentives and Sanctions A-10 • National Harbor 10 Search and Seizure and the Role of a Probation Officer A-11 • Chesapeake 7-9 Trauma Informed Judicial Decision Making A-12 • National Harbor 3 HEAT Update A-13 • National Harbor 4 Gender Responsive Strategies and Trauma Informed Care in Community Treatment A-14 • National Harbor 6-7 What Does My Drug Test Result Really Tell Me? A-15 • Chesapeake 4-6 Technology in YOUR Court: Learn How Web Based Case Management Can Support Performance Benchmarks and Best Practices Track 9 The Good, the Bad, and the Effective: Incentives and Sanctions Track 10 Supervision: The Challenges Faced by Probation and Law Enforcement NADCP 21st ANNUAL TRAINING CONFERENCE Track 11 Working with the Latino Community: Strategies for Better Outcomes Track 12 African American Clients: Improving Services and Outcomes Track 13 Trauma Track 14 Science and Technology Track 15 Science and Technology Alcohol Monitoring and Testing Technologies: A Primer for New Programs, a Refresher on Policies B-15 • Chesapeake 4-6 Target 25: Pennsylvania’s Nationally Recognized DUI Reduction Initiative B-14 • National Harbor 6-7 Implementing Trauma-Informed Care Principles into Your Program B-13 • National Harbor 4 From the Needle to the Pen: Telling it Like it is! – Addicted to Drugs or Addicted to the Lifestyle B-12 • National Harbor 3 Cultural Proficiency with Latinos in Drug Court Practice B-11 • Chesapeake 7-9 The Smoking Gun: The Role of Law Enforcement and Ethical Issues in a Drug Court Setting B-10 • National Harbor 10 Alcohol Improve Outcomes by Integrating On-site Drug Testing: A Collaborative Approach C-15 • Chesapeake 4-6 Making Evidence-Based Decisions: Using Technology to Assess People, Cases, and Outcomes C-14 • National Harbor 6-7 Vicarious Trauma and Vicarious Posttraumatic Growth Among Service Providers in ProblemSolving Courts The Ultimate Chain of Custody Machine D-15 • Chesapeake 4-6 Stone County, Missouri: 5 years of Implementing VIVITROL® (naltrexone for extendedrelease injectable suspension) in their Specialty Courts D-14 • National Harbor 6-7 Creating a Trauma Informed Juvenile Drug Court D-13 • National Harbor 4 From Boyz to Men: Saving Our Young African American Males from the Streets and from Themselves What’s in it for me? Attracting African Americans to Drug Court C-13 • National Harbor 4 D-12 • National Harbor 3 Homophobia and Transphobia with Hispanic LGBTQ Participants D-11 • Chesapeake 7-9 CBT for LEO (Part 1) D-10 • National Harbor 10 Incentives and Sanctions in Family Drug Court D-9 • Maryland C Marijuana D-8 • Maryland A 3:30 P.M. – 4:45 P.M. SESSION D C-12 • National Harbor 3 Immigration Consequences of Criminal Conduct: How Drug Courts Can Help C-11 • Chesapeake 7-9 Role of Probation in the Drug Court: Best Practices C-10 • National Harbor 10 Designer Drugs 101 C-8 • Maryland A Cocaine B-8 • Maryland A Keeping Ahead of the Curve: Drugs of Choice 2:00 P.M. – 3:15 P.M. A-8 • Maryland A 12:30 P.M. – 1:45 P.M. Track 8 10:15 A.M. – 11:30 A.M. TUESDAY, JULY 28 SESSION C SESSION A TRACKS SESSION B TRAINING TRACKSCONCURRENT WORKSHOP SESSIONS Addiction, Personality Disorders, and Trauma E-13 • National Harbor 4 African Americans and Mental Health E-12 • National Harbor 3 Serving the Needs of Latino Population in a FDC E-11 • Chesapeake 7-9 CBT for Probation Officers (Part 2) E-10 • National Harbor 10 Behavior Modification and the Seriously Mentally Ill or Functionally Impaired: Special Issues to Consider E-9 • Maryland C Methamphetamine E-8 • Maryland A 5:00 P.M. – 6:15 P.M. SESSION E Setting the Standard Annual Training Conference A-16 • Chesapeake 10-12 The 10 Guiding Principles of DWI Courts A-17 • Maryland 1-3 Keeping Kids Safely at Home: A Discussion on Legal Issues in an In-Home FDC Model A-18 • National Harbor 2 The new ASAM Criteria: Implications for Drug Courts and Treatment Providers A-19 • National Harbor 5 Working Effectively with Native Participants A-20 • Maryland B Five Ways to Wreck Your Career: Ethics for Treatment Providers A-21 • Chesapeake JKL Building Bridges between Drug Treatment Courts and the Addiction Recovery Community A-22 • Chesapeake DE Matrix Model for Criminal Justice Settings Track 16 DWI Courts Track 17 Legal Issues In and Beyond Problem-Solving Courts Track 18 Advanced Issues in Drug and Alcohol Treatment Track 19 Learning from Native Traditions: Tribal Healing to Wellness Courts Track 20 Legal and Ethical Issues in Problem-Solving Courts Track 21 Advocacy Track 22 Taking Your Drug Court to the Next Level 10:15 A.M. – 11:30 A.M. SESSION A TRACKS Is “Fair Treatment” an Evidence-Based Practice? How to Measure the Presence and Effects of Procedural Justice B-22 • Chesapeake DE Bring Drug Court to Your State Legislators B-21 • Chesapeake JKL The Zealous Advocate B-20 • Maryland B Tribal Youth Wellness: Responses to Underage Drinking Among Native Youth B-19 • National Harbor 5 Unique Aspects of Behavioral Healthcare in Drug Treatment Courts Alcoholics Anonymous: How We Cooperate with Courts and the Legal Community C-22 • Chesapeake DE The A, B, Cs of Meeting with Your Members of Congress C-21 • Chesapeake JKL Guess What? You’re a Family Court, Too (if your Clients have Children)— Legal Issues and Practical Considerations When Working with Families in Drug Courts C-20 • Maryland B Honoring Our Children by Honoring Our Traditions C-19 • National Harbor 5 The Urgency of Hepatitis C in Drug Treatment C-18 • National Harbor 2 Felony Deferred Prosecution: A Court Monitored Alternative to Traditional Prosecution for Low Risk/Low Need Offenders Indian Country Legal Implications B-18 • National Harbor 2 C-17 • Maryland 1-3 Research Says… Best Practices in Assessment, Management, and Treatment of Impaired Drivers C-16 • Chesapeake 10-12 2:00 P.M. – 3:15 P.M. TUESDAY, JULY 28 SESSION C B-17 • Maryland 1-3 The Computerized Assessment and Referral System (CARS) — Identifying Mental Health Disorders Among DUI Offenders B-16 • Chesapeake 10-12 12:30 P.M. – 1:45 P.M. SESSION B Innovative Use of Recovery Coaching to Improve Community Re-Integration for Drug Court Participants D-22 • Chesapeake DE Raise Your Voice: How to be an Effective Advocate for your Drug Court D-21 • Chesapeake JKL The Proactive Prosecutor D-20 • Maryland B Enablement Prevention Program D-19 • National Harbor 5 Improving Drug Court Outcomes for Young Adult Offenders D-18 • National Harbor 2 Immigration Consequences of Criminal Conduct: How Drug Courts Can Help D-17 • Maryland 1-3 DWI Court Research and Best Practices: What’s the Latest Evidence? D-16 • Chesapeake 10-12 3:30 P.M. – 4:45 P.M. SESSION D TRAINING TRACKSCONCURRENT WORKSHOP SESSIONS 5:00 P.M. – 6:15 P.M. Building Effective Interventions for Young Adults in Adult Drug Courts E-22 • Chesapeake DE Taking Your State Association to the Next Level E-21 • Chesapeake JKL Identifying Federal Firearm Prohibitions in Drug Courts E-20 • Maryland B Juvenile and Family Healing to Wellness Courts E-19 • National Harbor 5 The Importance of Universal Precautions: Effects of Trauma and Health Literacy on Health Outcomes in Drug Court E-18 • National Harbor 2 Search and Seizure: Overview of the Law E-17 • Maryland 1-3 Judicial Leadership and Strong Treatment Voice and Response E-16 • Chesapeake 10-12 SESSION E NADCP Washington, DC 2015 167 Setting the Standard Annual Training Conference CAPITOL HILL DAY KICK OFF WEDNESDAY, JULY 29 • 8:00 A.M. – 9:00 A.M. Potomac Ballroom CONCURRENT GENERAL SESSIONS WEDNESDAY, JULY 29 9:30 A.M. – 10:45 A.M. WEDNESDAY, JULY 29 11:00 A.M. – 12:15 P.M. CG-1 • National Harbor 11 CG-2 • National Harbor 12-13 CG-9 • Chesapeake 10-12 Matching Service to Need: Exploring What “High Risk/High Need” Means for FDCs Revisiting Phases: Risk Matters Collaborative Justice in All Treatment Crossover Youth: The Power of Courts: The PD and the Prosecutor: Treatment Courts to Impact the An Unlikely Couple (Joint NADCP and School to Prison Pipeline Vet Court Con Session) CG -3 • National Harbor 2-3 CG-4 • National Harbor 4-5 CG-11 • National Harbor 4-5 CG-12 • Maryland C Impacts on Health Care Reform for Offender Populations: What Works to Enhance Collaboration Ethics for Judges Criminal Justice Reform and Drug Courts Dilute Urine Samples: Court’s Response to Low Creatinine Specimens CG-5 • National Harbor 10 CG-6 • Maryland C CG-13 • National Harbor 2-3 CG-14 • Maryland D Confidentiality Designer Drugs: What Drug Court Practitioners Need to Know Role of Law Enforcement in Drug Court The New ASAM Criteria: Implications for Drug Courts CG-7 • Maryland A CG-8 • Maryland D CG-15 • Maryland A CG-16 • National Harbor 11 Prescription Drug Abuse Screening and Treatment, and Dealing with Chronic Pain without use of Narcotics: A Judge’s Guide Are All Drug Courts Collecting Reliable and Valid Data to Examine Potential Racial or Ethnic Disparities in Their Programs? Medically Assisted Treatment Legal Eagle WEDNESDAY, JULY 29 2:00 P.M. – 3:15 P.M. CG-10 • National Harbor 10 WEDNESDAY, JULY 29 3:30 P.M. – 4:45 P.M. CG-17 • National Harbor 11 CG-18 • National Harbor 12-13 CG-25 • Chesapeake 10-12 CG-26 • National Harbor 10 Matching Service to Need: Exploring What “High Risk/High Need” Means for FDCs Revisiting Phases: Risk Matters Collaborative Justice in All Treatment Crossover Youth: The Power of Courts: The PD and the Prosecutor: Treatment Courts to Impact the An Unlikely Couple (Joint NADCP and School to Prison Pipeline Vet Court Con Session) CG -19 • National Harbor 2-3 CG-20 • National Harbor 4-5 CG-27 • National Harbor 4-5 CG-28 • Maryland C Impacts on Health Care Reform for Offender Populations: What Works to Enhance Collaboration Ethics for Judges Criminal Justice Reform and Drug Courts Dilute Urine Samples: Court’s Response to Low Creatinine Specimens CG-21 • National Harbor 10 CG-22 • Maryland C CG-29 • National Harbor 2-3 CG-30 • Maryland A Confidentiality Designer Drugs: What Drug Court Practitioners Need to Know Role of Law Enforcement in Drug Court The New ASAM Criteria: Implications for Drug Courts CG-23 • Maryland D CG-24 • Maryland A CG-31 • Maryland D CG-32 • National Harbor 11 Prescription Drug Abuse Screening and Treatment, and Dealing with Chronic Pain without use of Narcotics: A Judge’s Guide Are All Drug Courts Collecting Reliable and Valid Data to Examine Potential Racial or Ethnic Disparities in Their Programs? Medically Assisted Treatment Legal Eagle GENERAL SESSION: Adult Drug Court Best Practice Standards THURSDAY, JULY 30 • 8:30 A.M. – 10:00 A.M. Potomac Ballroom NADCP/VET COURT CON CLOSING CEREMONY THURSDAY, JULY 30 • 10:30 A.M. – 12:30 P.M. Potomac Ballroom 168 NADCP 21st ANNUAL TRAINING CONFERENCE 22nd Annual Tr aining Conference Anaheim, CA Anaheim Convention Center June 1-4, 2016 Prince George’s Exhibit Hall CONVENTION CENTER / LEVEL 1 Prince George’s Exhibition Hall Drug Court Expo A B C D E Covered Terrace To Hotel, Restaurants and Retail Maryland and Potomac Ballrooms and Chesapeake Conference Rooms CONVENTION CENTER / LEVEL 2 L 6 K J 12 11 10 Chesapeake Conference Rooms 5 4 B D I H G 9 8 7 F E D 6 5 4 6 B D Maryland Ballroom Stage 4 Potomac Ballroom 3 2 5 3 A C C B A 1 2 3 A C 2 1 1 Escalators To Hotel Ballr oom Level Baltimore, Annapolis, Magnolia, and Woodrow Wilson Rooms National Harbor Conference Rooms CONVENTION CENTER | LEVEL 3 15 14 Maryland Ballroom Ceiling 8 7 6 13 12 5 4 11 10 3 2 9 National Harbor Conference Rooms 1 Escalators Potomac Ballroom Ceiling
Source Exif Data:
File Type : PDF File Type Extension : pdf MIME Type : application/pdf PDF Version : 1.6 Linearized : Yes XMP Toolkit : Adobe XMP Core 5.2-c001 63.139439, 2010/09/27-13:37:26 Producer : Acrobat Distiller 10.1.7 (Macintosh) Modify Date : 2015:06:30 21:52:54-04:00 Create Date : 2015:06:30 21:32:49-04:00 Metadata Date : 2015:06:30 21:52:54-04:00 Format : application/pdf Title : untitled Document ID : uuid:96ddf508-eee8-2243-96c4-c663f6f291bb Instance ID : uuid:ab699522-8987-084e-b7b7-8c7b89dd26b5 Page Count : 174EXIF Metadata provided by EXIF.tools